FantasyX personal page - To The Moon

FantasyX

FantasyX

No personal profile

116Follow

2Followers

0Topic

0Badge

2021-08-26

Hi

5 Stocks To Watch For August 26, 2021

2021-08-16

Nice

Sorry, the original content has been removed

2021-07-22

Wow

Delta Variant Can Still Clip U.S. Economy’s Wings

2021-08-03

Woe

August is among the worst months of year for the stock market. Here's how to play it.

2021-08-30

Ho

Sorry, the original content has been removed

2021-08-27

Mive

Wall Street loses ground, snapping rally on Afghanistan, Fed concerns

2021-08-17

Hi

Sorry, the original content has been removed

2021-08-09

Nice

Crypto sector stocks rose in premarket trading,BTCM shares jumped more than 30%,BITF surged more than 20%.

2021-08-05

Hi

Stocks open slightly higher after fall in jobless claims

2021-08-25

Hi

Sorry, the original content has been removed

2021-08-09

Nice

Sorry, the original content has been removed

2021-07-29

Ni e

Sorry, the original content has been removed

2021-08-15

Ok

Why 6 DoorDash Analysts Are Raising Price Targets After Q2 Earnings

2021-08-10

Hi

Sorry, the original content has been removed

2021-08-02

Hi

Can Last Year's Biggest Vaccine Stocks Crush the Market Again?

2021-08-24

Hi

What Jackson Hole Could Mean For Apple Stock

2021-08-04

Wow

Can You Retire a Millionaire With ETFs Alone?

2021-07-27

Wiw

Stock Split Watch: Is Amazon Next?

2021-07-23

Nice

Is It Too Late to Buy Moderna Stock?

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":3581492791156392,"uuid":"3581492791156392","gmtCreate":1618399598199,"gmtModify":1626584756234,"name":"FantasyX","pinyin":"fantasyx","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/d5be60dde27e883d6f8b569b3afe2f3f","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":2,"headSize":116,"tweetSize":34,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.01.10","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":9988518494,"gmtCreate":1666785905818,"gmtModify":1676537805898,"author":{"id":"3581492791156392","authorId":"3581492791156392","name":"FantasyX","avatar":"https://static.tigerbbs.com/d5be60dde27e883d6f8b569b3afe2f3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/AAPL\">$Apple(AAPL)$</a>","listText":"<a href=\"https://ttm.financial/S/AAPL\">$Apple(AAPL)$</a>","text":"$Apple(AAPL)$","images":[{"img":"https://community-static.tradeup.com/news/198fd190c92da4f742ff2edfab7f7cfc","width":"1080","height":"1782"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9988518494","isVote":1,"tweetType":1,"viewCount":20,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":811806284,"gmtCreate":1630304774548,"gmtModify":1676530262622,"author":{"id":"3581492791156392","authorId":"3581492791156392","name":"FantasyX","avatar":"https://static.tigerbbs.com/d5be60dde27e883d6f8b569b3afe2f3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Ho","listText":"Ho","text":"Ho","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/811806284","repostId":"2163776380","repostType":4,"isVote":1,"tweetType":1,"viewCount":263,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":819191431,"gmtCreate":1630040786423,"gmtModify":1676530208375,"author":{"id":"3581492791156392","authorId":"3581492791156392","name":"FantasyX","avatar":"https://static.tigerbbs.com/d5be60dde27e883d6f8b569b3afe2f3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Mive","listText":"Mive","text":"Mive","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/819191431","repostId":"2162847016","repostType":4,"repost":{"id":"2162847016","pubTimestamp":1630008724,"share":"https://www.laohu8.com/m/news/2162847016?lang=&edition=full","pubTime":"2021-08-27 04:12","market":"us","language":"en","title":"Wall Street loses ground, snapping rally on Afghanistan, Fed concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=2162847016","media":"Reuters","summary":"NEW YORK, Aug 26 (Reuters) - Wall Street closed lower on Thursday, ending a streak of all-time closi","content":"<p>NEW YORK, Aug 26 (Reuters) - Wall Street closed lower on Thursday, ending a streak of all-time closing highs on concerns over developments in Afghanistan, while fears of a potential shift in U.S. Federal Reserve policy prompted a broad but shallow sell-off the day before the Jackson Hole Symposium.</p>\n<p>All three major U.S. stock indexes ended the session in the red, with the S&amp;P and the Nasdaq notching their first down day in six.</p>\n<p>The sell-off firmed after hawkish commentary from Dallas Fed President Robert Kaplan and a blast outside the Kabul airport in Afghanistan helped strengthen the risk-off sentiment.</p>\n<p>Kaplan, who is not currently a voting member of the Federal Open Markets Committee, said he believes the progress of economic recovery warrants tapering of the Fed's asset purchases to commence in October or shortly thereafter.</p>\n<p>Kaplan's remarks followed earlier comments from the St. Louis Fed President James Bullard, who said that the central bank is \"coalescing\" around a plan to begin tapering process.</p>\n<p>\"(Kaplan’s statements) caused a little confusion about the taper timeline, but in my opinion the equity markets are focused on geopolitical issues,\" said Megan Horneman, director of portfolio strategy at Verdence Capital Advisors in Hunt Valley, Maryland. \"There’s a flight to safety during geopolitical tensions.\"</p>\n<p>\"I am surprised the market the market hasn’t fallen more, given the fear that it could take focus away from (U.S. President Joe Biden's) domestic agenda,\" Horneman added.</p>\n<p>The economy grew at a slightly faster pace than originally reported in the second quarter, fully recovering its losses from the most abrupt downturn in U.S. history, according to the Commerce Department. But jobless claims, though still on a downward trajectory, ticked higher last week.</p>\n<p>The data did little to move the needle with respect to expectations that the Fed is unlikely tip its hand regarding the taper timeline when Chairman Jerome Powell unmutes and delivers his speech at Friday's virtual Jackson Hole Symposium.</p>\n<p>\"We’re going to see a lot of market participants analyze every word (Powell) uses, but at the end of the day, they will begin tapering,\" Horneman said. \"I’m more concerned about the speed at which they taper. What are they going to start with? That will give us a clearer indication as whether they’re getting more hawkish.\"</p>\n<p>The Dow Jones Industrial Average fell 192.38 points, or 0.54%, to 35,213.12, the S&amp;P 500 lost 26.19 points, or 0.58%, to 4,470 and the Nasdaq Composite dropped 96.05 points, or 0.64%, to 14,945.81.</p>\n<p>Of the 11 major sectors in the S&amp;P 500, all but real estate ended the session lower, with energy stocks suffering the steepest percentage loss.</p>\n<p>Discount retailers Dollar General Corp and Dollar Tree Inc slid 3.8% and 12.1%, respectively, after warning higher transportation costs will hurt their bottom lines.</p>\n<p>Coty Inc jumped 14.7% after the cosmetics firm said it expects to post full-year sales growth for the first time in three years.</p>\n<p>Salesforce.com Inc hiked its earnings forecast as the shift to a hybrid work model is expected to fuel strong demand. Its shares advanced 2.7%.</p>\n<p>NetApp Inc jumped 4.7% as brokerages raised their price targets in the wake of the cloud computing firm's better-than-expected 2022 earnings outlook.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 2.99-to-1 ratio; on Nasdaq, a 1.83-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 31 new 52-week highs and two new lows; the Nasdaq Composite recorded 82 new highs and 39 new lows.</p>\n<p>Volume on U.S. exchanges was 8.27 billion shares, compared with the 8.96 billion average over the last 20 trading days. (Reporting by Stephen Culp; Additional reporting by Devik Jain in Bengaluru Editing by Marguerita Choy)</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street loses ground, snapping rally on Afghanistan, Fed concerns</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street loses ground, snapping rally on Afghanistan, Fed concerns\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-27 04:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/us-stocks-wall-street-loses-201204459.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>NEW YORK, Aug 26 (Reuters) - Wall Street closed lower on Thursday, ending a streak of all-time closing highs on concerns over developments in Afghanistan, while fears of a potential shift in U.S. ...</p>\n\n<a href=\"https://finance.yahoo.com/news/us-stocks-wall-street-loses-201204459.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF",".SPX":"S&P 500 Index","OEX":"标普100","COMP":"Compass, Inc.","OEF":"标普100指数ETF-iShares","UPRO":"三倍做多标普500ETF","IVV":"标普500指数ETF","SH":"标普500反向ETF","SSO":"两倍做多标普500ETF","SPXU":"三倍做空标普500ETF","SDS":"两倍做空标普500ETF"},"source_url":"https://finance.yahoo.com/news/us-stocks-wall-street-loses-201204459.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2162847016","content_text":"NEW YORK, Aug 26 (Reuters) - Wall Street closed lower on Thursday, ending a streak of all-time closing highs on concerns over developments in Afghanistan, while fears of a potential shift in U.S. Federal Reserve policy prompted a broad but shallow sell-off the day before the Jackson Hole Symposium.\nAll three major U.S. stock indexes ended the session in the red, with the S&P and the Nasdaq notching their first down day in six.\nThe sell-off firmed after hawkish commentary from Dallas Fed President Robert Kaplan and a blast outside the Kabul airport in Afghanistan helped strengthen the risk-off sentiment.\nKaplan, who is not currently a voting member of the Federal Open Markets Committee, said he believes the progress of economic recovery warrants tapering of the Fed's asset purchases to commence in October or shortly thereafter.\nKaplan's remarks followed earlier comments from the St. Louis Fed President James Bullard, who said that the central bank is \"coalescing\" around a plan to begin tapering process.\n\"(Kaplan’s statements) caused a little confusion about the taper timeline, but in my opinion the equity markets are focused on geopolitical issues,\" said Megan Horneman, director of portfolio strategy at Verdence Capital Advisors in Hunt Valley, Maryland. \"There’s a flight to safety during geopolitical tensions.\"\n\"I am surprised the market the market hasn’t fallen more, given the fear that it could take focus away from (U.S. President Joe Biden's) domestic agenda,\" Horneman added.\nThe economy grew at a slightly faster pace than originally reported in the second quarter, fully recovering its losses from the most abrupt downturn in U.S. history, according to the Commerce Department. But jobless claims, though still on a downward trajectory, ticked higher last week.\nThe data did little to move the needle with respect to expectations that the Fed is unlikely tip its hand regarding the taper timeline when Chairman Jerome Powell unmutes and delivers his speech at Friday's virtual Jackson Hole Symposium.\n\"We’re going to see a lot of market participants analyze every word (Powell) uses, but at the end of the day, they will begin tapering,\" Horneman said. \"I’m more concerned about the speed at which they taper. What are they going to start with? That will give us a clearer indication as whether they’re getting more hawkish.\"\nThe Dow Jones Industrial Average fell 192.38 points, or 0.54%, to 35,213.12, the S&P 500 lost 26.19 points, or 0.58%, to 4,470 and the Nasdaq Composite dropped 96.05 points, or 0.64%, to 14,945.81.\nOf the 11 major sectors in the S&P 500, all but real estate ended the session lower, with energy stocks suffering the steepest percentage loss.\nDiscount retailers Dollar General Corp and Dollar Tree Inc slid 3.8% and 12.1%, respectively, after warning higher transportation costs will hurt their bottom lines.\nCoty Inc jumped 14.7% after the cosmetics firm said it expects to post full-year sales growth for the first time in three years.\nSalesforce.com Inc hiked its earnings forecast as the shift to a hybrid work model is expected to fuel strong demand. Its shares advanced 2.7%.\nNetApp Inc jumped 4.7% as brokerages raised their price targets in the wake of the cloud computing firm's better-than-expected 2022 earnings outlook.\nDeclining issues outnumbered advancing ones on the NYSE by a 2.99-to-1 ratio; on Nasdaq, a 1.83-to-1 ratio favored decliners.\nThe S&P 500 posted 31 new 52-week highs and two new lows; the Nasdaq Composite recorded 82 new highs and 39 new lows.\nVolume on U.S. exchanges was 8.27 billion shares, compared with the 8.96 billion average over the last 20 trading days. (Reporting by Stephen Culp; Additional reporting by Devik Jain in Bengaluru Editing by Marguerita Choy)","news_type":1},"isVote":1,"tweetType":1,"viewCount":131,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":810626892,"gmtCreate":1629973702016,"gmtModify":1676530188636,"author":{"id":"3581492791156392","authorId":"3581492791156392","name":"FantasyX","avatar":"https://static.tigerbbs.com/d5be60dde27e883d6f8b569b3afe2f3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/810626892","repostId":"2162060923","repostType":4,"repost":{"id":"2162060923","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1629971488,"share":"https://www.laohu8.com/m/news/2162060923?lang=&edition=full","pubTime":"2021-08-26 17:51","market":"us","language":"en","title":"5 Stocks To Watch For August 26, 2021","url":"https://stock-news.laohu8.com/highlight/detail?id=2162060923","media":"Benzinga","summary":"Some of the stocks that may grab investor focus today are:\n\tWall Street expects  Dollar General Corp. (NYSE: DG) to report quarterly earnings at $2.57 per share on revenue of $8.59 billion before the opening bell. Dollar General shares rose 0.1% to $235.01 in after-hours trading.\n","content":"<p>Some of the stocks that may grab investor focus today are:</p>\n<ul>\n <li>Wall Street expects<b> <a href=\"https://laohu8.com/S/DG\">Dollar General</a> Corp.</b> (NYSE:DG) to report quarterly earnings at $2.57 per share on revenue of $8.59 billion before the opening bell. Dollar <a href=\"https://laohu8.com/S/BGC\">General</a> shares rose 0.1% to $235.01 in after-hours trading.</li>\n <li><b><a href=\"https://laohu8.com/S/CRM\">Salesforce.com</a> </b>(NYSE:CRM) reported better-than-expected results for its second quarter and boosted its FY22 guidance. <a href=\"https://laohu8.com/S/CRM\">Salesforce</a> shares gained 1.8% to $265.50 in the after-hours trading session.</li>\n <li>Analysts are expecting <b><a href=\"https://laohu8.com/S/HPQ\">HP Inc</a></b> (NYSE:HPQ) to have earned $0.84 per share on revenue of $15.91 billion for the latest quarter. The company will release earnings after the markets close. HP shares gained 0.8% to $29.63 in after-hours trading.</li>\n</ul>\n<ul>\n <li><b><a href=\"https://laohu8.com/S/WSM\">Williams-Sonoma</a>, Inc.</b> (NYSE:WSM) reported upbeat results for its second quarter. The company announced a $1.25 billion buyback and also raised its dividend from $0.59 to $0.71 per share. <a href=\"https://laohu8.com/S/WMB\">Williams</a>-Sonoma shares jumped 12.7% to $192.35 in the after-hours trading session.</li>\n <li>Analysts expect <b><a href=\"https://laohu8.com/S/DLTR\">Dollar Tree, Inc.</a></b> (NASDAQ:DLTR) to report quarterly earnings at $1.01 per share on revenue of $6.44 billion before the opening bell. <a href=\"https://laohu8.com/S/DLTR\">Dollar Tree</a> shares rose 1.6% to $108.02 in after-hours trading.</li>\n</ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Stocks To Watch For August 26, 2021</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Stocks To Watch For August 26, 2021\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-08-26 17:51</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Some of the stocks that may grab investor focus today are:</p>\n<ul>\n <li>Wall Street expects<b> <a href=\"https://laohu8.com/S/DG\">Dollar General</a> Corp.</b> (NYSE:DG) to report quarterly earnings at $2.57 per share on revenue of $8.59 billion before the opening bell. Dollar <a href=\"https://laohu8.com/S/BGC\">General</a> shares rose 0.1% to $235.01 in after-hours trading.</li>\n <li><b><a href=\"https://laohu8.com/S/CRM\">Salesforce.com</a> </b>(NYSE:CRM) reported better-than-expected results for its second quarter and boosted its FY22 guidance. <a href=\"https://laohu8.com/S/CRM\">Salesforce</a> shares gained 1.8% to $265.50 in the after-hours trading session.</li>\n <li>Analysts are expecting <b><a href=\"https://laohu8.com/S/HPQ\">HP Inc</a></b> (NYSE:HPQ) to have earned $0.84 per share on revenue of $15.91 billion for the latest quarter. The company will release earnings after the markets close. HP shares gained 0.8% to $29.63 in after-hours trading.</li>\n</ul>\n<ul>\n <li><b><a href=\"https://laohu8.com/S/WSM\">Williams-Sonoma</a>, Inc.</b> (NYSE:WSM) reported upbeat results for its second quarter. The company announced a $1.25 billion buyback and also raised its dividend from $0.59 to $0.71 per share. <a href=\"https://laohu8.com/S/WMB\">Williams</a>-Sonoma shares jumped 12.7% to $192.35 in the after-hours trading session.</li>\n <li>Analysts expect <b><a href=\"https://laohu8.com/S/DLTR\">Dollar Tree, Inc.</a></b> (NASDAQ:DLTR) to report quarterly earnings at $1.01 per share on revenue of $6.44 billion before the opening bell. <a href=\"https://laohu8.com/S/DLTR\">Dollar Tree</a> shares rose 1.6% to $108.02 in after-hours trading.</li>\n</ul>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"WSM":"Williams-Sonoma Inc","DG":"美国达乐公司","CRM":"赛富时","DLTR":"美元树公司"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2162060923","content_text":"Some of the stocks that may grab investor focus today are:\n\nWall Street expects Dollar General Corp. (NYSE:DG) to report quarterly earnings at $2.57 per share on revenue of $8.59 billion before the opening bell. Dollar General shares rose 0.1% to $235.01 in after-hours trading.\nSalesforce.com (NYSE:CRM) reported better-than-expected results for its second quarter and boosted its FY22 guidance. Salesforce shares gained 1.8% to $265.50 in the after-hours trading session.\nAnalysts are expecting HP Inc (NYSE:HPQ) to have earned $0.84 per share on revenue of $15.91 billion for the latest quarter. The company will release earnings after the markets close. HP shares gained 0.8% to $29.63 in after-hours trading.\n\n\nWilliams-Sonoma, Inc. (NYSE:WSM) reported upbeat results for its second quarter. The company announced a $1.25 billion buyback and also raised its dividend from $0.59 to $0.71 per share. Williams-Sonoma shares jumped 12.7% to $192.35 in the after-hours trading session.\nAnalysts expect Dollar Tree, Inc. (NASDAQ:DLTR) to report quarterly earnings at $1.01 per share on revenue of $6.44 billion before the opening bell. Dollar Tree shares rose 1.6% to $108.02 in after-hours trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":111,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":837270728,"gmtCreate":1629897397664,"gmtModify":1676530165389,"author":{"id":"3581492791156392","authorId":"3581492791156392","name":"FantasyX","avatar":"https://static.tigerbbs.com/d5be60dde27e883d6f8b569b3afe2f3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/837270728","repostId":"1153815600","repostType":4,"repost":{"id":"1153815600","pubTimestamp":1629895634,"share":"https://www.laohu8.com/m/news/1153815600?lang=&edition=full","pubTime":"2021-08-25 20:47","market":"us","language":"en","title":"Regulators Scrutinize a Robinhood Marketing Ploy: Free Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1153815600","media":"The Wall Street Journal","summary":"Online broker faces backlash from companies, scrutiny from regulators over cost of delivering proxy ","content":"<p>Online broker faces backlash from companies, scrutiny from regulators over cost of delivering proxy materials to millions of new shareholders</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/45c924f22b0ab0dff555780a1ad7754b\" tg-width=\"860\" tg-height=\"573\" width=\"100%\" height=\"auto\"><span>Robinhood started trading on the Nasdaq stock exchange on July 29.</span></p>\n<p>WASHINGTON—Robinhood MarketsInc.&nbsp;has for years given customers a free share of stock for opening an account or referring friends. The practice could soon cost the online brokerage a lot more money.</p>\n<p>Brokerages like Robinhood are required to deliver proxy materials to a public company’s shareholders ahead of annual meetings. They are then reimbursed by the public company for the cost of distribution.</p>\n<p>This means that Robinhood’s stock giveaways have saddled some companies with larger bills for delivering proxy statements. Now, the practice is sparking a backlash from companies and scrutiny from market regulators.</p>\n<p>One company pushing back is Florida-based drugmaker&nbsp;Catalyst Pharmaceuticals&nbsp;Inc.,which says Robinhood’s program cost it more than $200,000 last year and could be even more expensive this year.</p>\n<p>“Catalyst has become aware that Robinhood has been giving away shares of Catalyst’s common stock at no charge as part of its promotional program,” Catalyst Chief Executive Patrick McEnany wrote in a June comment letter to the Securities and Exchange Commission. “Catalyst believes that there are likely numerous companies facing this same issue, and that the costs of distributing materials to small stockholders under these circumstances is onerous and unreasonable.”</p>\n<p>Following this and other letters, on Aug. 13, the SEC approved a proposed rule change from the New York Stock Exchange that prohibits brokers from seeking reimbursement from companies for delivering proxy materials to investors who received shares from their broker at no cost.</p>\n<p>The new rule won’t immediately affect Robinhood, which isn’t a member of the NYSE.</p>\n<p>But companies are now urging the Financial Industry Regulatory Authority, or Finra, which oversees brokers including Robinhood, to pass a similar rule change.</p>\n<p>“We don’t expect the reimbursement exemption to impact us significantly, even if it were to be adopted by other regulators,” a Robinhood spokesman said. “Customers love our free-stock program and we think it fits squarely into our mission to democratize finance for all.”</p>\n<p>If Finra follows the NYSE’s lead in barring Robinhood from seeking reimbursement, it would be the latest in a string of regulatory actions targeting the fast-growing broker’s business practices.</p>\n<p>Earlier this year, Finra&nbsp;fined Robinhood nearly $70 million&nbsp;to resolve allegations that it misled customers, approved ineligible traders for risky strategies and didn’t supervise technology that failed and locked millions out of trading. Separately, the&nbsp;SEC is reviewing Robinhood’s&nbsp;and other brokers’ practice of sending customers’ stock orders to high-speed trading firms in exchange for cash—a practice known as payment for order flow.</p>\n<p>Last fall, Catalyst learned that the number of people who owned its stock had soared over the previous year to 280,000 from 25,000. The 74-employee company received a bill from a Robinhood service provider for $234,000 to cover the costs of sending out proxy materials to investors ahead of its 2020 shareholder meeting, up from $12,500 in 2019.</p>\n<p>Another company,Marathon Oil&nbsp;Corp., discovered that its shareholder ranks increased nearly 32-fold from 2019 to 2020 and that its proxy-distribution costs were 25 times higher.</p>\n<p>Both companies launched investigations to determine the cause. They found that most of the new investors held tiny stakes through Robinhood.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1473b6a67d91983a0e655acc6b483dc1\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\"><span>Marathon Oil said its proxy-distribution costs were 25 times higher in 2020 than in 2019.</span></p>\n<p>As one of its main marketing strategies, Robinhood randomly assigns a free share to users who link a bank account for the first time or refer a friend to its app. Robinhood users claimed $78.7 million in shares under the program in 2020, up from $29.4 million in 2019, as its customer base swelled during the coronavirus pandemic.</p>\n<p>While the stocks are selected randomly from Robinhood’s inventory and might be valued as high as $225 a share, customers have a 98% chance of receiving a share priced between $2.50 and $10, the broker says.</p>\n<p>In Marathon’s case, its shareholder ranks surged after its stock price fell to $3.12 from more than $13 between the start of 2020 and late March that year, as the pandemic battered energy companies. In other words, the company said, a falling share price ended up leading to “extraordinarily high” proxy-related costs at a time when it needed to cut expenses.</p>\n<p>“Not long after MRO became aware of this correlation, an MRO employee saw a Facebook advertisement offering free shares of stock upon opening a Robinhood account,” Marathon General Counsel Kim Warnica wrote in an April comment letter to the SEC, using the firm’s ticker symbol. “Additionally, the Corporate Secretary’s office was made aware of two individuals who received a free share of MRO stock as a result of the Robinhood program.”</p>\n<p>Securities lawyers say it is common for Finra to follow the NYSE’s lead on proxy-related issues, given that the exchange hosts a large number of public companies.</p>\n<p>A Finra spokesman said the agency is reviewing the SEC’s decision.</p>\n<p>An SEC spokeswoman declined to comment.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Regulators Scrutinize a Robinhood Marketing Ploy: Free Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRegulators Scrutinize a Robinhood Marketing Ploy: Free Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-25 20:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/articles/regulators-scrutinize-a-robinhood-marketing-ploy-free-shares-11629891014?mod=hp_lead_pos3><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Online broker faces backlash from companies, scrutiny from regulators over cost of delivering proxy materials to millions of new shareholders\nRobinhood started trading on the Nasdaq stock exchange on ...</p>\n\n<a href=\"https://www.wsj.com/articles/regulators-scrutinize-a-robinhood-marketing-ploy-free-shares-11629891014?mod=hp_lead_pos3\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HOOD":"Robinhood"},"source_url":"https://www.wsj.com/articles/regulators-scrutinize-a-robinhood-marketing-ploy-free-shares-11629891014?mod=hp_lead_pos3","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1153815600","content_text":"Online broker faces backlash from companies, scrutiny from regulators over cost of delivering proxy materials to millions of new shareholders\nRobinhood started trading on the Nasdaq stock exchange on July 29.\nWASHINGTON—Robinhood MarketsInc. has for years given customers a free share of stock for opening an account or referring friends. The practice could soon cost the online brokerage a lot more money.\nBrokerages like Robinhood are required to deliver proxy materials to a public company’s shareholders ahead of annual meetings. They are then reimbursed by the public company for the cost of distribution.\nThis means that Robinhood’s stock giveaways have saddled some companies with larger bills for delivering proxy statements. Now, the practice is sparking a backlash from companies and scrutiny from market regulators.\nOne company pushing back is Florida-based drugmaker Catalyst Pharmaceuticals Inc.,which says Robinhood’s program cost it more than $200,000 last year and could be even more expensive this year.\n“Catalyst has become aware that Robinhood has been giving away shares of Catalyst’s common stock at no charge as part of its promotional program,” Catalyst Chief Executive Patrick McEnany wrote in a June comment letter to the Securities and Exchange Commission. “Catalyst believes that there are likely numerous companies facing this same issue, and that the costs of distributing materials to small stockholders under these circumstances is onerous and unreasonable.”\nFollowing this and other letters, on Aug. 13, the SEC approved a proposed rule change from the New York Stock Exchange that prohibits brokers from seeking reimbursement from companies for delivering proxy materials to investors who received shares from their broker at no cost.\nThe new rule won’t immediately affect Robinhood, which isn’t a member of the NYSE.\nBut companies are now urging the Financial Industry Regulatory Authority, or Finra, which oversees brokers including Robinhood, to pass a similar rule change.\n“We don’t expect the reimbursement exemption to impact us significantly, even if it were to be adopted by other regulators,” a Robinhood spokesman said. “Customers love our free-stock program and we think it fits squarely into our mission to democratize finance for all.”\nIf Finra follows the NYSE’s lead in barring Robinhood from seeking reimbursement, it would be the latest in a string of regulatory actions targeting the fast-growing broker’s business practices.\nEarlier this year, Finra fined Robinhood nearly $70 million to resolve allegations that it misled customers, approved ineligible traders for risky strategies and didn’t supervise technology that failed and locked millions out of trading. Separately, the SEC is reviewing Robinhood’s and other brokers’ practice of sending customers’ stock orders to high-speed trading firms in exchange for cash—a practice known as payment for order flow.\nLast fall, Catalyst learned that the number of people who owned its stock had soared over the previous year to 280,000 from 25,000. The 74-employee company received a bill from a Robinhood service provider for $234,000 to cover the costs of sending out proxy materials to investors ahead of its 2020 shareholder meeting, up from $12,500 in 2019.\nAnother company,Marathon Oil Corp., discovered that its shareholder ranks increased nearly 32-fold from 2019 to 2020 and that its proxy-distribution costs were 25 times higher.\nBoth companies launched investigations to determine the cause. They found that most of the new investors held tiny stakes through Robinhood.\nMarathon Oil said its proxy-distribution costs were 25 times higher in 2020 than in 2019.\nAs one of its main marketing strategies, Robinhood randomly assigns a free share to users who link a bank account for the first time or refer a friend to its app. Robinhood users claimed $78.7 million in shares under the program in 2020, up from $29.4 million in 2019, as its customer base swelled during the coronavirus pandemic.\nWhile the stocks are selected randomly from Robinhood’s inventory and might be valued as high as $225 a share, customers have a 98% chance of receiving a share priced between $2.50 and $10, the broker says.\nIn Marathon’s case, its shareholder ranks surged after its stock price fell to $3.12 from more than $13 between the start of 2020 and late March that year, as the pandemic battered energy companies. In other words, the company said, a falling share price ended up leading to “extraordinarily high” proxy-related costs at a time when it needed to cut expenses.\n“Not long after MRO became aware of this correlation, an MRO employee saw a Facebook advertisement offering free shares of stock upon opening a Robinhood account,” Marathon General Counsel Kim Warnica wrote in an April comment letter to the SEC, using the firm’s ticker symbol. “Additionally, the Corporate Secretary’s office was made aware of two individuals who received a free share of MRO stock as a result of the Robinhood program.”\nSecurities lawyers say it is common for Finra to follow the NYSE’s lead on proxy-related issues, given that the exchange hosts a large number of public companies.\nA Finra spokesman said the agency is reviewing the SEC’s decision.\nAn SEC spokeswoman declined to comment.","news_type":1},"isVote":1,"tweetType":1,"viewCount":310,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":834243983,"gmtCreate":1629809891742,"gmtModify":1676530138006,"author":{"id":"3581492791156392","authorId":"3581492791156392","name":"FantasyX","avatar":"https://static.tigerbbs.com/d5be60dde27e883d6f8b569b3afe2f3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/834243983","repostId":"1192610173","repostType":4,"repost":{"id":"1192610173","pubTimestamp":1629809650,"share":"https://www.laohu8.com/m/news/1192610173?lang=&edition=full","pubTime":"2021-08-24 20:54","market":"us","language":"en","title":"What Jackson Hole Could Mean For Apple Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=1192610173","media":"TheStreet","summary":"In late August, the markets could be rocked by monetary policy news coming from Jackson Hole, Wyomin","content":"<p>In late August, the markets could be rocked by monetary policy news coming from Jackson Hole, Wyoming. Here is what Apple stock investors should expect.</p>\n<p>The week of August 23 will likely prove to be an important one in the markets. Starting on Thursday, central bank leaders from around the world will meet virtually to talk about monetary policy during a traditional&nbsp;event&nbsp;often referred to simply as “Jackson Hole”.</p>\n<p>Today, the Apple Maven discusses how the upcoming meeting of central bankers could impact Apple stock’s&nbsp;performance in the last few trading sessions of August.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/fb09ec199963ac68c7742982748bf7a0\" tg-width=\"1200\" tg-height=\"800\" width=\"100%\" height=\"auto\"><span>Figure 1: Federal Reserve Chair Jerome Powell in a screen display at NYSE.</span></p>\n<p><b>The interest rate risk</b></p>\n<p>There seems to be a consensus that Federal Reserve chairman Jerome Powell will do little to “rock the boat” this week. Easing off on monetary stimulus is widely expected to occur over the next several months, but few seem confident that Mr. Powell will announce a change in policy as early as August.</p>\n<p>Still, the risk that the Fed will start to scale back its asset purchases later this year is real. Analysts will probably dissect Jerome Powell’s keynote speech, on Friday, in search for clues on the exact timing. Comments perceived to be hawkish could send yields higher – the 10-year treasury rate is only 1.3%.</p>\n<p>If recent history can serve as a guide,climbing yields tend to be bad news&nbsp;for growth stocks. Below are the main reasons why this is the case, as previously discussed on this channel:</p>\n<blockquote>\n “First, monetary tightening is a negative for consumption, everything else held constant. Second, a higher discount rate makes Apple’s far-out financial results less valuable in present value terms.”\n</blockquote>\n<p>For instance, the 10-year rate shot up from around 1% to nearly 1.5% in February alone. Probably not a coincidence, AAPL sank 8% that same month, while the value-rich Dow index managed to reach higher.</p>\n<p><b>Brace for possible volatility</b></p>\n<p>Regardless of which way the stock market may head following the Jackson Hole symposium, volatility could rise as August comes to a close. This is the case because speculation, both on the bullish and bearish sides of the argument, tends to increase around important events like this.</p>\n<p>Volatility is both good and bad news for Apple stock. Market jitters can be uncomfortable for many investors, and some might be tempted to sell or trim their positions after a selloff. On the other hand, a possible pullback that is unrelated to the company’s fundamentals could open an opportunity to buy AAPL on weakness.</p>\n<p>This is precisely what happened in mid-June, following an important Federal Reserve meeting that the market perceived as hawkish. Those&nbsp;who bought AAPL at those levels, a move defended by the Apple Maven, saw the value of their investment rise by 14% in a matter of only about 10 weeks.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>What Jackson Hole Could Mean For Apple Stock</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhat Jackson Hole Could Mean For Apple Stock\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-24 20:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/apple/news/what-jackson-hole-could-mean-for-apple-stock><strong>TheStreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>In late August, the markets could be rocked by monetary policy news coming from Jackson Hole, Wyoming. Here is what Apple stock investors should expect.\nThe week of August 23 will likely prove to be ...</p>\n\n<a href=\"https://www.thestreet.com/apple/news/what-jackson-hole-could-mean-for-apple-stock\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.thestreet.com/apple/news/what-jackson-hole-could-mean-for-apple-stock","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1192610173","content_text":"In late August, the markets could be rocked by monetary policy news coming from Jackson Hole, Wyoming. Here is what Apple stock investors should expect.\nThe week of August 23 will likely prove to be an important one in the markets. Starting on Thursday, central bank leaders from around the world will meet virtually to talk about monetary policy during a traditional event often referred to simply as “Jackson Hole”.\nToday, the Apple Maven discusses how the upcoming meeting of central bankers could impact Apple stock’s performance in the last few trading sessions of August.\nFigure 1: Federal Reserve Chair Jerome Powell in a screen display at NYSE.\nThe interest rate risk\nThere seems to be a consensus that Federal Reserve chairman Jerome Powell will do little to “rock the boat” this week. Easing off on monetary stimulus is widely expected to occur over the next several months, but few seem confident that Mr. Powell will announce a change in policy as early as August.\nStill, the risk that the Fed will start to scale back its asset purchases later this year is real. Analysts will probably dissect Jerome Powell’s keynote speech, on Friday, in search for clues on the exact timing. Comments perceived to be hawkish could send yields higher – the 10-year treasury rate is only 1.3%.\nIf recent history can serve as a guide,climbing yields tend to be bad news for growth stocks. Below are the main reasons why this is the case, as previously discussed on this channel:\n\n “First, monetary tightening is a negative for consumption, everything else held constant. Second, a higher discount rate makes Apple’s far-out financial results less valuable in present value terms.”\n\nFor instance, the 10-year rate shot up from around 1% to nearly 1.5% in February alone. Probably not a coincidence, AAPL sank 8% that same month, while the value-rich Dow index managed to reach higher.\nBrace for possible volatility\nRegardless of which way the stock market may head following the Jackson Hole symposium, volatility could rise as August comes to a close. This is the case because speculation, both on the bullish and bearish sides of the argument, tends to increase around important events like this.\nVolatility is both good and bad news for Apple stock. Market jitters can be uncomfortable for many investors, and some might be tempted to sell or trim their positions after a selloff. On the other hand, a possible pullback that is unrelated to the company’s fundamentals could open an opportunity to buy AAPL on weakness.\nThis is precisely what happened in mid-June, following an important Federal Reserve meeting that the market perceived as hawkish. Those who bought AAPL at those levels, a move defended by the Apple Maven, saw the value of their investment rise by 14% in a matter of only about 10 weeks.","news_type":1},"isVote":1,"tweetType":1,"viewCount":96,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":831106376,"gmtCreate":1629293500295,"gmtModify":1676529993822,"author":{"id":"3581492791156392","authorId":"3581492791156392","name":"FantasyX","avatar":"https://static.tigerbbs.com/d5be60dde27e883d6f8b569b3afe2f3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/831106376","repostId":"2160473456","repostType":4,"isVote":1,"tweetType":1,"viewCount":333,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":833385441,"gmtCreate":1629206272683,"gmtModify":1676529965262,"author":{"id":"3581492791156392","authorId":"3581492791156392","name":"FantasyX","avatar":"https://static.tigerbbs.com/d5be60dde27e883d6f8b569b3afe2f3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/833385441","repostId":"1156515289","repostType":4,"repost":{"id":"1156515289","pubTimestamp":1629203903,"share":"https://www.laohu8.com/m/news/1156515289?lang=&edition=full","pubTime":"2021-08-17 20:38","market":"us","language":"en","title":"U.S. retail sales fall 1.1% in July, vs 0.3% drop expected","url":"https://stock-news.laohu8.com/highlight/detail?id=1156515289","media":"cnbc","summary":"Shoppers in the U.S. cut back their purchases in July even more than expected as worries over the de","content":"<div>\n<p>Shoppers in the U.S. cut back their purchases in July even more than expected as worries over the delta variant of Covid-19 dampened activity and government stimulus dried up.\nRetail sales for the ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/17/retail-sales-july-2021.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. retail sales fall 1.1% in July, vs 0.3% drop expected</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. retail sales fall 1.1% in July, vs 0.3% drop expected\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-17 20:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/08/17/retail-sales-july-2021.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shoppers in the U.S. cut back their purchases in July even more than expected as worries over the delta variant of Covid-19 dampened activity and government stimulus dried up.\nRetail sales for the ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/17/retail-sales-july-2021.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯","SPY":"标普500ETF",".IXIC":"NASDAQ Composite"},"source_url":"https://www.cnbc.com/2021/08/17/retail-sales-july-2021.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1156515289","content_text":"Shoppers in the U.S. cut back their purchases in July even more than expected as worries over the delta variant of Covid-19 dampened activity and government stimulus dried up.\nRetail sales for the month fell 1.1%, worse than the Dow Jones estimate of a 0.3% decline.\nExcluding automobiles, sales declined 0.4%, according to Commerce Department figures released Tuesday.\nMarkets showed little initial reaction to the news, with futures tied to the Dow Jones Industrial Average off more than 200 points and government bond yields lower across the board.","news_type":1},"isVote":1,"tweetType":1,"viewCount":243,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":830574407,"gmtCreate":1629086128209,"gmtModify":1676529925079,"author":{"id":"3581492791156392","authorId":"3581492791156392","name":"FantasyX","avatar":"https://static.tigerbbs.com/d5be60dde27e883d6f8b569b3afe2f3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/830574407","repostId":"1145684106","repostType":4,"isVote":1,"tweetType":1,"viewCount":403,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":830326997,"gmtCreate":1629015248819,"gmtModify":1676529911322,"author":{"id":"3581492791156392","authorId":"3581492791156392","name":"FantasyX","avatar":"https://static.tigerbbs.com/d5be60dde27e883d6f8b569b3afe2f3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/830326997","repostId":"2159215676","repostType":4,"repost":{"id":"2159215676","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1628992609,"share":"https://www.laohu8.com/m/news/2159215676?lang=&edition=full","pubTime":"2021-08-15 09:56","market":"us","language":"en","title":"Why 6 DoorDash Analysts Are Raising Price Targets After Q2 Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2159215676","media":"Benzinga","summary":"Analysts share their reactions and new price targets on shares of DoorDash Inc (NYSE: DASH), which reported second-quarter earnings Thursday after market close.","content":"<p>Analysts share their reactions and new price targets on shares of <b>DoorDash Inc</b> (NYSE:DASH), which reported second-quarter earnings Thursday after market close.</p>\n<p><b>The DoorDash Analysts: </b>Barclays analyst Ross Sandler had&nbsp;an Equal Weight rating and raised&nbsp;the price target from $160 to $183.</p>\n<p>JMP Securities analyst Ronald V. Josey had&nbsp;a Market Outperform rating and raised&nbsp;the price target from $195 to $210.</p>\n<p>Wells Fargo analyst Brian Fitzgerald had&nbsp;an Overweight rating and raised&nbsp;the price target from $215 to $235.</p>\n<p>RBC Capital analyst Brad Erickson had&nbsp;an Outperform rating and raised&nbsp;the price target from $175 to $210.</p>\n<p>Mizuho Securities analyst James Lee had&nbsp;a Neutral rating and raised&nbsp;the price target from $155 to $175.</p>\n<p>Needham analyst Bernie McTernan had&nbsp;a Buy rating and raised&nbsp;the price target from $195 to $230.</p>\n<p><b>The Analyst Takeaways: </b>DoorDash gained three percentage points in market share for the U.S. food delivery share, Josey said. The analyst notes a highly engaged customer based and also highlighted frequency hitting an all-time high in the quarter.</p>\n<p>“DashPass subscribers grew more than 2x as fast as non-DashPass MAUs year-over-year,” Josey said.</p>\n<p>DoorDash management said its order frequency has not reached its peak yet, Fitzgerald added.</p>\n<p>A focus on gross profit dollars and reinvestment in growth initiatives was called out by Erickson in the updated note.</p>\n<p>“On top of beating gross order volume, revenue and EBITDA and raising its FY guide, specific encouraging demand highlights includes 300 bps of U.S. shares gains year-over-year,” Erickson said.</p>\n<p>The analyst noted&nbsp;company management mentioned progress in Canada and Australia and other international launches coming.</p>\n<p>“Volume growth was the highlight of 2Q earnings to us, highlighting consumer delivery habits are still sticky late into the pandemic,” McTernan said. The analyst was surprised by the upside in volume in the late stages of the pandemic.</p>\n<p><b>Non-Food Delivery Growth:</b> Sandler highlighted the growth of DoorDash in non-restaurant areas like grocery, convenience, pets and alcohol. This segment is helping drive frequency, retention and efficiency for the company with frequency hitting record highs in the quarter.</p>\n<p>DoorDash’s non-restaurant orders could have been placed by 10% of the company’s users in the second quarter, compared to 7% of orders in the first quarter, Josey said.</p>\n<p>The analyst also noted&nbsp;the addition of more than 5,000 convenience stores in the second quarter including <b><a href=\"https://laohu8.com/S/WBA\">Walgreens Boots Alliance</a> Inc</b> (NASDAQ:WBA), <b>Rite Aid Corporation</b> (NYSE:RAD), <b>Albertsons Companies Inc</b> (NYSE:ACI), <b>PetSmart</b> and <b>Bed Bath &amp; Beyond Inc.</b>&nbsp;(NASDAQ:BBBY) locations.</p>\n<p>“Over 30% of DASH’s business came from orders outside restaurants in Q2, early data suggest that multi-category customers increase both their retention and engagement rates,” Fitzgerald said.</p>\n<p><b>What’s Next: </b>International growth, investments in new categories and a healthy supply of Dashers are highlighted by Josey.</p>\n<p>“DASH deserves a premium to the peer set,” Sandler said.</p>\n<p>“We expect DASH shares to continue to grind higher as its U.S. market share and momentum continue to resonate,” Fitzgerald said. “If DASH can replicate the operational prowess it has demonstrated in the U.S. as a fast follower in international markets, we think shares have significantly more upside in the coming years.”</p>\n<p>Additional grocery delivery is expected to roll out in the second half of the year “providing opportunities to become a second logistics source for some key accounts,” highlights Fitzgerald.</p>\n<p>DoorDash has some regulatory headwinds in large cities such as&nbsp;San Francisco and New York City but Lee sees these being less than feared. Management sees momentum carrying into the third quarter, the analyst notes.</p>\n<p>“Given investments in new categories and international markets we believe the level of incremental investment represents the greatest risk to our forecast,” McTernan said.</p>\n<p><b>DASH Price Action: </b>DoorDash shares rose 3.5% to $194.79&nbsp;on Friday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why 6 DoorDash Analysts Are Raising Price Targets After Q2 Earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy 6 DoorDash Analysts Are Raising Price Targets After Q2 Earnings\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-08-15 09:56</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Analysts share their reactions and new price targets on shares of <b>DoorDash Inc</b> (NYSE:DASH), which reported second-quarter earnings Thursday after market close.</p>\n<p><b>The DoorDash Analysts: </b>Barclays analyst Ross Sandler had&nbsp;an Equal Weight rating and raised&nbsp;the price target from $160 to $183.</p>\n<p>JMP Securities analyst Ronald V. Josey had&nbsp;a Market Outperform rating and raised&nbsp;the price target from $195 to $210.</p>\n<p>Wells Fargo analyst Brian Fitzgerald had&nbsp;an Overweight rating and raised&nbsp;the price target from $215 to $235.</p>\n<p>RBC Capital analyst Brad Erickson had&nbsp;an Outperform rating and raised&nbsp;the price target from $175 to $210.</p>\n<p>Mizuho Securities analyst James Lee had&nbsp;a Neutral rating and raised&nbsp;the price target from $155 to $175.</p>\n<p>Needham analyst Bernie McTernan had&nbsp;a Buy rating and raised&nbsp;the price target from $195 to $230.</p>\n<p><b>The Analyst Takeaways: </b>DoorDash gained three percentage points in market share for the U.S. food delivery share, Josey said. The analyst notes a highly engaged customer based and also highlighted frequency hitting an all-time high in the quarter.</p>\n<p>“DashPass subscribers grew more than 2x as fast as non-DashPass MAUs year-over-year,” Josey said.</p>\n<p>DoorDash management said its order frequency has not reached its peak yet, Fitzgerald added.</p>\n<p>A focus on gross profit dollars and reinvestment in growth initiatives was called out by Erickson in the updated note.</p>\n<p>“On top of beating gross order volume, revenue and EBITDA and raising its FY guide, specific encouraging demand highlights includes 300 bps of U.S. shares gains year-over-year,” Erickson said.</p>\n<p>The analyst noted&nbsp;company management mentioned progress in Canada and Australia and other international launches coming.</p>\n<p>“Volume growth was the highlight of 2Q earnings to us, highlighting consumer delivery habits are still sticky late into the pandemic,” McTernan said. The analyst was surprised by the upside in volume in the late stages of the pandemic.</p>\n<p><b>Non-Food Delivery Growth:</b> Sandler highlighted the growth of DoorDash in non-restaurant areas like grocery, convenience, pets and alcohol. This segment is helping drive frequency, retention and efficiency for the company with frequency hitting record highs in the quarter.</p>\n<p>DoorDash’s non-restaurant orders could have been placed by 10% of the company’s users in the second quarter, compared to 7% of orders in the first quarter, Josey said.</p>\n<p>The analyst also noted&nbsp;the addition of more than 5,000 convenience stores in the second quarter including <b><a href=\"https://laohu8.com/S/WBA\">Walgreens Boots Alliance</a> Inc</b> (NASDAQ:WBA), <b>Rite Aid Corporation</b> (NYSE:RAD), <b>Albertsons Companies Inc</b> (NYSE:ACI), <b>PetSmart</b> and <b>Bed Bath &amp; Beyond Inc.</b>&nbsp;(NASDAQ:BBBY) locations.</p>\n<p>“Over 30% of DASH’s business came from orders outside restaurants in Q2, early data suggest that multi-category customers increase both their retention and engagement rates,” Fitzgerald said.</p>\n<p><b>What’s Next: </b>International growth, investments in new categories and a healthy supply of Dashers are highlighted by Josey.</p>\n<p>“DASH deserves a premium to the peer set,” Sandler said.</p>\n<p>“We expect DASH shares to continue to grind higher as its U.S. market share and momentum continue to resonate,” Fitzgerald said. “If DASH can replicate the operational prowess it has demonstrated in the U.S. as a fast follower in international markets, we think shares have significantly more upside in the coming years.”</p>\n<p>Additional grocery delivery is expected to roll out in the second half of the year “providing opportunities to become a second logistics source for some key accounts,” highlights Fitzgerald.</p>\n<p>DoorDash has some regulatory headwinds in large cities such as&nbsp;San Francisco and New York City but Lee sees these being less than feared. Management sees momentum carrying into the third quarter, the analyst notes.</p>\n<p>“Given investments in new categories and international markets we believe the level of incremental investment represents the greatest risk to our forecast,” McTernan said.</p>\n<p><b>DASH Price Action: </b>DoorDash shares rose 3.5% to $194.79&nbsp;on Friday.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BBBY":"3B家居","QTWO":"Q2 Holdings Inc","DASH":"DoorDash, Inc.","ACI":"艾伯森","RAD":"来德爱","WBA":"沃尔格林联合博姿"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2159215676","content_text":"Analysts share their reactions and new price targets on shares of DoorDash Inc (NYSE:DASH), which reported second-quarter earnings Thursday after market close.\nThe DoorDash Analysts: Barclays analyst Ross Sandler had an Equal Weight rating and raised the price target from $160 to $183.\nJMP Securities analyst Ronald V. Josey had a Market Outperform rating and raised the price target from $195 to $210.\nWells Fargo analyst Brian Fitzgerald had an Overweight rating and raised the price target from $215 to $235.\nRBC Capital analyst Brad Erickson had an Outperform rating and raised the price target from $175 to $210.\nMizuho Securities analyst James Lee had a Neutral rating and raised the price target from $155 to $175.\nNeedham analyst Bernie McTernan had a Buy rating and raised the price target from $195 to $230.\nThe Analyst Takeaways: DoorDash gained three percentage points in market share for the U.S. food delivery share, Josey said. The analyst notes a highly engaged customer based and also highlighted frequency hitting an all-time high in the quarter.\n“DashPass subscribers grew more than 2x as fast as non-DashPass MAUs year-over-year,” Josey said.\nDoorDash management said its order frequency has not reached its peak yet, Fitzgerald added.\nA focus on gross profit dollars and reinvestment in growth initiatives was called out by Erickson in the updated note.\n“On top of beating gross order volume, revenue and EBITDA and raising its FY guide, specific encouraging demand highlights includes 300 bps of U.S. shares gains year-over-year,” Erickson said.\nThe analyst noted company management mentioned progress in Canada and Australia and other international launches coming.\n“Volume growth was the highlight of 2Q earnings to us, highlighting consumer delivery habits are still sticky late into the pandemic,” McTernan said. The analyst was surprised by the upside in volume in the late stages of the pandemic.\nNon-Food Delivery Growth: Sandler highlighted the growth of DoorDash in non-restaurant areas like grocery, convenience, pets and alcohol. This segment is helping drive frequency, retention and efficiency for the company with frequency hitting record highs in the quarter.\nDoorDash’s non-restaurant orders could have been placed by 10% of the company’s users in the second quarter, compared to 7% of orders in the first quarter, Josey said.\nThe analyst also noted the addition of more than 5,000 convenience stores in the second quarter including Walgreens Boots Alliance Inc (NASDAQ:WBA), Rite Aid Corporation (NYSE:RAD), Albertsons Companies Inc (NYSE:ACI), PetSmart and Bed Bath & Beyond Inc. (NASDAQ:BBBY) locations.\n“Over 30% of DASH’s business came from orders outside restaurants in Q2, early data suggest that multi-category customers increase both their retention and engagement rates,” Fitzgerald said.\nWhat’s Next: International growth, investments in new categories and a healthy supply of Dashers are highlighted by Josey.\n“DASH deserves a premium to the peer set,” Sandler said.\n“We expect DASH shares to continue to grind higher as its U.S. market share and momentum continue to resonate,” Fitzgerald said. “If DASH can replicate the operational prowess it has demonstrated in the U.S. as a fast follower in international markets, we think shares have significantly more upside in the coming years.”\nAdditional grocery delivery is expected to roll out in the second half of the year “providing opportunities to become a second logistics source for some key accounts,” highlights Fitzgerald.\nDoorDash has some regulatory headwinds in large cities such as San Francisco and New York City but Lee sees these being less than feared. Management sees momentum carrying into the third quarter, the analyst notes.\n“Given investments in new categories and international markets we believe the level of incremental investment represents the greatest risk to our forecast,” McTernan said.\nDASH Price Action: DoorDash shares rose 3.5% to $194.79 on Friday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":570,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":894703989,"gmtCreate":1628853144941,"gmtModify":1676529875174,"author":{"id":"3581492791156392","authorId":"3581492791156392","name":"FantasyX","avatar":"https://static.tigerbbs.com/d5be60dde27e883d6f8b569b3afe2f3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/894703989","repostId":"2159962232","repostType":4,"isVote":1,"tweetType":1,"viewCount":21,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":892256128,"gmtCreate":1628667305864,"gmtModify":1676529814830,"author":{"id":"3581492791156392","authorId":"3581492791156392","name":"FantasyX","avatar":"https://static.tigerbbs.com/d5be60dde27e883d6f8b569b3afe2f3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/892256128","repostId":"1187715628","repostType":4,"repost":{"id":"1187715628","pubTimestamp":1628665044,"share":"https://www.laohu8.com/m/news/1187715628?lang=&edition=full","pubTime":"2021-08-11 14:57","market":"us","language":"en","title":"Wind turbine maker Vestas cuts 2021 outlook on supply constraints and costs","url":"https://stock-news.laohu8.com/highlight/detail?id=1187715628","media":"Reuters","summary":"COPENHAGEN, Aug 11 (Reuters) - Vestas cut its 2021 outlook on Wednesday after missing second-quarter","content":"<p>COPENHAGEN, Aug 11 (Reuters) - Vestas cut its 2021 outlook on Wednesday after missing second-quarter operating profit forecasts as the world’s largest maker of wind turbines was hurt by supply chain disruptions and higher costs.</p>\n<p>Demand for its wind turbines, seen as crucial to curb global warming, remains healthy but took a hit by constraints in the freight market where several events in the wake of COVID-19 have conspired to drive global supply chains towards a breaking point.</p>\n<p>The Danish company reported an operating profit before special items of 101 million euros ($118.32 million), while analysts on average had expected a profit of 170 million euros, a poll of analysts supplied by Vestas showed.</p>\n<p>It now expects full-year revenue of 15.5 billion to 16.5 billion euros, down from a previous forecast of 16-17 billion euros. It also lowered expectations to its operating profit margin to 5-7% from previously 6% to 8% - a far cry from its long-term target of a 10% margin.</p>\n<p>“To reflect the challenges from cost inflation and the global environment we operate in, we have revised our guidance for 2021,” said chief executive Henrik Andersen in a statement.</p>\n<p>Its margin, however, still remains well above that of its main rival Siemens Gamesa, which reported a negative margin of 5.6% in the same period and last month cut its profit margin outlook for the year to between -1% and 0%.</p>\n<p>“Vestas’ downgrade is a consequence of the general challenges that Siemens Gamesa has also faced and had to cut twice. It’s no sensation and no disaster but it should cause a drop in share price,” analysts at online brokerage Nordnet in a note.</p>","source":"lsy1601381805984","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wind turbine maker Vestas cuts 2021 outlook on supply constraints and costs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWind turbine maker Vestas cuts 2021 outlook on supply constraints and costs\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-11 14:57 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.reuters.com/article/vestas-results/update-1-wind-turbine-maker-vestas-cuts-2021-outlook-on-supply-constraints-and-costs-idUSL1N2PI0D2><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>COPENHAGEN, Aug 11 (Reuters) - Vestas cut its 2021 outlook on Wednesday after missing second-quarter operating profit forecasts as the world’s largest maker of wind turbines was hurt by supply chain ...</p>\n\n<a href=\"https://www.reuters.com/article/vestas-results/update-1-wind-turbine-maker-vestas-cuts-2021-outlook-on-supply-constraints-and-costs-idUSL1N2PI0D2\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VWDRY":"Vestas Wind Systems A/S"},"source_url":"https://www.reuters.com/article/vestas-results/update-1-wind-turbine-maker-vestas-cuts-2021-outlook-on-supply-constraints-and-costs-idUSL1N2PI0D2","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1187715628","content_text":"COPENHAGEN, Aug 11 (Reuters) - Vestas cut its 2021 outlook on Wednesday after missing second-quarter operating profit forecasts as the world’s largest maker of wind turbines was hurt by supply chain disruptions and higher costs.\nDemand for its wind turbines, seen as crucial to curb global warming, remains healthy but took a hit by constraints in the freight market where several events in the wake of COVID-19 have conspired to drive global supply chains towards a breaking point.\nThe Danish company reported an operating profit before special items of 101 million euros ($118.32 million), while analysts on average had expected a profit of 170 million euros, a poll of analysts supplied by Vestas showed.\nIt now expects full-year revenue of 15.5 billion to 16.5 billion euros, down from a previous forecast of 16-17 billion euros. It also lowered expectations to its operating profit margin to 5-7% from previously 6% to 8% - a far cry from its long-term target of a 10% margin.\n“To reflect the challenges from cost inflation and the global environment we operate in, we have revised our guidance for 2021,” said chief executive Henrik Andersen in a statement.\nIts margin, however, still remains well above that of its main rival Siemens Gamesa, which reported a negative margin of 5.6% in the same period and last month cut its profit margin outlook for the year to between -1% and 0%.\n“Vestas’ downgrade is a consequence of the general challenges that Siemens Gamesa has also faced and had to cut twice. It’s no sensation and no disaster but it should cause a drop in share price,” analysts at online brokerage Nordnet in a note.","news_type":1},"isVote":1,"tweetType":1,"viewCount":39,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":896420564,"gmtCreate":1628602326258,"gmtModify":1676529793082,"author":{"id":"3581492791156392","authorId":"3581492791156392","name":"FantasyX","avatar":"https://static.tigerbbs.com/d5be60dde27e883d6f8b569b3afe2f3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/896420564","repostId":"2158048475","repostType":4,"repost":{"id":"2158048475","pubTimestamp":1628600160,"share":"https://www.laohu8.com/m/news/2158048475?lang=&edition=full","pubTime":"2021-08-10 20:56","market":"us","language":"en","title":"Here's Who's Making a $1 Billion Bet on Moderna","url":"https://stock-news.laohu8.com/highlight/detail?id=2158048475","media":"Motley Fool","summary":"The total bet size is even higher.","content":"<p>Few stocks are as hot as&nbsp;<b>Moderna</b> (NASDAQ:MRNA) is right now. The vaccine maker's shares have soared more than 360% so far this year. And that comes on top of the 434% gain in 2020.</p>\n<p>That kind of performance tends to attract investors' attention -- and deservedly so. Some might view the vaccine stock as overpriced now that its market cap tops $190 billion. But not everyone.</p>\n<p>There's <a href=\"https://laohu8.com/S/AONE.U\">one</a> investor preparing to make a $1 billion bet on Moderna. Who is it? None other than Moderna itself.</p>\n<h2>Investing heavily</h2>\n<p>Moderna stated in its second-quarter update that its board of directors authorized a share repurchase program of up to $1 billion. Don't expect the company to spend all that money at one time, though. The authorized funds can be used over a two-year period to buy back shares.</p>\n<p>Actually, Moderna has invested and will invest a lot more than just $1 billion in its business. CFO David Meline noted in the company's Q2 conference call that Moderna more than tripled its research and development spending year over year in the first half of 2021. He said to expect significantly increased R&amp;D investments going forward.</p>\n<p>In addition, Moderna plans to make between $450 million and $550 million this year in capital investments. These investments include a major expansion of capacity to be able to manufacture up to 3 billion doses of its COVID-19 vaccine in 2022. The company is also investing in technology improvements and beefing up its global commercial operations.</p>\n<h2>Why buy back shares?</h2>\n<p>Probably the most important reason why Moderna is preparing to invest so much in itself is that the company's management team is very confident in its business prospects. CEO Stéphane Bancel said in the Q2 call, \"We are very optimistic about the future of Moderna and we are just getting started.\"</p>\n<p>Another reason why Moderna is ready to spend up to $1 billion in stock buybacks is that it's likely going to have more cash than it knows what to do with. The company ended the second quarter with a cash stockpile of $12.2 billion. That amount will almost certainly continue to grow.</p>\n<p>Moderna expects to rake in $20 billion in sales from its COVID-19 vaccine this year. It already has advance purchase agreements worth $12 billion plus another $8 billion in options for next year.</p>\n<p>Repurchasing shares is actually Moderna's third investment priority. The company first wants to reinvest in its base business, which includes the aforementioned increased R&amp;D and capital spending. Moderna also is interested in expanding its pipeline through business development, deals including licensing and acquisitions.</p>\n<p>Moderna's board seems to think that the company will still have plenty of money left over after investing in those two top priorities. Based on the company's revenue projections, it should easily be able to spare $1 billion for stock buybacks.</p>\n<h2>A good bet?</h2>\n<p>Just because Moderna <i>can</i> spend $1 billion on share repurchases doesn't mean that it <i>should</i> do so. I don't think Moderna should make that $1 billion bet in buying back shares.&nbsp;My view is that stock buybacks at Moderna's current valuation (or anywhere close to it) would be ill-advised.</p>\n<p>Of course, Moderna could wait to buy back shares only on pullbacks.&nbsp;However, unless its shares plunge significantly, I think that Moderna would better serve its shareholders by making a strategic acquisition with the $1 billion than buying its own richly priced shares.</p>\n<p>The company needs to be able to generate growth after the worst of the pandemic ends. With only one non-COVID-19 pipeline candidate soon to enter late-stage testing, buying a smaller biotech is the easiest way to achieve that growth.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here's Who's Making a $1 Billion Bet on Moderna</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere's Who's Making a $1 Billion Bet on Moderna\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-10 20:56 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/10/heres-whos-making-a-1-billion-bet-on-moderna/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Few stocks are as hot as Moderna (NASDAQ:MRNA) is right now. The vaccine maker's shares have soared more than 360% so far this year. And that comes on top of the 434% gain in 2020.\nThat kind of ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/10/heres-whos-making-a-1-billion-bet-on-moderna/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://www.fool.com/investing/2021/08/10/heres-whos-making-a-1-billion-bet-on-moderna/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2158048475","content_text":"Few stocks are as hot as Moderna (NASDAQ:MRNA) is right now. The vaccine maker's shares have soared more than 360% so far this year. And that comes on top of the 434% gain in 2020.\nThat kind of performance tends to attract investors' attention -- and deservedly so. Some might view the vaccine stock as overpriced now that its market cap tops $190 billion. But not everyone.\nThere's one investor preparing to make a $1 billion bet on Moderna. Who is it? None other than Moderna itself.\nInvesting heavily\nModerna stated in its second-quarter update that its board of directors authorized a share repurchase program of up to $1 billion. Don't expect the company to spend all that money at one time, though. The authorized funds can be used over a two-year period to buy back shares.\nActually, Moderna has invested and will invest a lot more than just $1 billion in its business. CFO David Meline noted in the company's Q2 conference call that Moderna more than tripled its research and development spending year over year in the first half of 2021. He said to expect significantly increased R&D investments going forward.\nIn addition, Moderna plans to make between $450 million and $550 million this year in capital investments. These investments include a major expansion of capacity to be able to manufacture up to 3 billion doses of its COVID-19 vaccine in 2022. The company is also investing in technology improvements and beefing up its global commercial operations.\nWhy buy back shares?\nProbably the most important reason why Moderna is preparing to invest so much in itself is that the company's management team is very confident in its business prospects. CEO Stéphane Bancel said in the Q2 call, \"We are very optimistic about the future of Moderna and we are just getting started.\"\nAnother reason why Moderna is ready to spend up to $1 billion in stock buybacks is that it's likely going to have more cash than it knows what to do with. The company ended the second quarter with a cash stockpile of $12.2 billion. That amount will almost certainly continue to grow.\nModerna expects to rake in $20 billion in sales from its COVID-19 vaccine this year. It already has advance purchase agreements worth $12 billion plus another $8 billion in options for next year.\nRepurchasing shares is actually Moderna's third investment priority. The company first wants to reinvest in its base business, which includes the aforementioned increased R&D and capital spending. Moderna also is interested in expanding its pipeline through business development, deals including licensing and acquisitions.\nModerna's board seems to think that the company will still have plenty of money left over after investing in those two top priorities. Based on the company's revenue projections, it should easily be able to spare $1 billion for stock buybacks.\nA good bet?\nJust because Moderna can spend $1 billion on share repurchases doesn't mean that it should do so. I don't think Moderna should make that $1 billion bet in buying back shares. My view is that stock buybacks at Moderna's current valuation (or anywhere close to it) would be ill-advised.\nOf course, Moderna could wait to buy back shares only on pullbacks. However, unless its shares plunge significantly, I think that Moderna would better serve its shareholders by making a strategic acquisition with the $1 billion than buying its own richly priced shares.\nThe company needs to be able to generate growth after the worst of the pandemic ends. With only one non-COVID-19 pipeline candidate soon to enter late-stage testing, buying a smaller biotech is the easiest way to achieve that growth.","news_type":1},"isVote":1,"tweetType":1,"viewCount":54,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":898522502,"gmtCreate":1628512921606,"gmtModify":1703507316736,"author":{"id":"3581492791156392","authorId":"3581492791156392","name":"FantasyX","avatar":"https://static.tigerbbs.com/d5be60dde27e883d6f8b569b3afe2f3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/898522502","repostId":"2158844506","repostType":4,"repost":{"id":"2158844506","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1628508062,"share":"https://www.laohu8.com/m/news/2158844506?lang=&edition=full","pubTime":"2021-08-09 19:21","market":"us","language":"en","title":"BioNTech says has supplied more than 1 bln COVID-19 vaccine doses so far","url":"https://stock-news.laohu8.com/highlight/detail?id=2158844506","media":"Reuters","summary":"FRANKFURT, Aug 9 (Reuters) - BioNTech and partner Pfizer have supplied more than one billion doses o","content":"<p>FRANKFURT, Aug 9 (Reuters) - BioNTech and partner Pfizer have supplied more than <a href=\"https://laohu8.com/S/AONE.U\">one</a> billion doses of their COVID-19 vaccine as per July 21, a bigger number than delivered by competitor AstraZeneca , the German biotech group said on Monday.</p>\n<p>AstraZeneca said on July 29 that it and its manufacturing partner, India-based Serum Institute, had supplied a billion doses to 170 countries at the time.</p>\n<p>Based on delivery contracts so far, BioNTech said in a statement it expects 15.9 billion euros ($18.7 billion) in revenue accruing to it from the vaccine this year, up from a forecast in May of 12.4 billion euros.</p>\n<p>That includes sales, milestone payments from partners and a share of gross profit in its partners' territories, the company added. ($1 = 0.8509 euros)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BioNTech says has supplied more than 1 bln COVID-19 vaccine doses so far</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioNTech says has supplied more than 1 bln COVID-19 vaccine doses so far\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-09 19:21</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>FRANKFURT, Aug 9 (Reuters) - BioNTech and partner Pfizer have supplied more than <a href=\"https://laohu8.com/S/AONE.U\">one</a> billion doses of their COVID-19 vaccine as per July 21, a bigger number than delivered by competitor AstraZeneca , the German biotech group said on Monday.</p>\n<p>AstraZeneca said on July 29 that it and its manufacturing partner, India-based Serum Institute, had supplied a billion doses to 170 countries at the time.</p>\n<p>Based on delivery contracts so far, BioNTech said in a statement it expects 15.9 billion euros ($18.7 billion) in revenue accruing to it from the vaccine this year, up from a forecast in May of 12.4 billion euros.</p>\n<p>That includes sales, milestone payments from partners and a share of gross profit in its partners' territories, the company added. ($1 = 0.8509 euros)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2158844506","content_text":"FRANKFURT, Aug 9 (Reuters) - BioNTech and partner Pfizer have supplied more than one billion doses of their COVID-19 vaccine as per July 21, a bigger number than delivered by competitor AstraZeneca , the German biotech group said on Monday.\nAstraZeneca said on July 29 that it and its manufacturing partner, India-based Serum Institute, had supplied a billion doses to 170 countries at the time.\nBased on delivery contracts so far, BioNTech said in a statement it expects 15.9 billion euros ($18.7 billion) in revenue accruing to it from the vaccine this year, up from a forecast in May of 12.4 billion euros.\nThat includes sales, milestone payments from partners and a share of gross profit in its partners' territories, the company added. ($1 = 0.8509 euros)","news_type":1},"isVote":1,"tweetType":1,"viewCount":79,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":898522282,"gmtCreate":1628512908346,"gmtModify":1703507317392,"author":{"id":"3581492791156392","authorId":"3581492791156392","name":"FantasyX","avatar":"https://static.tigerbbs.com/d5be60dde27e883d6f8b569b3afe2f3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/898522282","repostId":"1122651143","repostType":4,"repost":{"id":"1122651143","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628508488,"share":"https://www.laohu8.com/m/news/1122651143?lang=&edition=full","pubTime":"2021-08-09 19:28","market":"us","language":"en","title":"Crypto sector stocks rose in premarket trading,BTCM shares jumped more than 30%,BITF surged more than 20%.","url":"https://stock-news.laohu8.com/highlight/detail?id=1122651143","media":"Tiger Newspress","summary":"Crypto sector stocks rose in premarket trading,BTCM shares jumped more than 30%,BITF surged more tha","content":"<p>Crypto&nbsp;sector&nbsp;stocks&nbsp;rose&nbsp;in&nbsp;premarket&nbsp;trading,BTCM&nbsp;shares&nbsp;jumped&nbsp;more&nbsp;than&nbsp;30%,BITF&nbsp;surged&nbsp;more&nbsp;than&nbsp;20%.</p>\n<p><img src=\"https://static.tigerbbs.com/9ece56572cf91d8de69991add19a22f4\" tg-width=\"1287\" tg-height=\"619\" referrerpolicy=\"no-referrer\">Investors in stock trading platforms are citing the momentum in cryptocurrencies as being the driving force for the stock price increase. The price of the Bitcoin cryptocurrency is up more than 9% over the past week. And Ethereum is up more than 12% over the past week.</p>\n<p>Late last month, BIT Mining announced it entered into a definitive purchase agreement to buy 2,500 new bitcoin mining machines for a total consideration of approximately US$6.6 million. And when deployed, the company expects the Acquired Machines to increase its theoretical maximum total hash rate capacity by about 165 peta hashes per second (PH/s).</p>\n<p>The acquired machines are expected to be delivered within one week from today. And following delivery, the company plans for them to be shipped to Kazakhstan for deployment.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Crypto sector stocks rose in premarket trading,BTCM shares jumped more than 30%,BITF surged more than 20%.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCrypto sector stocks rose in premarket trading,BTCM shares jumped more than 30%,BITF surged more than 20%.\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-09 19:28</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Crypto&nbsp;sector&nbsp;stocks&nbsp;rose&nbsp;in&nbsp;premarket&nbsp;trading,BTCM&nbsp;shares&nbsp;jumped&nbsp;more&nbsp;than&nbsp;30%,BITF&nbsp;surged&nbsp;more&nbsp;than&nbsp;20%.</p>\n<p><img src=\"https://static.tigerbbs.com/9ece56572cf91d8de69991add19a22f4\" tg-width=\"1287\" tg-height=\"619\" referrerpolicy=\"no-referrer\">Investors in stock trading platforms are citing the momentum in cryptocurrencies as being the driving force for the stock price increase. The price of the Bitcoin cryptocurrency is up more than 9% over the past week. And Ethereum is up more than 12% over the past week.</p>\n<p>Late last month, BIT Mining announced it entered into a definitive purchase agreement to buy 2,500 new bitcoin mining machines for a total consideration of approximately US$6.6 million. And when deployed, the company expects the Acquired Machines to increase its theoretical maximum total hash rate capacity by about 165 peta hashes per second (PH/s).</p>\n<p>The acquired machines are expected to be delivered within one week from today. And following delivery, the company plans for them to be shipped to Kazakhstan for deployment.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BTCM":"BIT Mining","BITF":"Bitfarms Ltd."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122651143","content_text":"Crypto sector stocks rose in premarket trading,BTCM shares jumped more than 30%,BITF surged more than 20%.\nInvestors in stock trading platforms are citing the momentum in cryptocurrencies as being the driving force for the stock price increase. The price of the Bitcoin cryptocurrency is up more than 9% over the past week. And Ethereum is up more than 12% over the past week.\nLate last month, BIT Mining announced it entered into a definitive purchase agreement to buy 2,500 new bitcoin mining machines for a total consideration of approximately US$6.6 million. And when deployed, the company expects the Acquired Machines to increase its theoretical maximum total hash rate capacity by about 165 peta hashes per second (PH/s).\nThe acquired machines are expected to be delivered within one week from today. And following delivery, the company plans for them to be shipped to Kazakhstan for deployment.","news_type":1},"isVote":1,"tweetType":1,"viewCount":62,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":899807224,"gmtCreate":1628172113068,"gmtModify":1703502544208,"author":{"id":"3581492791156392","authorId":"3581492791156392","name":"FantasyX","avatar":"https://static.tigerbbs.com/d5be60dde27e883d6f8b569b3afe2f3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/899807224","repostId":"1102705333","repostType":4,"isVote":1,"tweetType":1,"viewCount":83,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":890361126,"gmtCreate":1628084077765,"gmtModify":1703500886221,"author":{"id":"3581492791156392","authorId":"3581492791156392","name":"FantasyX","avatar":"https://static.tigerbbs.com/d5be60dde27e883d6f8b569b3afe2f3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/890361126","repostId":"2156909108","repostType":4,"repost":{"id":"2156909108","pubTimestamp":1628082780,"share":"https://www.laohu8.com/m/news/2156909108?lang=&edition=full","pubTime":"2021-08-04 21:13","market":"us","language":"en","title":"Can You Retire a Millionaire With ETFs Alone?","url":"https://stock-news.laohu8.com/highlight/detail?id=2156909108","media":"Motley Fool","summary":"ETFs can make you a millionaire, but you have to follow some investment rules to get there.","content":"<p>You can enjoy the retirement of your dreams using exchange-traded funds instead of some complex investing strategy -- but there are a few catches. Reaching $1 million in your investment account isn't easy; that's why most people don't do it. Still, there are some key steps you can follow that don't involve stock picking, high risk, or any advanced trading techniques. There's no guarantee you'll get there as life throws its hurdles at you, but some core rules will lay the groundwork for plenty of long-term growth.</p>\n<h3>How to accumulate $1 million</h3>\n<p>The equation to reach $1 million is simple from a numbers standpoint. Make money, save a fraction of it, and invest those savings for growth. The complications arise in strategy and execution.</p>\n<p>If you can save $500 each month, and you invest those savings to achieve an 8% average annual growth rate, then you'll have accumulated $1 million after 35 years. The<b> S&amp;P 500</b> long-term rate of return is around 10%, so that piece of the plan isn't far-fetched. Instead, this process can get thrown off the rails by inconsistent stock performance or shifting investment goals.</p>\n<p>In real life, you probably won't be able to save the same amount every single month. Not every family can set aside $500 every month. Young families with new children, new mortgages, and other monthly bills usually have to navigate those challenges before they reach their peak earning potential. Unexpected expenses and income disruptions also pop up along the way, and there will be times that you simply can't save.</p>\n<p>On top of all that, most people have to start monitoring volatility as they approach retirement. If you're hit by a market crash too close to the day you stop working, then your 401(k) might not have time to recover. As a result, most people increase their bond allocation as they approach retirement. This is a smart move, but it also limits your growth potential. Suddenly that 8% rate of return isn't as easy to achieve across your entire portfolio.</p>\n<p>As a result, it's important to take full advantage of responsible growth opportunities throughout your investing lifetime. Growth stocks have been a great source of wealth creation for countless investors, but they can be risky and difficult to manage. For many people, growth-focused ETFs are a perfect solution.</p>\n<p><img src=\"https://static.tigerbbs.com/bf6d6e37e27339f7facea56dd3d06885\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Image source: Getty Images.</p>\n<h3>The best ETFs for building wealth</h3>\n<p>The returns provided by index funds are fine for most investors, but you don't have to settle for those growth rates. There are numerous ETFs that have outpaced the S&amp;P 500 over the long term, but they still provide enough diversification to reduce risk and volatility in a way that you can't achieve with individual stocks.</p>\n<p>The <b>Vanguard Growth ETF</b> (NYSEMKT:VUG) is probably the most popular growth-focused ETF, with nearly $83 billion in assets under management. The Vanguard Growth fund offers excellent liquidity and razor-thin expense margins, which are both great for investors. It provides efficient exposure to nearly 300 different large-cap companies with more growth upside than the S&amp;P 500. It's outpaced the market by almost 200 percentage points since 2007, rewarding investors who are willing to take on the higher volatility inherent in growth stock investing. Don't be shocked if this fund gets rocked harder during bear markets, owing to heavy concentration in tech stocks and companies with aggressive valuations.</p>\n<p>The <b>Invesco S&amp;P 500 Equal Weight Technology ETF</b> (NYSEMKT:RYT) is an alternative with a different approach. This fund holds 75 tech stocks from the S&amp;P 500 index, but no single holding makes up more than 2% of the total allocation. This keeps huge companies like <b>Apple</b>, <b>Microsoft</b>, <b>Amazon</b>, and <b>Alphabet</b> from dominating its performance. The result is serious long-term growth. The ETF has returned nearly 600% since launching in 2007, more than 70 percentage points ahead of the Vanguard Growth ETF. Investors have to pay up for the privilege, though -- the 0.4% expense ratio is high compared to most index funds, but it's justified that cost over the long term.</p>\n<p>The <b>Invesco S&amp;P 500 Equal Weight Health Care ETF</b> (NYSEMKT:RYH) is nearly identical, but it holds more than 60 healthcare stocks. Its mixture of device makers, pharmaceutical stocks, biotechs, and care providers has propelled well beyond the S&amp;P 500 since the fund's launch, and it provides a different flavor than most of the other growth ETFs.</p>\n<p><img src=\"https://static.tigerbbs.com/cea9483966e6aa6aa7ca3e22183a1861\" tg-width=\"720\" tg-height=\"387\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>VUG Total Return Level data by YCharts</p>\n<p>There's a huge list of growth ETFs that will provide more than enough growth to achieve millionaire status, but you have to get the fundamentals right to take advantage of the opportunity.</p>\n<p>Retiring a millionaire requires some combination of a solid household income, a high savings rate, and investment growth -- most likely a combination of all three. There's no magic investment strategy that can make up for insufficient savings. Most people aren't successful stock-pickers over the long term, so they'll turn elsewhere to accomplish their goals. If you're doing the hard work to save enough each month, then there are great ETFs available that are more than good enough to make you a millionaire.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Can You Retire a Millionaire With ETFs Alone?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCan You Retire a Millionaire With ETFs Alone?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-04 21:13 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/04/can-you-retire-a-millionaire-with-etfs-alone/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>You can enjoy the retirement of your dreams using exchange-traded funds instead of some complex investing strategy -- but there are a few catches. Reaching $1 million in your investment account isn't ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/04/can-you-retire-a-millionaire-with-etfs-alone/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","SPXU":"三倍做空标普500ETF","OEF":"标普100指数ETF-iShares","SDS":"两倍做空标普500ETF","IVV":"标普500指数ETF","UPRO":"三倍做多标普500ETF","SSO":"两倍做多标普500ETF",".SPX":"S&P 500 Index","SPY":"标普500ETF","OEX":"标普100","SH":"标普500反向ETF"},"source_url":"https://www.fool.com/investing/2021/08/04/can-you-retire-a-millionaire-with-etfs-alone/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2156909108","content_text":"You can enjoy the retirement of your dreams using exchange-traded funds instead of some complex investing strategy -- but there are a few catches. Reaching $1 million in your investment account isn't easy; that's why most people don't do it. Still, there are some key steps you can follow that don't involve stock picking, high risk, or any advanced trading techniques. There's no guarantee you'll get there as life throws its hurdles at you, but some core rules will lay the groundwork for plenty of long-term growth.\nHow to accumulate $1 million\nThe equation to reach $1 million is simple from a numbers standpoint. Make money, save a fraction of it, and invest those savings for growth. The complications arise in strategy and execution.\nIf you can save $500 each month, and you invest those savings to achieve an 8% average annual growth rate, then you'll have accumulated $1 million after 35 years. The S&P 500 long-term rate of return is around 10%, so that piece of the plan isn't far-fetched. Instead, this process can get thrown off the rails by inconsistent stock performance or shifting investment goals.\nIn real life, you probably won't be able to save the same amount every single month. Not every family can set aside $500 every month. Young families with new children, new mortgages, and other monthly bills usually have to navigate those challenges before they reach their peak earning potential. Unexpected expenses and income disruptions also pop up along the way, and there will be times that you simply can't save.\nOn top of all that, most people have to start monitoring volatility as they approach retirement. If you're hit by a market crash too close to the day you stop working, then your 401(k) might not have time to recover. As a result, most people increase their bond allocation as they approach retirement. This is a smart move, but it also limits your growth potential. Suddenly that 8% rate of return isn't as easy to achieve across your entire portfolio.\nAs a result, it's important to take full advantage of responsible growth opportunities throughout your investing lifetime. Growth stocks have been a great source of wealth creation for countless investors, but they can be risky and difficult to manage. For many people, growth-focused ETFs are a perfect solution.\n\nImage source: Getty Images.\nThe best ETFs for building wealth\nThe returns provided by index funds are fine for most investors, but you don't have to settle for those growth rates. There are numerous ETFs that have outpaced the S&P 500 over the long term, but they still provide enough diversification to reduce risk and volatility in a way that you can't achieve with individual stocks.\nThe Vanguard Growth ETF (NYSEMKT:VUG) is probably the most popular growth-focused ETF, with nearly $83 billion in assets under management. The Vanguard Growth fund offers excellent liquidity and razor-thin expense margins, which are both great for investors. It provides efficient exposure to nearly 300 different large-cap companies with more growth upside than the S&P 500. It's outpaced the market by almost 200 percentage points since 2007, rewarding investors who are willing to take on the higher volatility inherent in growth stock investing. Don't be shocked if this fund gets rocked harder during bear markets, owing to heavy concentration in tech stocks and companies with aggressive valuations.\nThe Invesco S&P 500 Equal Weight Technology ETF (NYSEMKT:RYT) is an alternative with a different approach. This fund holds 75 tech stocks from the S&P 500 index, but no single holding makes up more than 2% of the total allocation. This keeps huge companies like Apple, Microsoft, Amazon, and Alphabet from dominating its performance. The result is serious long-term growth. The ETF has returned nearly 600% since launching in 2007, more than 70 percentage points ahead of the Vanguard Growth ETF. Investors have to pay up for the privilege, though -- the 0.4% expense ratio is high compared to most index funds, but it's justified that cost over the long term.\nThe Invesco S&P 500 Equal Weight Health Care ETF (NYSEMKT:RYH) is nearly identical, but it holds more than 60 healthcare stocks. Its mixture of device makers, pharmaceutical stocks, biotechs, and care providers has propelled well beyond the S&P 500 since the fund's launch, and it provides a different flavor than most of the other growth ETFs.\n\nVUG Total Return Level data by YCharts\nThere's a huge list of growth ETFs that will provide more than enough growth to achieve millionaire status, but you have to get the fundamentals right to take advantage of the opportunity.\nRetiring a millionaire requires some combination of a solid household income, a high savings rate, and investment growth -- most likely a combination of all three. There's no magic investment strategy that can make up for insufficient savings. Most people aren't successful stock-pickers over the long term, so they'll turn elsewhere to accomplish their goals. If you're doing the hard work to save enough each month, then there are great ETFs available that are more than good enough to make you a millionaire.","news_type":1},"isVote":1,"tweetType":1,"viewCount":121,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":807096428,"gmtCreate":1627986787164,"gmtModify":1703499123034,"author":{"id":"3581492791156392","authorId":"3581492791156392","name":"FantasyX","avatar":"https://static.tigerbbs.com/d5be60dde27e883d6f8b569b3afe2f3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Woe","listText":"Woe","text":"Woe","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/807096428","repostId":"2156100119","repostType":4,"isVote":1,"tweetType":1,"viewCount":147,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":807098566,"gmtCreate":1627986720255,"gmtModify":1703499121733,"author":{"id":"3581492791156392","authorId":"3581492791156392","name":"FantasyX","avatar":"https://static.tigerbbs.com/d5be60dde27e883d6f8b569b3afe2f3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/807098566","repostId":"1158700064","repostType":4,"isVote":1,"tweetType":1,"viewCount":122,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":804038781,"gmtCreate":1627911555543,"gmtModify":1703497711425,"author":{"id":"3581492791156392","authorId":"3581492791156392","name":"FantasyX","avatar":"https://static.tigerbbs.com/d5be60dde27e883d6f8b569b3afe2f3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/804038781","repostId":"2156192895","repostType":4,"repost":{"id":"2156192895","pubTimestamp":1627909020,"share":"https://www.laohu8.com/m/news/2156192895?lang=&edition=full","pubTime":"2021-08-02 20:57","market":"us","language":"en","title":"Can Last Year's Biggest Vaccine Stocks Crush the Market Again?","url":"https://stock-news.laohu8.com/highlight/detail?id=2156192895","media":"Motley Fool","summary":"These players delivered triple- and quadruple-digit gains.","content":"<blockquote>\n <b>These players delivered triple- and quadruple-digit gains.</b>\n</blockquote>\n<p><b>Key <a href=\"https://laohu8.com/S/PCOM\">Points</a></b></p>\n<ul>\n <li>Last year, most coronavirus vaccine stocks were high risk.</li>\n <li>Today, there are investment opportunities for aggressive investors and cautious investors.</li>\n</ul>\n<p>Coronavirus vaccine stocks were the biggest investment theme of 2020. Some players soared more than 1,000% as investors bet on their abilities to bring a billion-dollar product to market. That's as the S&amp;P 500 Index rose about 16%.</p>\n<p>Since, two biotech companies --<b>Moderna</b> (NASDAQ:MRNA) and&nbsp;<b><a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a></b> -- actually have commercialized their vaccines. And they are indeed generating billions of dollars in revenue. But what about some of the other vaccine stocks that scored big on the stock market last year? Let's take a look at where they're at with vaccine programs -- and whether they're on track to beat the market in the second half.</p>\n<p><img src=\"https://static.tigerbbs.com/4892523d64861e597e6e75e31fe85713\" tg-width=\"700\" tg-height=\"467\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: <a href=\"https://laohu8.com/S/GTY\">Getty</a> Images.</p>\n<p><b><a href=\"https://laohu8.com/S/NVAX\">Novavax</a></b></p>\n<p>The program:&nbsp;<b><a href=\"https://laohu8.com/S/NVAX\">Novavax</a></b>'s U.S. phase 3 trial of its vaccine candidate showed 90.4% overall efficacy. It demonstrated 100% efficacy in moderate and severe disease. The company fell behind in its submissions to regulators as it ramped up its manufacturing network. For instance, it's faced shortages of certain raw materials needed to produce the vaccine candidate. In May, Novavax said it would file for authorization in various locations worldwide -- including the U.S. -- in the third quarter. And Novavax predicts manufacturing will operate at full capacity as of the fourth quarter.</p>\n<p>The share price: The stock rose 90% in the first half. That's after soaring 2,700% last year.</p>\n<p>Are more share gains on the horizon? Novavax said in its latest earnings call that it expects to generate billions of dollars in revenue over the next four to six quarters. If Novavax wins vaccine authorization in the coming months, this could become a reality. The company already has orders to deliver 200 million doses to various countries. All of this could equal solid share performance in the second half.</p>\n<p><img src=\"https://static.tigerbbs.com/54a0fc748f5a7357128a290dd852b959\" tg-width=\"720\" tg-height=\"534\" referrerpolicy=\"no-referrer\"></p>\n<p>NVAX data by YCharts</p>\n<p><b>Vaxart</b></p>\n<p>The program:&nbsp;<b><a href=\"https://laohu8.com/S/VXRT\">Vaxart, Inc</a></b> seemed out of the race earlier in the year. The company's phase 1 trial showed its oral vaccine candidate didn't produce neutralizing antibodies. They are seen as key to preventing infection. But additional trial data demonstrated strength in producing killer T cell responses. This powerful immune system tool is another way to fight infection. Vaxart said it would launch a phase 2 study of its candidate mid-year. It will start a phase 1/2 study of a variant-specific candidate in the third quarter.</p>\n<p>The share price: Vaxart shares climbed 31% in the first half. That follows last year's 1,500% increase.</p>\n<p>Are more share gains on the horizon? Vaxart remains risky. Any negative news in the second half could be disastrous. Still, the idea of a vaccine in pill form could be a game-changer. If the company announces trial starts as planned, the shares may outperform the market in the coming months. And any positive data could offer a major boost.</p>\n<p><b><a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a></b></p>\n<p>The program: Moderna reported more than $1 billion in profit -- its first profit ever -- after <a href=\"https://laohu8.com/S/AONE.U\">one</a> full quarter of coronavirus vaccine sales. The company expects at least $19.2 billion in vaccine revenue this year. It's already won 2022 orders from countries including the U.S., Israel, and Switzerland. And the company predicts need for the vaccine could be greater next year than this year.</p>\n<p>The share price: Moderna shares rose about 125% in the first half -- and added more than 40% over the past month. That's after a 434% increase last year.</p>\n<p>Are more share gains on the horizon? Moderna is likely to beat the S&amp;P 500 in the second half if three key things happen: The company reports new contracts for 2022, successfully gains authorization for the use of its vaccine in teens, and gets the regulatory nod for a booster. I'm pretty optimistic about each.</p>\n<p><b><a href=\"https://laohu8.com/S/ARCT\">Arcturus Therapeutics Ltd.</a> </b></p>\n<p>The program:<b>Arcturus Therapeutics</b> (NASDAQ:ARCT) is testing its mRNA vaccine in a phase 2 study and plans on reporting data in the second half. The product could stand out from mRNA rivals<b><a href=\"https://laohu8.com/S/PFE\">Pfizer</a></b> and Moderna because it's freeze-dried and given in <a href=\"https://laohu8.com/S/AONE.U\">one</a> dose. The Pfizer and Moderna vaccines require cold storage and are given in two shots.</p>\n<p>The share price: Arcturus shares slipped 22% in the first half. Last year, they surged 299%.</p>\n<p>Is a share price recovery on the horizon? The above advantages sound great. But here's the problem: In a phase 1 study, Arcturus' candidate produced lower neutralizing antibody levels than the Pfizer and Moderna jabs. This translates into lower efficacy. If the next batch of data shows stronger results, the shares could climb. But if performance remains well below rivals, I wouldn't expect Arcturus to beat the S&amp;P 500 in the second half.</p>\n<p><img src=\"https://static.tigerbbs.com/cd5cf54e35734c9da8a1260f2c3436bc\" tg-width=\"720\" tg-height=\"534\" referrerpolicy=\"no-referrer\"></p>\n<p>NVAX data by YCharts</p>\n<p><b>Ocugen</b></p>\n<p>The program:&nbsp;<b>Ocugen</b> (NASDAQ:OCGN) in December announced it would partner with India's Bharat Biotech to co-commercialize its late-stage coronavirus vaccine in the U.S. More recently, the U.S. Food and Drug Administration advised Ocugen to pursue a traditional regulatory path rather than Emergency Use Authorization (EUA). Ocugen also gained rights to co-commercialize the candidate in Canada and has started a rolling submission there.</p>\n<p>The share price: Ocugen stock soared 338% in the first half. That's after climbing more than 251% last year (with almost all of that gain coming after the Bharat partnership announcement).</p>\n<p>Are more share gains on the horizon? Ocugen remains high risk. <a href=\"https://laohu8.com/S/ISBC\">Investors</a> were betting on big revenue from a possible EUA in the U.S. Now, revenue possibilities seem lower and farther off. The stock may continue to climb in the second half if Canada moves quickly on an authorization. But in my opinion, over the long term, the shares are like a house of cards. If U.S. approval doesn't happen or takes too long, they may collapse.</p>\n<p><b><a href=\"https://laohu8.com/S/INO\">Inovio Pharmaceuticals</a> </b></p>\n<p>The program: Earlier this year, the U.S. government dropped plans to fund<b><a href=\"https://laohu8.com/S/INO\">Inovio Pharmaceuticals</a></b>' (NASDAQ:INO) phase 3 trial. The government cited the rapid launch of other vaccines into the marketplace. As a result, Inovio said it would conduct phase 3 primarily outside of the U.S. The company aims to launch the trial with Chinese partner Advaccine Biopharmaceuticals Suzhou this summer. Inovio also is working on a next-generation \"pan-COVID\" vaccine candidate. It plans to start clinical testing on the candidate this year.</p>\n<p>The share price: Inovio added 4.8% in the first half. That's after climbing 168% last year.</p>\n<p>Are more share gains on the horizon? Inovio is another high-risk stock. Its initial candidate may have trouble carving out share in a market dominated by solid players. Most promising is the pan-COVID candidate. Especially considering the growth of variants. But we'll need clinical trial data to see if the potential product actually works. I would be surprised if Inovio beat the S&amp;P 500 in the second half of this year. The pan-COVID candidate makes Inovio a stock to watch -- but from a distance.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Can Last Year's Biggest Vaccine Stocks Crush the Market Again?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCan Last Year's Biggest Vaccine Stocks Crush the Market Again?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-02 20:57 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/02/can-these-big-vaccine-stocks-crush-market-again/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>These players delivered triple- and quadruple-digit gains.\n\nKey Points\n\nLast year, most coronavirus vaccine stocks were high risk.\nToday, there are investment opportunities for aggressive investors ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/02/can-these-big-vaccine-stocks-crush-market-again/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","NVAX":"诺瓦瓦克斯医药","BNTX":"BioNTech SE","VXRT":"Vaxart, Inc","PFE":"辉瑞","ARCT":"Arcturus Therapeutics Ltd.","INO":"伊诺维奥制药","OCGN":"Ocugen"},"source_url":"https://www.fool.com/investing/2021/08/02/can-these-big-vaccine-stocks-crush-market-again/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2156192895","content_text":"These players delivered triple- and quadruple-digit gains.\n\nKey Points\n\nLast year, most coronavirus vaccine stocks were high risk.\nToday, there are investment opportunities for aggressive investors and cautious investors.\n\nCoronavirus vaccine stocks were the biggest investment theme of 2020. Some players soared more than 1,000% as investors bet on their abilities to bring a billion-dollar product to market. That's as the S&P 500 Index rose about 16%.\nSince, two biotech companies --Moderna (NASDAQ:MRNA) and BioNTech SE -- actually have commercialized their vaccines. And they are indeed generating billions of dollars in revenue. But what about some of the other vaccine stocks that scored big on the stock market last year? Let's take a look at where they're at with vaccine programs -- and whether they're on track to beat the market in the second half.\n\nImage source: Getty Images.\nNovavax\nThe program: Novavax's U.S. phase 3 trial of its vaccine candidate showed 90.4% overall efficacy. It demonstrated 100% efficacy in moderate and severe disease. The company fell behind in its submissions to regulators as it ramped up its manufacturing network. For instance, it's faced shortages of certain raw materials needed to produce the vaccine candidate. In May, Novavax said it would file for authorization in various locations worldwide -- including the U.S. -- in the third quarter. And Novavax predicts manufacturing will operate at full capacity as of the fourth quarter.\nThe share price: The stock rose 90% in the first half. That's after soaring 2,700% last year.\nAre more share gains on the horizon? Novavax said in its latest earnings call that it expects to generate billions of dollars in revenue over the next four to six quarters. If Novavax wins vaccine authorization in the coming months, this could become a reality. The company already has orders to deliver 200 million doses to various countries. All of this could equal solid share performance in the second half.\n\nNVAX data by YCharts\nVaxart\nThe program: Vaxart, Inc seemed out of the race earlier in the year. The company's phase 1 trial showed its oral vaccine candidate didn't produce neutralizing antibodies. They are seen as key to preventing infection. But additional trial data demonstrated strength in producing killer T cell responses. This powerful immune system tool is another way to fight infection. Vaxart said it would launch a phase 2 study of its candidate mid-year. It will start a phase 1/2 study of a variant-specific candidate in the third quarter.\nThe share price: Vaxart shares climbed 31% in the first half. That follows last year's 1,500% increase.\nAre more share gains on the horizon? Vaxart remains risky. Any negative news in the second half could be disastrous. Still, the idea of a vaccine in pill form could be a game-changer. If the company announces trial starts as planned, the shares may outperform the market in the coming months. And any positive data could offer a major boost.\nModerna, Inc.\nThe program: Moderna reported more than $1 billion in profit -- its first profit ever -- after one full quarter of coronavirus vaccine sales. The company expects at least $19.2 billion in vaccine revenue this year. It's already won 2022 orders from countries including the U.S., Israel, and Switzerland. And the company predicts need for the vaccine could be greater next year than this year.\nThe share price: Moderna shares rose about 125% in the first half -- and added more than 40% over the past month. That's after a 434% increase last year.\nAre more share gains on the horizon? Moderna is likely to beat the S&P 500 in the second half if three key things happen: The company reports new contracts for 2022, successfully gains authorization for the use of its vaccine in teens, and gets the regulatory nod for a booster. I'm pretty optimistic about each.\nArcturus Therapeutics Ltd. \nThe program:Arcturus Therapeutics (NASDAQ:ARCT) is testing its mRNA vaccine in a phase 2 study and plans on reporting data in the second half. The product could stand out from mRNA rivalsPfizer and Moderna because it's freeze-dried and given in one dose. The Pfizer and Moderna vaccines require cold storage and are given in two shots.\nThe share price: Arcturus shares slipped 22% in the first half. Last year, they surged 299%.\nIs a share price recovery on the horizon? The above advantages sound great. But here's the problem: In a phase 1 study, Arcturus' candidate produced lower neutralizing antibody levels than the Pfizer and Moderna jabs. This translates into lower efficacy. If the next batch of data shows stronger results, the shares could climb. But if performance remains well below rivals, I wouldn't expect Arcturus to beat the S&P 500 in the second half.\n\nNVAX data by YCharts\nOcugen\nThe program: Ocugen (NASDAQ:OCGN) in December announced it would partner with India's Bharat Biotech to co-commercialize its late-stage coronavirus vaccine in the U.S. More recently, the U.S. Food and Drug Administration advised Ocugen to pursue a traditional regulatory path rather than Emergency Use Authorization (EUA). Ocugen also gained rights to co-commercialize the candidate in Canada and has started a rolling submission there.\nThe share price: Ocugen stock soared 338% in the first half. That's after climbing more than 251% last year (with almost all of that gain coming after the Bharat partnership announcement).\nAre more share gains on the horizon? Ocugen remains high risk. Investors were betting on big revenue from a possible EUA in the U.S. Now, revenue possibilities seem lower and farther off. The stock may continue to climb in the second half if Canada moves quickly on an authorization. But in my opinion, over the long term, the shares are like a house of cards. If U.S. approval doesn't happen or takes too long, they may collapse.\nInovio Pharmaceuticals \nThe program: Earlier this year, the U.S. government dropped plans to fundInovio Pharmaceuticals' (NASDAQ:INO) phase 3 trial. The government cited the rapid launch of other vaccines into the marketplace. As a result, Inovio said it would conduct phase 3 primarily outside of the U.S. The company aims to launch the trial with Chinese partner Advaccine Biopharmaceuticals Suzhou this summer. Inovio also is working on a next-generation \"pan-COVID\" vaccine candidate. It plans to start clinical testing on the candidate this year.\nThe share price: Inovio added 4.8% in the first half. That's after climbing 168% last year.\nAre more share gains on the horizon? Inovio is another high-risk stock. Its initial candidate may have trouble carving out share in a market dominated by solid players. Most promising is the pan-COVID candidate. Especially considering the growth of variants. But we'll need clinical trial data to see if the potential product actually works. I would be surprised if Inovio beat the S&P 500 in the second half of this year. The pan-COVID candidate makes Inovio a stock to watch -- but from a distance.","news_type":1},"isVote":1,"tweetType":1,"viewCount":115,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":810626892,"gmtCreate":1629973702016,"gmtModify":1676530188636,"author":{"id":"3581492791156392","authorId":"3581492791156392","name":"FantasyX","avatar":"https://static.tigerbbs.com/d5be60dde27e883d6f8b569b3afe2f3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/810626892","repostId":"2162060923","repostType":4,"repost":{"id":"2162060923","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1629971488,"share":"https://www.laohu8.com/m/news/2162060923?lang=&edition=full","pubTime":"2021-08-26 17:51","market":"us","language":"en","title":"5 Stocks To Watch For August 26, 2021","url":"https://stock-news.laohu8.com/highlight/detail?id=2162060923","media":"Benzinga","summary":"Some of the stocks that may grab investor focus today are:\n\tWall Street expects  Dollar General Corp. (NYSE: DG) to report quarterly earnings at $2.57 per share on revenue of $8.59 billion before the opening bell. Dollar General shares rose 0.1% to $235.01 in after-hours trading.\n","content":"<p>Some of the stocks that may grab investor focus today are:</p>\n<ul>\n <li>Wall Street expects<b> <a href=\"https://laohu8.com/S/DG\">Dollar General</a> Corp.</b> (NYSE:DG) to report quarterly earnings at $2.57 per share on revenue of $8.59 billion before the opening bell. Dollar <a href=\"https://laohu8.com/S/BGC\">General</a> shares rose 0.1% to $235.01 in after-hours trading.</li>\n <li><b><a href=\"https://laohu8.com/S/CRM\">Salesforce.com</a> </b>(NYSE:CRM) reported better-than-expected results for its second quarter and boosted its FY22 guidance. <a href=\"https://laohu8.com/S/CRM\">Salesforce</a> shares gained 1.8% to $265.50 in the after-hours trading session.</li>\n <li>Analysts are expecting <b><a href=\"https://laohu8.com/S/HPQ\">HP Inc</a></b> (NYSE:HPQ) to have earned $0.84 per share on revenue of $15.91 billion for the latest quarter. The company will release earnings after the markets close. HP shares gained 0.8% to $29.63 in after-hours trading.</li>\n</ul>\n<ul>\n <li><b><a href=\"https://laohu8.com/S/WSM\">Williams-Sonoma</a>, Inc.</b> (NYSE:WSM) reported upbeat results for its second quarter. The company announced a $1.25 billion buyback and also raised its dividend from $0.59 to $0.71 per share. <a href=\"https://laohu8.com/S/WMB\">Williams</a>-Sonoma shares jumped 12.7% to $192.35 in the after-hours trading session.</li>\n <li>Analysts expect <b><a href=\"https://laohu8.com/S/DLTR\">Dollar Tree, Inc.</a></b> (NASDAQ:DLTR) to report quarterly earnings at $1.01 per share on revenue of $6.44 billion before the opening bell. <a href=\"https://laohu8.com/S/DLTR\">Dollar Tree</a> shares rose 1.6% to $108.02 in after-hours trading.</li>\n</ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Stocks To Watch For August 26, 2021</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Stocks To Watch For August 26, 2021\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-08-26 17:51</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Some of the stocks that may grab investor focus today are:</p>\n<ul>\n <li>Wall Street expects<b> <a href=\"https://laohu8.com/S/DG\">Dollar General</a> Corp.</b> (NYSE:DG) to report quarterly earnings at $2.57 per share on revenue of $8.59 billion before the opening bell. Dollar <a href=\"https://laohu8.com/S/BGC\">General</a> shares rose 0.1% to $235.01 in after-hours trading.</li>\n <li><b><a href=\"https://laohu8.com/S/CRM\">Salesforce.com</a> </b>(NYSE:CRM) reported better-than-expected results for its second quarter and boosted its FY22 guidance. <a href=\"https://laohu8.com/S/CRM\">Salesforce</a> shares gained 1.8% to $265.50 in the after-hours trading session.</li>\n <li>Analysts are expecting <b><a href=\"https://laohu8.com/S/HPQ\">HP Inc</a></b> (NYSE:HPQ) to have earned $0.84 per share on revenue of $15.91 billion for the latest quarter. The company will release earnings after the markets close. HP shares gained 0.8% to $29.63 in after-hours trading.</li>\n</ul>\n<ul>\n <li><b><a href=\"https://laohu8.com/S/WSM\">Williams-Sonoma</a>, Inc.</b> (NYSE:WSM) reported upbeat results for its second quarter. The company announced a $1.25 billion buyback and also raised its dividend from $0.59 to $0.71 per share. <a href=\"https://laohu8.com/S/WMB\">Williams</a>-Sonoma shares jumped 12.7% to $192.35 in the after-hours trading session.</li>\n <li>Analysts expect <b><a href=\"https://laohu8.com/S/DLTR\">Dollar Tree, Inc.</a></b> (NASDAQ:DLTR) to report quarterly earnings at $1.01 per share on revenue of $6.44 billion before the opening bell. <a href=\"https://laohu8.com/S/DLTR\">Dollar Tree</a> shares rose 1.6% to $108.02 in after-hours trading.</li>\n</ul>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"WSM":"Williams-Sonoma Inc","DG":"美国达乐公司","CRM":"赛富时","DLTR":"美元树公司"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2162060923","content_text":"Some of the stocks that may grab investor focus today are:\n\nWall Street expects Dollar General Corp. (NYSE:DG) to report quarterly earnings at $2.57 per share on revenue of $8.59 billion before the opening bell. Dollar General shares rose 0.1% to $235.01 in after-hours trading.\nSalesforce.com (NYSE:CRM) reported better-than-expected results for its second quarter and boosted its FY22 guidance. Salesforce shares gained 1.8% to $265.50 in the after-hours trading session.\nAnalysts are expecting HP Inc (NYSE:HPQ) to have earned $0.84 per share on revenue of $15.91 billion for the latest quarter. The company will release earnings after the markets close. HP shares gained 0.8% to $29.63 in after-hours trading.\n\n\nWilliams-Sonoma, Inc. (NYSE:WSM) reported upbeat results for its second quarter. The company announced a $1.25 billion buyback and also raised its dividend from $0.59 to $0.71 per share. Williams-Sonoma shares jumped 12.7% to $192.35 in the after-hours trading session.\nAnalysts expect Dollar Tree, Inc. (NASDAQ:DLTR) to report quarterly earnings at $1.01 per share on revenue of $6.44 billion before the opening bell. Dollar Tree shares rose 1.6% to $108.02 in after-hours trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":111,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":830574407,"gmtCreate":1629086128209,"gmtModify":1676529925079,"author":{"id":"3581492791156392","authorId":"3581492791156392","name":"FantasyX","avatar":"https://static.tigerbbs.com/d5be60dde27e883d6f8b569b3afe2f3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/830574407","repostId":"1145684106","repostType":4,"isVote":1,"tweetType":1,"viewCount":403,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":172655858,"gmtCreate":1626960649474,"gmtModify":1703481379482,"author":{"id":"3581492791156392","authorId":"3581492791156392","name":"FantasyX","avatar":"https://static.tigerbbs.com/d5be60dde27e883d6f8b569b3afe2f3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/172655858","repostId":"1170462111","repostType":4,"repost":{"id":"1170462111","pubTimestamp":1626960206,"share":"https://www.laohu8.com/m/news/1170462111?lang=&edition=full","pubTime":"2021-07-22 21:23","market":"us","language":"en","title":"Delta Variant Can Still Clip U.S. Economy’s Wings","url":"https://stock-news.laohu8.com/highlight/detail?id=1170462111","media":"The Wall Street Journal","summary":"Variant might not have the same impact as previous surges, but spotty rates of vaccination mean it c","content":"<blockquote>\n Variant might not have the same impact as previous surges, but spotty rates of vaccination mean it could slow growth.\n</blockquote>\n<p>The Delta variant of the coronavirus probablywon’t derail the U.S. economy. That doesn’t mean it can’t damage parts of it.</p>\n<p>For a while, America’s progress against the Covid-19 pandemic looked very good. Millions of people were getting vaccinated each day, Covid-19 cases, hospitalizations and deaths were falling, and a return to something like normal beckoned. But then the vaccine rollout slowed markedly just as the far more contagiousDelta variant took hold. Cases, hospitalizations and deaths have begun to rise.</p>\n<p>It is tempting to imagine the Delta variant won’t dent the economy at all.</p>\n<p>Across the board, state and local officials seem far less apt to dial up restrictions in response to rising Covid-19 cases than they were a year ago, while the places with low vaccine uptake also happen to be the places that are most resistant to restrictions. Moreover, many people are vaccinated—particularly the elderly—and with the apparent efficacy of current vaccines against the Delta variant, the U.S. seems unlikely to revisit the staggering mortality statistics of the sort it experienced before vaccines became widely available. Finally, the savings many Americans built up over the past year left them with ample money to throw around, while businesses’ scramble for workers points to a labor market that should keep generating income gains.</p>\n<p><img src=\"https://static.tigerbbs.com/dc6f808b2d4e2353d6504f76af7f3af0\" tg-width=\"737\" tg-height=\"511\" width=\"100%\" height=\"auto\">Those are all things that should ensure the economy continues to grow, but it probably won’t grow as swiftly as it otherwise could have. Worries about the Delta variant will lead some people to refrain from entering crowded settings, such as restaurants or airplanes, while also making them more cautious about spending down any savings. Some companieswill delay their return to the office, as Apple just did, and that will hurt downtown restaurants and the like that depend on office workers’ business.</p>\n<p>Bear in mind that the places where vaccine hesitancy is high and Covid-19 worries low aren’t monolithic: Some share of the population will up their caution, in some cases even if they are fully vaccinated for fear of a breakthrough infection. And the more new cases there are in their communities, the more cautious they will become.</p>\n<p>Nor are places where vaccination rates are better necessarily going to avoid the fallout from the contagious Delta variant. Around 72% of the 18 and over population of Los Angeles County have received at least once shot, more than the country at large, yet with case rates and hospitalizations rising, last week it reinstatedan order to wear masks indoorsin businesses and public places.</p>\n<p>Then there is the question of what the start of the coming school year might look like. Children under the age of 12 aren’t eligible for vaccination, and authorization for children between 5 and 11 looks as if it won’t comeuntil sometime in the fall, at the earliest. Most schools intend to return to in-person classes, with some offering remote options, but the Delta variant could upend some of those plans.</p>\n<p>At the very least parents might need to prepare for the possibility of a positive Covid test shutting down a classroom, leaving their children, and them, stuck at home. Strategists at Evercore ISI point out that the return to school this fall was supposed to free parents for work, boosting the labor supply. But some of the job growth and easing of hiring strains that could create might now be deferred.</p>\n<p>The economy has been growing since April last year—a point brought home by the National Bureau of Economic Research’srecent determinationthat that was when the brief, severe recession the pandemic brought on ended. It kept growing despite a new surge in Covid-19 infections last summer and another wave in the late fall through winter. Unlike in those previous surges, many Americans have been vaccinated so the impact won’t be as severe as it otherwise might have been.</p>\n<p>But things could have been so much better.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Delta Variant Can Still Clip U.S. Economy’s Wings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDelta Variant Can Still Clip U.S. Economy’s Wings\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-22 21:23 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/articles/delta-variant-can-still-clip-u-s-economys-wings-11626959045?mod=rss_markets_main><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Variant might not have the same impact as previous surges, but spotty rates of vaccination mean it could slow growth.\n\nThe Delta variant of the coronavirus probablywon’t derail the U.S. economy. That ...</p>\n\n<a href=\"https://www.wsj.com/articles/delta-variant-can-still-clip-u-s-economys-wings-11626959045?mod=rss_markets_main\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯","SPY":"标普500ETF",".IXIC":"NASDAQ Composite"},"source_url":"https://www.wsj.com/articles/delta-variant-can-still-clip-u-s-economys-wings-11626959045?mod=rss_markets_main","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1170462111","content_text":"Variant might not have the same impact as previous surges, but spotty rates of vaccination mean it could slow growth.\n\nThe Delta variant of the coronavirus probablywon’t derail the U.S. economy. That doesn’t mean it can’t damage parts of it.\nFor a while, America’s progress against the Covid-19 pandemic looked very good. Millions of people were getting vaccinated each day, Covid-19 cases, hospitalizations and deaths were falling, and a return to something like normal beckoned. But then the vaccine rollout slowed markedly just as the far more contagiousDelta variant took hold. Cases, hospitalizations and deaths have begun to rise.\nIt is tempting to imagine the Delta variant won’t dent the economy at all.\nAcross the board, state and local officials seem far less apt to dial up restrictions in response to rising Covid-19 cases than they were a year ago, while the places with low vaccine uptake also happen to be the places that are most resistant to restrictions. Moreover, many people are vaccinated—particularly the elderly—and with the apparent efficacy of current vaccines against the Delta variant, the U.S. seems unlikely to revisit the staggering mortality statistics of the sort it experienced before vaccines became widely available. Finally, the savings many Americans built up over the past year left them with ample money to throw around, while businesses’ scramble for workers points to a labor market that should keep generating income gains.\nThose are all things that should ensure the economy continues to grow, but it probably won’t grow as swiftly as it otherwise could have. Worries about the Delta variant will lead some people to refrain from entering crowded settings, such as restaurants or airplanes, while also making them more cautious about spending down any savings. Some companieswill delay their return to the office, as Apple just did, and that will hurt downtown restaurants and the like that depend on office workers’ business.\nBear in mind that the places where vaccine hesitancy is high and Covid-19 worries low aren’t monolithic: Some share of the population will up their caution, in some cases even if they are fully vaccinated for fear of a breakthrough infection. And the more new cases there are in their communities, the more cautious they will become.\nNor are places where vaccination rates are better necessarily going to avoid the fallout from the contagious Delta variant. Around 72% of the 18 and over population of Los Angeles County have received at least once shot, more than the country at large, yet with case rates and hospitalizations rising, last week it reinstatedan order to wear masks indoorsin businesses and public places.\nThen there is the question of what the start of the coming school year might look like. Children under the age of 12 aren’t eligible for vaccination, and authorization for children between 5 and 11 looks as if it won’t comeuntil sometime in the fall, at the earliest. Most schools intend to return to in-person classes, with some offering remote options, but the Delta variant could upend some of those plans.\nAt the very least parents might need to prepare for the possibility of a positive Covid test shutting down a classroom, leaving their children, and them, stuck at home. Strategists at Evercore ISI point out that the return to school this fall was supposed to free parents for work, boosting the labor supply. But some of the job growth and easing of hiring strains that could create might now be deferred.\nThe economy has been growing since April last year—a point brought home by the National Bureau of Economic Research’srecent determinationthat that was when the brief, severe recession the pandemic brought on ended. It kept growing despite a new surge in Covid-19 infections last summer and another wave in the late fall through winter. Unlike in those previous surges, many Americans have been vaccinated so the impact won’t be as severe as it otherwise might have been.\nBut things could have been so much better.","news_type":1},"isVote":1,"tweetType":1,"viewCount":68,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":807096428,"gmtCreate":1627986787164,"gmtModify":1703499123034,"author":{"id":"3581492791156392","authorId":"3581492791156392","name":"FantasyX","avatar":"https://static.tigerbbs.com/d5be60dde27e883d6f8b569b3afe2f3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Woe","listText":"Woe","text":"Woe","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/807096428","repostId":"2156100119","repostType":4,"repost":{"id":"2156100119","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1627983900,"share":"https://www.laohu8.com/m/news/2156100119?lang=&edition=full","pubTime":"2021-08-03 17:45","market":"us","language":"en","title":"August is among the worst months of year for the stock market. Here's how to play it.","url":"https://stock-news.laohu8.com/highlight/detail?id=2156100119","media":"Dow Jones","summary":"On Wall Street, August is off to a solid start, but the month tends to accompany a bout of turbulenc","content":"<p>On Wall Street, August is off to a solid start, but the month tends to accompany a bout of turbulence in equity markets.</p>\n<p>The month is associated with the worst performances for the Dow Jones Industrial Average , S&amp;P 500 index , as well as the small cap Russell 2000 and large-cap Russell1000 indexes, over the past three decades, according to the folks at Stock Trader's Almanac.</p>\n<p>The research outfit said that from 1988 to 2020 average declines for the benchmarks ranged from 0.4% for the Russell 2000 to 0.8% by Dow. For the Nasdaq Composite, meanwhile, August ranks as second-worst, with an average gain of 0.2% over the same period, with September being the worst month for the technology-heavy index.</p>\n<p>To be sure, a year ago, in the midst of the COVID-19 pandemic, August produced stellar returns across the board as investors bet on an eventual rebound in pandemic-plagued markets.</p>\n<p>However, last year's uncharacteristically strong performance, which saw monthly gains of over 9% for the Nasdaq Composite and over 7% for the Dow and S&amp;P 500, doesn't mean the long-term trend has changed.</p>\n<p>\"As shown in the LPL Chart of the Day, August and September have been historically two of the weakest months of the year,\" wrote Ryan Detrick, chief market strategist for LPL Financial, in a Monday research note.</p>\n<p>Check out the monthly returns on average since 1950:</p>\n<p>Here are the historical rankings by month via LPL:</p>\n<p>The folks at Bespoke Investment Group put a finer point on the underperformance for August, especially after a strong year-to-date performance, as has been enjoyed in 2021.</p>\n<p>\"Since 1983, the weakest August returns tend to come in years where the S&amp;P 500 was up over 10% YTD heading into the month,\" the researchers note.</p>\n<p>The markets performance thus far has come on the back of stellar earnings results as American corporations rebound from COVID-19, but there are lingering fears that the U.S. has reached or is near peak earnings and economic growth .</p>\n<p><b>So how to play the turbulent stretch?</b></p>\n<p>Jeff Hirsch, editor of the Stock Trader's Almanac, said that the first nine trading days of August tend to be the most prone to weakness while the rest of the month is better. That said, he warns that the expirations of futures and options contracts toward the end of the month tend to create a fresh bout of chop in August, heading toward September, another rough patch for stocks.</p>\n<p>\"The end of August tends to be weaker when traders evacuate Wall Street for the summer finale,\" Hirsch wrote.</p>\n<p>\"Expiration week is down more than half the time since 1990, with some sizable losses,\" he said.</p>\n<p>Stock Trader's Almanac indicated that bullishness prevails in the market, however. \"Bullish forces continue to persist. The Fed remains easy and accommodative. More fiscal stimulus is likely from Washington as Congress nears finalizing the deals on infrastructure and spending,\" the data company wrote. But it cautioned that outperforming second-quarter earnings and the spread of the Delta variant of COVID-19 \"is a concern and poses a threat to the bull and the economic expansion.\"</p>\n<p>\"Political wrangling here in the States and geopolitical machinations around world could also knock the market off course momentarily,\" Stock Trader's Almanac wrote, while noting that its outlook for the S&amp;P 500 sees a push to the 4500-4600 range or even higher.</p>\n<p>Strategists continue to recommend investment prudence, especially with the benchmark 10-year Treasury yields hanging around a multi-month low near 1.15%.</p>\n<p>Bespoke Investment Group also points to a strong 2021, even if the next two months are a bit bumpy, noting that that final stretch of the year tends to be strong when the months leading up to August also have been healthy.</p>\n<p>\"While the average and median returns for August may be lackluster, the final four months of the year have seen an average gain of 5.94% (median: 8.03%) with gains 12 out of 14 times (85%). That's pretty consistent,\" the analysts wrote.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>August is among the worst months of year for the stock market. Here's how to play it.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAugust is among the worst months of year for the stock market. Here's how to play it.\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-08-03 17:45</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>On Wall Street, August is off to a solid start, but the month tends to accompany a bout of turbulence in equity markets.</p>\n<p>The month is associated with the worst performances for the Dow Jones Industrial Average , S&amp;P 500 index , as well as the small cap Russell 2000 and large-cap Russell1000 indexes, over the past three decades, according to the folks at Stock Trader's Almanac.</p>\n<p>The research outfit said that from 1988 to 2020 average declines for the benchmarks ranged from 0.4% for the Russell 2000 to 0.8% by Dow. For the Nasdaq Composite, meanwhile, August ranks as second-worst, with an average gain of 0.2% over the same period, with September being the worst month for the technology-heavy index.</p>\n<p>To be sure, a year ago, in the midst of the COVID-19 pandemic, August produced stellar returns across the board as investors bet on an eventual rebound in pandemic-plagued markets.</p>\n<p>However, last year's uncharacteristically strong performance, which saw monthly gains of over 9% for the Nasdaq Composite and over 7% for the Dow and S&amp;P 500, doesn't mean the long-term trend has changed.</p>\n<p>\"As shown in the LPL Chart of the Day, August and September have been historically two of the weakest months of the year,\" wrote Ryan Detrick, chief market strategist for LPL Financial, in a Monday research note.</p>\n<p>Check out the monthly returns on average since 1950:</p>\n<p>Here are the historical rankings by month via LPL:</p>\n<p>The folks at Bespoke Investment Group put a finer point on the underperformance for August, especially after a strong year-to-date performance, as has been enjoyed in 2021.</p>\n<p>\"Since 1983, the weakest August returns tend to come in years where the S&amp;P 500 was up over 10% YTD heading into the month,\" the researchers note.</p>\n<p>The markets performance thus far has come on the back of stellar earnings results as American corporations rebound from COVID-19, but there are lingering fears that the U.S. has reached or is near peak earnings and economic growth .</p>\n<p><b>So how to play the turbulent stretch?</b></p>\n<p>Jeff Hirsch, editor of the Stock Trader's Almanac, said that the first nine trading days of August tend to be the most prone to weakness while the rest of the month is better. That said, he warns that the expirations of futures and options contracts toward the end of the month tend to create a fresh bout of chop in August, heading toward September, another rough patch for stocks.</p>\n<p>\"The end of August tends to be weaker when traders evacuate Wall Street for the summer finale,\" Hirsch wrote.</p>\n<p>\"Expiration week is down more than half the time since 1990, with some sizable losses,\" he said.</p>\n<p>Stock Trader's Almanac indicated that bullishness prevails in the market, however. \"Bullish forces continue to persist. The Fed remains easy and accommodative. More fiscal stimulus is likely from Washington as Congress nears finalizing the deals on infrastructure and spending,\" the data company wrote. But it cautioned that outperforming second-quarter earnings and the spread of the Delta variant of COVID-19 \"is a concern and poses a threat to the bull and the economic expansion.\"</p>\n<p>\"Political wrangling here in the States and geopolitical machinations around world could also knock the market off course momentarily,\" Stock Trader's Almanac wrote, while noting that its outlook for the S&amp;P 500 sees a push to the 4500-4600 range or even higher.</p>\n<p>Strategists continue to recommend investment prudence, especially with the benchmark 10-year Treasury yields hanging around a multi-month low near 1.15%.</p>\n<p>Bespoke Investment Group also points to a strong 2021, even if the next two months are a bit bumpy, noting that that final stretch of the year tends to be strong when the months leading up to August also have been healthy.</p>\n<p>\"While the average and median returns for August may be lackluster, the final four months of the year have seen an average gain of 5.94% (median: 8.03%) with gains 12 out of 14 times (85%). That's pretty consistent,\" the analysts wrote.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","SH":"标普500反向ETF","SPXU":"三倍做空标普500ETF","SSO":"两倍做多标普500ETF",".SPX":"S&P 500 Index","OEX":"标普100","IVV":"标普500指数ETF","SDS":"两倍做空标普500ETF","OEF":"标普100指数ETF-iShares","UPRO":"三倍做多标普500ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2156100119","content_text":"On Wall Street, August is off to a solid start, but the month tends to accompany a bout of turbulence in equity markets.\nThe month is associated with the worst performances for the Dow Jones Industrial Average , S&P 500 index , as well as the small cap Russell 2000 and large-cap Russell1000 indexes, over the past three decades, according to the folks at Stock Trader's Almanac.\nThe research outfit said that from 1988 to 2020 average declines for the benchmarks ranged from 0.4% for the Russell 2000 to 0.8% by Dow. For the Nasdaq Composite, meanwhile, August ranks as second-worst, with an average gain of 0.2% over the same period, with September being the worst month for the technology-heavy index.\nTo be sure, a year ago, in the midst of the COVID-19 pandemic, August produced stellar returns across the board as investors bet on an eventual rebound in pandemic-plagued markets.\nHowever, last year's uncharacteristically strong performance, which saw monthly gains of over 9% for the Nasdaq Composite and over 7% for the Dow and S&P 500, doesn't mean the long-term trend has changed.\n\"As shown in the LPL Chart of the Day, August and September have been historically two of the weakest months of the year,\" wrote Ryan Detrick, chief market strategist for LPL Financial, in a Monday research note.\nCheck out the monthly returns on average since 1950:\nHere are the historical rankings by month via LPL:\nThe folks at Bespoke Investment Group put a finer point on the underperformance for August, especially after a strong year-to-date performance, as has been enjoyed in 2021.\n\"Since 1983, the weakest August returns tend to come in years where the S&P 500 was up over 10% YTD heading into the month,\" the researchers note.\nThe markets performance thus far has come on the back of stellar earnings results as American corporations rebound from COVID-19, but there are lingering fears that the U.S. has reached or is near peak earnings and economic growth .\nSo how to play the turbulent stretch?\nJeff Hirsch, editor of the Stock Trader's Almanac, said that the first nine trading days of August tend to be the most prone to weakness while the rest of the month is better. That said, he warns that the expirations of futures and options contracts toward the end of the month tend to create a fresh bout of chop in August, heading toward September, another rough patch for stocks.\n\"The end of August tends to be weaker when traders evacuate Wall Street for the summer finale,\" Hirsch wrote.\n\"Expiration week is down more than half the time since 1990, with some sizable losses,\" he said.\nStock Trader's Almanac indicated that bullishness prevails in the market, however. \"Bullish forces continue to persist. The Fed remains easy and accommodative. More fiscal stimulus is likely from Washington as Congress nears finalizing the deals on infrastructure and spending,\" the data company wrote. But it cautioned that outperforming second-quarter earnings and the spread of the Delta variant of COVID-19 \"is a concern and poses a threat to the bull and the economic expansion.\"\n\"Political wrangling here in the States and geopolitical machinations around world could also knock the market off course momentarily,\" Stock Trader's Almanac wrote, while noting that its outlook for the S&P 500 sees a push to the 4500-4600 range or even higher.\nStrategists continue to recommend investment prudence, especially with the benchmark 10-year Treasury yields hanging around a multi-month low near 1.15%.\nBespoke Investment Group also points to a strong 2021, even if the next two months are a bit bumpy, noting that that final stretch of the year tends to be strong when the months leading up to August also have been healthy.\n\"While the average and median returns for August may be lackluster, the final four months of the year have seen an average gain of 5.94% (median: 8.03%) with gains 12 out of 14 times (85%). That's pretty consistent,\" the analysts wrote.","news_type":1},"isVote":1,"tweetType":1,"viewCount":147,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":811806284,"gmtCreate":1630304774548,"gmtModify":1676530262622,"author":{"id":"3581492791156392","authorId":"3581492791156392","name":"FantasyX","avatar":"https://static.tigerbbs.com/d5be60dde27e883d6f8b569b3afe2f3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Ho","listText":"Ho","text":"Ho","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/811806284","repostId":"2163776380","repostType":4,"isVote":1,"tweetType":1,"viewCount":263,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":819191431,"gmtCreate":1630040786423,"gmtModify":1676530208375,"author":{"id":"3581492791156392","authorId":"3581492791156392","name":"FantasyX","avatar":"https://static.tigerbbs.com/d5be60dde27e883d6f8b569b3afe2f3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Mive","listText":"Mive","text":"Mive","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/819191431","repostId":"2162847016","repostType":4,"repost":{"id":"2162847016","pubTimestamp":1630008724,"share":"https://www.laohu8.com/m/news/2162847016?lang=&edition=full","pubTime":"2021-08-27 04:12","market":"us","language":"en","title":"Wall Street loses ground, snapping rally on Afghanistan, Fed concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=2162847016","media":"Reuters","summary":"NEW YORK, Aug 26 (Reuters) - Wall Street closed lower on Thursday, ending a streak of all-time closi","content":"<p>NEW YORK, Aug 26 (Reuters) - Wall Street closed lower on Thursday, ending a streak of all-time closing highs on concerns over developments in Afghanistan, while fears of a potential shift in U.S. Federal Reserve policy prompted a broad but shallow sell-off the day before the Jackson Hole Symposium.</p>\n<p>All three major U.S. stock indexes ended the session in the red, with the S&amp;P and the Nasdaq notching their first down day in six.</p>\n<p>The sell-off firmed after hawkish commentary from Dallas Fed President Robert Kaplan and a blast outside the Kabul airport in Afghanistan helped strengthen the risk-off sentiment.</p>\n<p>Kaplan, who is not currently a voting member of the Federal Open Markets Committee, said he believes the progress of economic recovery warrants tapering of the Fed's asset purchases to commence in October or shortly thereafter.</p>\n<p>Kaplan's remarks followed earlier comments from the St. Louis Fed President James Bullard, who said that the central bank is \"coalescing\" around a plan to begin tapering process.</p>\n<p>\"(Kaplan’s statements) caused a little confusion about the taper timeline, but in my opinion the equity markets are focused on geopolitical issues,\" said Megan Horneman, director of portfolio strategy at Verdence Capital Advisors in Hunt Valley, Maryland. \"There’s a flight to safety during geopolitical tensions.\"</p>\n<p>\"I am surprised the market the market hasn’t fallen more, given the fear that it could take focus away from (U.S. President Joe Biden's) domestic agenda,\" Horneman added.</p>\n<p>The economy grew at a slightly faster pace than originally reported in the second quarter, fully recovering its losses from the most abrupt downturn in U.S. history, according to the Commerce Department. But jobless claims, though still on a downward trajectory, ticked higher last week.</p>\n<p>The data did little to move the needle with respect to expectations that the Fed is unlikely tip its hand regarding the taper timeline when Chairman Jerome Powell unmutes and delivers his speech at Friday's virtual Jackson Hole Symposium.</p>\n<p>\"We’re going to see a lot of market participants analyze every word (Powell) uses, but at the end of the day, they will begin tapering,\" Horneman said. \"I’m more concerned about the speed at which they taper. What are they going to start with? That will give us a clearer indication as whether they’re getting more hawkish.\"</p>\n<p>The Dow Jones Industrial Average fell 192.38 points, or 0.54%, to 35,213.12, the S&amp;P 500 lost 26.19 points, or 0.58%, to 4,470 and the Nasdaq Composite dropped 96.05 points, or 0.64%, to 14,945.81.</p>\n<p>Of the 11 major sectors in the S&amp;P 500, all but real estate ended the session lower, with energy stocks suffering the steepest percentage loss.</p>\n<p>Discount retailers Dollar General Corp and Dollar Tree Inc slid 3.8% and 12.1%, respectively, after warning higher transportation costs will hurt their bottom lines.</p>\n<p>Coty Inc jumped 14.7% after the cosmetics firm said it expects to post full-year sales growth for the first time in three years.</p>\n<p>Salesforce.com Inc hiked its earnings forecast as the shift to a hybrid work model is expected to fuel strong demand. Its shares advanced 2.7%.</p>\n<p>NetApp Inc jumped 4.7% as brokerages raised their price targets in the wake of the cloud computing firm's better-than-expected 2022 earnings outlook.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 2.99-to-1 ratio; on Nasdaq, a 1.83-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 31 new 52-week highs and two new lows; the Nasdaq Composite recorded 82 new highs and 39 new lows.</p>\n<p>Volume on U.S. exchanges was 8.27 billion shares, compared with the 8.96 billion average over the last 20 trading days. (Reporting by Stephen Culp; Additional reporting by Devik Jain in Bengaluru Editing by Marguerita Choy)</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street loses ground, snapping rally on Afghanistan, Fed concerns</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street loses ground, snapping rally on Afghanistan, Fed concerns\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-27 04:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/us-stocks-wall-street-loses-201204459.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>NEW YORK, Aug 26 (Reuters) - Wall Street closed lower on Thursday, ending a streak of all-time closing highs on concerns over developments in Afghanistan, while fears of a potential shift in U.S. ...</p>\n\n<a href=\"https://finance.yahoo.com/news/us-stocks-wall-street-loses-201204459.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF",".SPX":"S&P 500 Index","OEX":"标普100","COMP":"Compass, Inc.","OEF":"标普100指数ETF-iShares","UPRO":"三倍做多标普500ETF","IVV":"标普500指数ETF","SH":"标普500反向ETF","SSO":"两倍做多标普500ETF","SPXU":"三倍做空标普500ETF","SDS":"两倍做空标普500ETF"},"source_url":"https://finance.yahoo.com/news/us-stocks-wall-street-loses-201204459.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2162847016","content_text":"NEW YORK, Aug 26 (Reuters) - Wall Street closed lower on Thursday, ending a streak of all-time closing highs on concerns over developments in Afghanistan, while fears of a potential shift in U.S. Federal Reserve policy prompted a broad but shallow sell-off the day before the Jackson Hole Symposium.\nAll three major U.S. stock indexes ended the session in the red, with the S&P and the Nasdaq notching their first down day in six.\nThe sell-off firmed after hawkish commentary from Dallas Fed President Robert Kaplan and a blast outside the Kabul airport in Afghanistan helped strengthen the risk-off sentiment.\nKaplan, who is not currently a voting member of the Federal Open Markets Committee, said he believes the progress of economic recovery warrants tapering of the Fed's asset purchases to commence in October or shortly thereafter.\nKaplan's remarks followed earlier comments from the St. Louis Fed President James Bullard, who said that the central bank is \"coalescing\" around a plan to begin tapering process.\n\"(Kaplan’s statements) caused a little confusion about the taper timeline, but in my opinion the equity markets are focused on geopolitical issues,\" said Megan Horneman, director of portfolio strategy at Verdence Capital Advisors in Hunt Valley, Maryland. \"There’s a flight to safety during geopolitical tensions.\"\n\"I am surprised the market the market hasn’t fallen more, given the fear that it could take focus away from (U.S. President Joe Biden's) domestic agenda,\" Horneman added.\nThe economy grew at a slightly faster pace than originally reported in the second quarter, fully recovering its losses from the most abrupt downturn in U.S. history, according to the Commerce Department. But jobless claims, though still on a downward trajectory, ticked higher last week.\nThe data did little to move the needle with respect to expectations that the Fed is unlikely tip its hand regarding the taper timeline when Chairman Jerome Powell unmutes and delivers his speech at Friday's virtual Jackson Hole Symposium.\n\"We’re going to see a lot of market participants analyze every word (Powell) uses, but at the end of the day, they will begin tapering,\" Horneman said. \"I’m more concerned about the speed at which they taper. What are they going to start with? That will give us a clearer indication as whether they’re getting more hawkish.\"\nThe Dow Jones Industrial Average fell 192.38 points, or 0.54%, to 35,213.12, the S&P 500 lost 26.19 points, or 0.58%, to 4,470 and the Nasdaq Composite dropped 96.05 points, or 0.64%, to 14,945.81.\nOf the 11 major sectors in the S&P 500, all but real estate ended the session lower, with energy stocks suffering the steepest percentage loss.\nDiscount retailers Dollar General Corp and Dollar Tree Inc slid 3.8% and 12.1%, respectively, after warning higher transportation costs will hurt their bottom lines.\nCoty Inc jumped 14.7% after the cosmetics firm said it expects to post full-year sales growth for the first time in three years.\nSalesforce.com Inc hiked its earnings forecast as the shift to a hybrid work model is expected to fuel strong demand. Its shares advanced 2.7%.\nNetApp Inc jumped 4.7% as brokerages raised their price targets in the wake of the cloud computing firm's better-than-expected 2022 earnings outlook.\nDeclining issues outnumbered advancing ones on the NYSE by a 2.99-to-1 ratio; on Nasdaq, a 1.83-to-1 ratio favored decliners.\nThe S&P 500 posted 31 new 52-week highs and two new lows; the Nasdaq Composite recorded 82 new highs and 39 new lows.\nVolume on U.S. exchanges was 8.27 billion shares, compared with the 8.96 billion average over the last 20 trading days. (Reporting by Stephen Culp; Additional reporting by Devik Jain in Bengaluru Editing by Marguerita Choy)","news_type":1},"isVote":1,"tweetType":1,"viewCount":131,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":833385441,"gmtCreate":1629206272683,"gmtModify":1676529965262,"author":{"id":"3581492791156392","authorId":"3581492791156392","name":"FantasyX","avatar":"https://static.tigerbbs.com/d5be60dde27e883d6f8b569b3afe2f3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/833385441","repostId":"1156515289","repostType":4,"isVote":1,"tweetType":1,"viewCount":243,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":898522282,"gmtCreate":1628512908346,"gmtModify":1703507317392,"author":{"id":"3581492791156392","authorId":"3581492791156392","name":"FantasyX","avatar":"https://static.tigerbbs.com/d5be60dde27e883d6f8b569b3afe2f3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/898522282","repostId":"1122651143","repostType":4,"repost":{"id":"1122651143","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628508488,"share":"https://www.laohu8.com/m/news/1122651143?lang=&edition=full","pubTime":"2021-08-09 19:28","market":"us","language":"en","title":"Crypto sector stocks rose in premarket trading,BTCM shares jumped more than 30%,BITF surged more than 20%.","url":"https://stock-news.laohu8.com/highlight/detail?id=1122651143","media":"Tiger Newspress","summary":"Crypto sector stocks rose in premarket trading,BTCM shares jumped more than 30%,BITF surged more tha","content":"<p>Crypto&nbsp;sector&nbsp;stocks&nbsp;rose&nbsp;in&nbsp;premarket&nbsp;trading,BTCM&nbsp;shares&nbsp;jumped&nbsp;more&nbsp;than&nbsp;30%,BITF&nbsp;surged&nbsp;more&nbsp;than&nbsp;20%.</p>\n<p><img src=\"https://static.tigerbbs.com/9ece56572cf91d8de69991add19a22f4\" tg-width=\"1287\" tg-height=\"619\" referrerpolicy=\"no-referrer\">Investors in stock trading platforms are citing the momentum in cryptocurrencies as being the driving force for the stock price increase. The price of the Bitcoin cryptocurrency is up more than 9% over the past week. And Ethereum is up more than 12% over the past week.</p>\n<p>Late last month, BIT Mining announced it entered into a definitive purchase agreement to buy 2,500 new bitcoin mining machines for a total consideration of approximately US$6.6 million. And when deployed, the company expects the Acquired Machines to increase its theoretical maximum total hash rate capacity by about 165 peta hashes per second (PH/s).</p>\n<p>The acquired machines are expected to be delivered within one week from today. And following delivery, the company plans for them to be shipped to Kazakhstan for deployment.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Crypto sector stocks rose in premarket trading,BTCM shares jumped more than 30%,BITF surged more than 20%.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCrypto sector stocks rose in premarket trading,BTCM shares jumped more than 30%,BITF surged more than 20%.\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-09 19:28</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Crypto&nbsp;sector&nbsp;stocks&nbsp;rose&nbsp;in&nbsp;premarket&nbsp;trading,BTCM&nbsp;shares&nbsp;jumped&nbsp;more&nbsp;than&nbsp;30%,BITF&nbsp;surged&nbsp;more&nbsp;than&nbsp;20%.</p>\n<p><img src=\"https://static.tigerbbs.com/9ece56572cf91d8de69991add19a22f4\" tg-width=\"1287\" tg-height=\"619\" referrerpolicy=\"no-referrer\">Investors in stock trading platforms are citing the momentum in cryptocurrencies as being the driving force for the stock price increase. The price of the Bitcoin cryptocurrency is up more than 9% over the past week. And Ethereum is up more than 12% over the past week.</p>\n<p>Late last month, BIT Mining announced it entered into a definitive purchase agreement to buy 2,500 new bitcoin mining machines for a total consideration of approximately US$6.6 million. And when deployed, the company expects the Acquired Machines to increase its theoretical maximum total hash rate capacity by about 165 peta hashes per second (PH/s).</p>\n<p>The acquired machines are expected to be delivered within one week from today. And following delivery, the company plans for them to be shipped to Kazakhstan for deployment.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BTCM":"BIT Mining","BITF":"Bitfarms Ltd."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122651143","content_text":"Crypto sector stocks rose in premarket trading,BTCM shares jumped more than 30%,BITF surged more than 20%.\nInvestors in stock trading platforms are citing the momentum in cryptocurrencies as being the driving force for the stock price increase. The price of the Bitcoin cryptocurrency is up more than 9% over the past week. And Ethereum is up more than 12% over the past week.\nLate last month, BIT Mining announced it entered into a definitive purchase agreement to buy 2,500 new bitcoin mining machines for a total consideration of approximately US$6.6 million. And when deployed, the company expects the Acquired Machines to increase its theoretical maximum total hash rate capacity by about 165 peta hashes per second (PH/s).\nThe acquired machines are expected to be delivered within one week from today. And following delivery, the company plans for them to be shipped to Kazakhstan for deployment.","news_type":1},"isVote":1,"tweetType":1,"viewCount":62,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":899807224,"gmtCreate":1628172113068,"gmtModify":1703502544208,"author":{"id":"3581492791156392","authorId":"3581492791156392","name":"FantasyX","avatar":"https://static.tigerbbs.com/d5be60dde27e883d6f8b569b3afe2f3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/899807224","repostId":"1102705333","repostType":4,"repost":{"id":"1102705333","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628170059,"share":"https://www.laohu8.com/m/news/1102705333?lang=&edition=full","pubTime":"2021-08-05 21:27","market":"us","language":"en","title":"Stocks open slightly higher after fall in jobless claims","url":"https://stock-news.laohu8.com/highlight/detail?id=1102705333","media":"Tiger Newspress","summary":"(Aug 5) Stocks open slightly higher after fall in jobless claims.\nDow industrials up 94 points, or 0","content":"<p>(Aug 5)&nbsp;Stocks open slightly higher after fall in jobless claims.</p>\n<p>Dow industrials up 94 points, or 0.3%.&nbsp;S&amp;P 500 up 0.3% at 4,414.12.&nbsp;Nasdaq Composite up less than 0.1% at 14,784.61.&nbsp;</p>\n<p>Fastly plunges over&nbsp;23% in morning trading&nbsp;after the company's downside Q3 and full-year guidance due to the widespread outage in June.</p>\n<p><img src=\"https://static.tigerbbs.com/44fbcf9492918a352919cdff1fd27498\" tg-width=\"727\" tg-height=\"497\" width=\"100%\" height=\"auto\"></p>\n<p>The moves in the stocks came after a mostly lower regular session on Wednesday. The Dow dropped more than 300 points, or 0.9%, and closed near its session low. The S&amp;P 500 slipped about 0.5%, while the Nasdaq Composite ticked up 0.1%.</p>\n<p>Weekly initial jobless claims came in at385,000 on Thursday,in-line with expectations. Recent earnings and economic data have been strong overall, but some economists worry economic growth and employment gains will taper from here.</p>\n<p>The jobless claims data was the last reading before the key July jobs report, which will be released on Friday morning. There is a wide range of estimates from economists and what the report will show, and some metrics for employment gains have disappointed despite a high level of reported job openings.</p>\n<p>\"Many factors are likely driving worker shortages; concerns about catching the virus, childcare responsibilities, skills mismatches, and generous unemployment insurance benefits,\" PNC Senior Economist Abbey Omodunbi said in an email. In the second half of the year, \"more competition for workers, particularly in the leisure and hospitality sector, will support acceleration in wage growth, boosting household incomes and consumer spending.\"</p>\n<p>The results of an ADP private payroll survey released Wednesday showed again of 330,000 jobs for July,well short of the consensus estimate of 653,000. The Labor Department's official jobs report, which typically has more impact on investors, will be released on Friday. Economists expect the report will show the U.S. added 845,000 in non-farm payrolls in July, about even with the previous month, according to Dow Jones estimates.</p>\n<p>The10-year Treasury yieldwas holding steady near 1.8% on Thursday. The yield briefly dipping below 1.13% on Wednesday before bouncing back in late morning trading.</p>\n<p>Shares ofRokudropped 6% after the company issued quarterly results.Etsyfell 12% in early trading after the company gave guidance for the current quarter that indicated the pandemic-fueled commerce boommay be coming to an end.</p>\n<p>However, earnings season has been strong overall. Goldman Sachs raised its year-end target for the S&amp;P 500 to 4,700, representing 7% upside, in part due to an improving earnings outlook going.</p>\n<p>During regular trading Wednesday, shares of Robinhoodsurged 50%, continuing a volatile jump after last week's soft initial public offering. Semiconductor stocks were another bright spot, withNvidiaandAdvanced Micro Devicesrising.</p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks open slightly higher after fall in jobless claims</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks open slightly higher after fall in jobless claims\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-05 21:27</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Aug 5)&nbsp;Stocks open slightly higher after fall in jobless claims.</p>\n<p>Dow industrials up 94 points, or 0.3%.&nbsp;S&amp;P 500 up 0.3% at 4,414.12.&nbsp;Nasdaq Composite up less than 0.1% at 14,784.61.&nbsp;</p>\n<p>Fastly plunges over&nbsp;23% in morning trading&nbsp;after the company's downside Q3 and full-year guidance due to the widespread outage in June.</p>\n<p><img src=\"https://static.tigerbbs.com/44fbcf9492918a352919cdff1fd27498\" tg-width=\"727\" tg-height=\"497\" width=\"100%\" height=\"auto\"></p>\n<p>The moves in the stocks came after a mostly lower regular session on Wednesday. The Dow dropped more than 300 points, or 0.9%, and closed near its session low. The S&amp;P 500 slipped about 0.5%, while the Nasdaq Composite ticked up 0.1%.</p>\n<p>Weekly initial jobless claims came in at385,000 on Thursday,in-line with expectations. Recent earnings and economic data have been strong overall, but some economists worry economic growth and employment gains will taper from here.</p>\n<p>The jobless claims data was the last reading before the key July jobs report, which will be released on Friday morning. There is a wide range of estimates from economists and what the report will show, and some metrics for employment gains have disappointed despite a high level of reported job openings.</p>\n<p>\"Many factors are likely driving worker shortages; concerns about catching the virus, childcare responsibilities, skills mismatches, and generous unemployment insurance benefits,\" PNC Senior Economist Abbey Omodunbi said in an email. In the second half of the year, \"more competition for workers, particularly in the leisure and hospitality sector, will support acceleration in wage growth, boosting household incomes and consumer spending.\"</p>\n<p>The results of an ADP private payroll survey released Wednesday showed again of 330,000 jobs for July,well short of the consensus estimate of 653,000. The Labor Department's official jobs report, which typically has more impact on investors, will be released on Friday. Economists expect the report will show the U.S. added 845,000 in non-farm payrolls in July, about even with the previous month, according to Dow Jones estimates.</p>\n<p>The10-year Treasury yieldwas holding steady near 1.8% on Thursday. The yield briefly dipping below 1.13% on Wednesday before bouncing back in late morning trading.</p>\n<p>Shares ofRokudropped 6% after the company issued quarterly results.Etsyfell 12% in early trading after the company gave guidance for the current quarter that indicated the pandemic-fueled commerce boommay be coming to an end.</p>\n<p>However, earnings season has been strong overall. Goldman Sachs raised its year-end target for the S&amp;P 500 to 4,700, representing 7% upside, in part due to an improving earnings outlook going.</p>\n<p>During regular trading Wednesday, shares of Robinhoodsurged 50%, continuing a volatile jump after last week's soft initial public offering. Semiconductor stocks were another bright spot, withNvidiaandAdvanced Micro Devicesrising.</p>\n<p></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SPY":"标普500ETF",".DJI":"道琼斯",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1102705333","content_text":"(Aug 5) Stocks open slightly higher after fall in jobless claims.\nDow industrials up 94 points, or 0.3%. S&P 500 up 0.3% at 4,414.12. Nasdaq Composite up less than 0.1% at 14,784.61. \nFastly plunges over 23% in morning trading after the company's downside Q3 and full-year guidance due to the widespread outage in June.\n\nThe moves in the stocks came after a mostly lower regular session on Wednesday. The Dow dropped more than 300 points, or 0.9%, and closed near its session low. The S&P 500 slipped about 0.5%, while the Nasdaq Composite ticked up 0.1%.\nWeekly initial jobless claims came in at385,000 on Thursday,in-line with expectations. Recent earnings and economic data have been strong overall, but some economists worry economic growth and employment gains will taper from here.\nThe jobless claims data was the last reading before the key July jobs report, which will be released on Friday morning. There is a wide range of estimates from economists and what the report will show, and some metrics for employment gains have disappointed despite a high level of reported job openings.\n\"Many factors are likely driving worker shortages; concerns about catching the virus, childcare responsibilities, skills mismatches, and generous unemployment insurance benefits,\" PNC Senior Economist Abbey Omodunbi said in an email. In the second half of the year, \"more competition for workers, particularly in the leisure and hospitality sector, will support acceleration in wage growth, boosting household incomes and consumer spending.\"\nThe results of an ADP private payroll survey released Wednesday showed again of 330,000 jobs for July,well short of the consensus estimate of 653,000. The Labor Department's official jobs report, which typically has more impact on investors, will be released on Friday. Economists expect the report will show the U.S. added 845,000 in non-farm payrolls in July, about even with the previous month, according to Dow Jones estimates.\nThe10-year Treasury yieldwas holding steady near 1.8% on Thursday. The yield briefly dipping below 1.13% on Wednesday before bouncing back in late morning trading.\nShares ofRokudropped 6% after the company issued quarterly results.Etsyfell 12% in early trading after the company gave guidance for the current quarter that indicated the pandemic-fueled commerce boommay be coming to an end.\nHowever, earnings season has been strong overall. Goldman Sachs raised its year-end target for the S&P 500 to 4,700, representing 7% upside, in part due to an improving earnings outlook going.\nDuring regular trading Wednesday, shares of Robinhoodsurged 50%, continuing a volatile jump after last week's soft initial public offering. Semiconductor stocks were another bright spot, withNvidiaandAdvanced Micro Devicesrising.","news_type":1},"isVote":1,"tweetType":1,"viewCount":83,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":837270728,"gmtCreate":1629897397664,"gmtModify":1676530165389,"author":{"id":"3581492791156392","authorId":"3581492791156392","name":"FantasyX","avatar":"https://static.tigerbbs.com/d5be60dde27e883d6f8b569b3afe2f3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/837270728","repostId":"1153815600","repostType":4,"isVote":1,"tweetType":1,"viewCount":310,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":898522502,"gmtCreate":1628512921606,"gmtModify":1703507316736,"author":{"id":"3581492791156392","authorId":"3581492791156392","name":"FantasyX","avatar":"https://static.tigerbbs.com/d5be60dde27e883d6f8b569b3afe2f3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/898522502","repostId":"2158844506","repostType":4,"isVote":1,"tweetType":1,"viewCount":79,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":801585806,"gmtCreate":1627523138705,"gmtModify":1703491605077,"author":{"id":"3581492791156392","authorId":"3581492791156392","name":"FantasyX","avatar":"https://static.tigerbbs.com/d5be60dde27e883d6f8b569b3afe2f3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Ni e","listText":"Ni e","text":"Ni e","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/801585806","repostId":"2155027927","repostType":4,"isVote":1,"tweetType":1,"viewCount":130,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":830326997,"gmtCreate":1629015248819,"gmtModify":1676529911322,"author":{"id":"3581492791156392","authorId":"3581492791156392","name":"FantasyX","avatar":"https://static.tigerbbs.com/d5be60dde27e883d6f8b569b3afe2f3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/830326997","repostId":"2159215676","repostType":4,"repost":{"id":"2159215676","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1628992609,"share":"https://www.laohu8.com/m/news/2159215676?lang=&edition=full","pubTime":"2021-08-15 09:56","market":"us","language":"en","title":"Why 6 DoorDash Analysts Are Raising Price Targets After Q2 Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2159215676","media":"Benzinga","summary":"Analysts share their reactions and new price targets on shares of DoorDash Inc (NYSE: DASH), which reported second-quarter earnings Thursday after market close.","content":"<p>Analysts share their reactions and new price targets on shares of <b>DoorDash Inc</b> (NYSE:DASH), which reported second-quarter earnings Thursday after market close.</p>\n<p><b>The DoorDash Analysts: </b>Barclays analyst Ross Sandler had&nbsp;an Equal Weight rating and raised&nbsp;the price target from $160 to $183.</p>\n<p>JMP Securities analyst Ronald V. Josey had&nbsp;a Market Outperform rating and raised&nbsp;the price target from $195 to $210.</p>\n<p>Wells Fargo analyst Brian Fitzgerald had&nbsp;an Overweight rating and raised&nbsp;the price target from $215 to $235.</p>\n<p>RBC Capital analyst Brad Erickson had&nbsp;an Outperform rating and raised&nbsp;the price target from $175 to $210.</p>\n<p>Mizuho Securities analyst James Lee had&nbsp;a Neutral rating and raised&nbsp;the price target from $155 to $175.</p>\n<p>Needham analyst Bernie McTernan had&nbsp;a Buy rating and raised&nbsp;the price target from $195 to $230.</p>\n<p><b>The Analyst Takeaways: </b>DoorDash gained three percentage points in market share for the U.S. food delivery share, Josey said. The analyst notes a highly engaged customer based and also highlighted frequency hitting an all-time high in the quarter.</p>\n<p>“DashPass subscribers grew more than 2x as fast as non-DashPass MAUs year-over-year,” Josey said.</p>\n<p>DoorDash management said its order frequency has not reached its peak yet, Fitzgerald added.</p>\n<p>A focus on gross profit dollars and reinvestment in growth initiatives was called out by Erickson in the updated note.</p>\n<p>“On top of beating gross order volume, revenue and EBITDA and raising its FY guide, specific encouraging demand highlights includes 300 bps of U.S. shares gains year-over-year,” Erickson said.</p>\n<p>The analyst noted&nbsp;company management mentioned progress in Canada and Australia and other international launches coming.</p>\n<p>“Volume growth was the highlight of 2Q earnings to us, highlighting consumer delivery habits are still sticky late into the pandemic,” McTernan said. The analyst was surprised by the upside in volume in the late stages of the pandemic.</p>\n<p><b>Non-Food Delivery Growth:</b> Sandler highlighted the growth of DoorDash in non-restaurant areas like grocery, convenience, pets and alcohol. This segment is helping drive frequency, retention and efficiency for the company with frequency hitting record highs in the quarter.</p>\n<p>DoorDash’s non-restaurant orders could have been placed by 10% of the company’s users in the second quarter, compared to 7% of orders in the first quarter, Josey said.</p>\n<p>The analyst also noted&nbsp;the addition of more than 5,000 convenience stores in the second quarter including <b><a href=\"https://laohu8.com/S/WBA\">Walgreens Boots Alliance</a> Inc</b> (NASDAQ:WBA), <b>Rite Aid Corporation</b> (NYSE:RAD), <b>Albertsons Companies Inc</b> (NYSE:ACI), <b>PetSmart</b> and <b>Bed Bath &amp; Beyond Inc.</b>&nbsp;(NASDAQ:BBBY) locations.</p>\n<p>“Over 30% of DASH’s business came from orders outside restaurants in Q2, early data suggest that multi-category customers increase both their retention and engagement rates,” Fitzgerald said.</p>\n<p><b>What’s Next: </b>International growth, investments in new categories and a healthy supply of Dashers are highlighted by Josey.</p>\n<p>“DASH deserves a premium to the peer set,” Sandler said.</p>\n<p>“We expect DASH shares to continue to grind higher as its U.S. market share and momentum continue to resonate,” Fitzgerald said. “If DASH can replicate the operational prowess it has demonstrated in the U.S. as a fast follower in international markets, we think shares have significantly more upside in the coming years.”</p>\n<p>Additional grocery delivery is expected to roll out in the second half of the year “providing opportunities to become a second logistics source for some key accounts,” highlights Fitzgerald.</p>\n<p>DoorDash has some regulatory headwinds in large cities such as&nbsp;San Francisco and New York City but Lee sees these being less than feared. Management sees momentum carrying into the third quarter, the analyst notes.</p>\n<p>“Given investments in new categories and international markets we believe the level of incremental investment represents the greatest risk to our forecast,” McTernan said.</p>\n<p><b>DASH Price Action: </b>DoorDash shares rose 3.5% to $194.79&nbsp;on Friday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why 6 DoorDash Analysts Are Raising Price Targets After Q2 Earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy 6 DoorDash Analysts Are Raising Price Targets After Q2 Earnings\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-08-15 09:56</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Analysts share their reactions and new price targets on shares of <b>DoorDash Inc</b> (NYSE:DASH), which reported second-quarter earnings Thursday after market close.</p>\n<p><b>The DoorDash Analysts: </b>Barclays analyst Ross Sandler had&nbsp;an Equal Weight rating and raised&nbsp;the price target from $160 to $183.</p>\n<p>JMP Securities analyst Ronald V. Josey had&nbsp;a Market Outperform rating and raised&nbsp;the price target from $195 to $210.</p>\n<p>Wells Fargo analyst Brian Fitzgerald had&nbsp;an Overweight rating and raised&nbsp;the price target from $215 to $235.</p>\n<p>RBC Capital analyst Brad Erickson had&nbsp;an Outperform rating and raised&nbsp;the price target from $175 to $210.</p>\n<p>Mizuho Securities analyst James Lee had&nbsp;a Neutral rating and raised&nbsp;the price target from $155 to $175.</p>\n<p>Needham analyst Bernie McTernan had&nbsp;a Buy rating and raised&nbsp;the price target from $195 to $230.</p>\n<p><b>The Analyst Takeaways: </b>DoorDash gained three percentage points in market share for the U.S. food delivery share, Josey said. The analyst notes a highly engaged customer based and also highlighted frequency hitting an all-time high in the quarter.</p>\n<p>“DashPass subscribers grew more than 2x as fast as non-DashPass MAUs year-over-year,” Josey said.</p>\n<p>DoorDash management said its order frequency has not reached its peak yet, Fitzgerald added.</p>\n<p>A focus on gross profit dollars and reinvestment in growth initiatives was called out by Erickson in the updated note.</p>\n<p>“On top of beating gross order volume, revenue and EBITDA and raising its FY guide, specific encouraging demand highlights includes 300 bps of U.S. shares gains year-over-year,” Erickson said.</p>\n<p>The analyst noted&nbsp;company management mentioned progress in Canada and Australia and other international launches coming.</p>\n<p>“Volume growth was the highlight of 2Q earnings to us, highlighting consumer delivery habits are still sticky late into the pandemic,” McTernan said. The analyst was surprised by the upside in volume in the late stages of the pandemic.</p>\n<p><b>Non-Food Delivery Growth:</b> Sandler highlighted the growth of DoorDash in non-restaurant areas like grocery, convenience, pets and alcohol. This segment is helping drive frequency, retention and efficiency for the company with frequency hitting record highs in the quarter.</p>\n<p>DoorDash’s non-restaurant orders could have been placed by 10% of the company’s users in the second quarter, compared to 7% of orders in the first quarter, Josey said.</p>\n<p>The analyst also noted&nbsp;the addition of more than 5,000 convenience stores in the second quarter including <b><a href=\"https://laohu8.com/S/WBA\">Walgreens Boots Alliance</a> Inc</b> (NASDAQ:WBA), <b>Rite Aid Corporation</b> (NYSE:RAD), <b>Albertsons Companies Inc</b> (NYSE:ACI), <b>PetSmart</b> and <b>Bed Bath &amp; Beyond Inc.</b>&nbsp;(NASDAQ:BBBY) locations.</p>\n<p>“Over 30% of DASH’s business came from orders outside restaurants in Q2, early data suggest that multi-category customers increase both their retention and engagement rates,” Fitzgerald said.</p>\n<p><b>What’s Next: </b>International growth, investments in new categories and a healthy supply of Dashers are highlighted by Josey.</p>\n<p>“DASH deserves a premium to the peer set,” Sandler said.</p>\n<p>“We expect DASH shares to continue to grind higher as its U.S. market share and momentum continue to resonate,” Fitzgerald said. “If DASH can replicate the operational prowess it has demonstrated in the U.S. as a fast follower in international markets, we think shares have significantly more upside in the coming years.”</p>\n<p>Additional grocery delivery is expected to roll out in the second half of the year “providing opportunities to become a second logistics source for some key accounts,” highlights Fitzgerald.</p>\n<p>DoorDash has some regulatory headwinds in large cities such as&nbsp;San Francisco and New York City but Lee sees these being less than feared. Management sees momentum carrying into the third quarter, the analyst notes.</p>\n<p>“Given investments in new categories and international markets we believe the level of incremental investment represents the greatest risk to our forecast,” McTernan said.</p>\n<p><b>DASH Price Action: </b>DoorDash shares rose 3.5% to $194.79&nbsp;on Friday.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BBBY":"3B家居","QTWO":"Q2 Holdings Inc","DASH":"DoorDash, Inc.","ACI":"艾伯森","RAD":"来德爱","WBA":"沃尔格林联合博姿"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2159215676","content_text":"Analysts share their reactions and new price targets on shares of DoorDash Inc (NYSE:DASH), which reported second-quarter earnings Thursday after market close.\nThe DoorDash Analysts: Barclays analyst Ross Sandler had an Equal Weight rating and raised the price target from $160 to $183.\nJMP Securities analyst Ronald V. Josey had a Market Outperform rating and raised the price target from $195 to $210.\nWells Fargo analyst Brian Fitzgerald had an Overweight rating and raised the price target from $215 to $235.\nRBC Capital analyst Brad Erickson had an Outperform rating and raised the price target from $175 to $210.\nMizuho Securities analyst James Lee had a Neutral rating and raised the price target from $155 to $175.\nNeedham analyst Bernie McTernan had a Buy rating and raised the price target from $195 to $230.\nThe Analyst Takeaways: DoorDash gained three percentage points in market share for the U.S. food delivery share, Josey said. The analyst notes a highly engaged customer based and also highlighted frequency hitting an all-time high in the quarter.\n“DashPass subscribers grew more than 2x as fast as non-DashPass MAUs year-over-year,” Josey said.\nDoorDash management said its order frequency has not reached its peak yet, Fitzgerald added.\nA focus on gross profit dollars and reinvestment in growth initiatives was called out by Erickson in the updated note.\n“On top of beating gross order volume, revenue and EBITDA and raising its FY guide, specific encouraging demand highlights includes 300 bps of U.S. shares gains year-over-year,” Erickson said.\nThe analyst noted company management mentioned progress in Canada and Australia and other international launches coming.\n“Volume growth was the highlight of 2Q earnings to us, highlighting consumer delivery habits are still sticky late into the pandemic,” McTernan said. The analyst was surprised by the upside in volume in the late stages of the pandemic.\nNon-Food Delivery Growth: Sandler highlighted the growth of DoorDash in non-restaurant areas like grocery, convenience, pets and alcohol. This segment is helping drive frequency, retention and efficiency for the company with frequency hitting record highs in the quarter.\nDoorDash’s non-restaurant orders could have been placed by 10% of the company’s users in the second quarter, compared to 7% of orders in the first quarter, Josey said.\nThe analyst also noted the addition of more than 5,000 convenience stores in the second quarter including Walgreens Boots Alliance Inc (NASDAQ:WBA), Rite Aid Corporation (NYSE:RAD), Albertsons Companies Inc (NYSE:ACI), PetSmart and Bed Bath & Beyond Inc. (NASDAQ:BBBY) locations.\n“Over 30% of DASH’s business came from orders outside restaurants in Q2, early data suggest that multi-category customers increase both their retention and engagement rates,” Fitzgerald said.\nWhat’s Next: International growth, investments in new categories and a healthy supply of Dashers are highlighted by Josey.\n“DASH deserves a premium to the peer set,” Sandler said.\n“We expect DASH shares to continue to grind higher as its U.S. market share and momentum continue to resonate,” Fitzgerald said. “If DASH can replicate the operational prowess it has demonstrated in the U.S. as a fast follower in international markets, we think shares have significantly more upside in the coming years.”\nAdditional grocery delivery is expected to roll out in the second half of the year “providing opportunities to become a second logistics source for some key accounts,” highlights Fitzgerald.\nDoorDash has some regulatory headwinds in large cities such as San Francisco and New York City but Lee sees these being less than feared. Management sees momentum carrying into the third quarter, the analyst notes.\n“Given investments in new categories and international markets we believe the level of incremental investment represents the greatest risk to our forecast,” McTernan said.\nDASH Price Action: DoorDash shares rose 3.5% to $194.79 on Friday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":570,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":896420564,"gmtCreate":1628602326258,"gmtModify":1676529793082,"author":{"id":"3581492791156392","authorId":"3581492791156392","name":"FantasyX","avatar":"https://static.tigerbbs.com/d5be60dde27e883d6f8b569b3afe2f3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/896420564","repostId":"2158048475","repostType":4,"isVote":1,"tweetType":1,"viewCount":54,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":804038781,"gmtCreate":1627911555543,"gmtModify":1703497711425,"author":{"id":"3581492791156392","authorId":"3581492791156392","name":"FantasyX","avatar":"https://static.tigerbbs.com/d5be60dde27e883d6f8b569b3afe2f3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/804038781","repostId":"2156192895","repostType":4,"repost":{"id":"2156192895","pubTimestamp":1627909020,"share":"https://www.laohu8.com/m/news/2156192895?lang=&edition=full","pubTime":"2021-08-02 20:57","market":"us","language":"en","title":"Can Last Year's Biggest Vaccine Stocks Crush the Market Again?","url":"https://stock-news.laohu8.com/highlight/detail?id=2156192895","media":"Motley Fool","summary":"These players delivered triple- and quadruple-digit gains.","content":"<blockquote>\n <b>These players delivered triple- and quadruple-digit gains.</b>\n</blockquote>\n<p><b>Key <a href=\"https://laohu8.com/S/PCOM\">Points</a></b></p>\n<ul>\n <li>Last year, most coronavirus vaccine stocks were high risk.</li>\n <li>Today, there are investment opportunities for aggressive investors and cautious investors.</li>\n</ul>\n<p>Coronavirus vaccine stocks were the biggest investment theme of 2020. Some players soared more than 1,000% as investors bet on their abilities to bring a billion-dollar product to market. That's as the S&amp;P 500 Index rose about 16%.</p>\n<p>Since, two biotech companies --<b>Moderna</b> (NASDAQ:MRNA) and&nbsp;<b><a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a></b> -- actually have commercialized their vaccines. And they are indeed generating billions of dollars in revenue. But what about some of the other vaccine stocks that scored big on the stock market last year? Let's take a look at where they're at with vaccine programs -- and whether they're on track to beat the market in the second half.</p>\n<p><img src=\"https://static.tigerbbs.com/4892523d64861e597e6e75e31fe85713\" tg-width=\"700\" tg-height=\"467\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: <a href=\"https://laohu8.com/S/GTY\">Getty</a> Images.</p>\n<p><b><a href=\"https://laohu8.com/S/NVAX\">Novavax</a></b></p>\n<p>The program:&nbsp;<b><a href=\"https://laohu8.com/S/NVAX\">Novavax</a></b>'s U.S. phase 3 trial of its vaccine candidate showed 90.4% overall efficacy. It demonstrated 100% efficacy in moderate and severe disease. The company fell behind in its submissions to regulators as it ramped up its manufacturing network. For instance, it's faced shortages of certain raw materials needed to produce the vaccine candidate. In May, Novavax said it would file for authorization in various locations worldwide -- including the U.S. -- in the third quarter. And Novavax predicts manufacturing will operate at full capacity as of the fourth quarter.</p>\n<p>The share price: The stock rose 90% in the first half. That's after soaring 2,700% last year.</p>\n<p>Are more share gains on the horizon? Novavax said in its latest earnings call that it expects to generate billions of dollars in revenue over the next four to six quarters. If Novavax wins vaccine authorization in the coming months, this could become a reality. The company already has orders to deliver 200 million doses to various countries. All of this could equal solid share performance in the second half.</p>\n<p><img src=\"https://static.tigerbbs.com/54a0fc748f5a7357128a290dd852b959\" tg-width=\"720\" tg-height=\"534\" referrerpolicy=\"no-referrer\"></p>\n<p>NVAX data by YCharts</p>\n<p><b>Vaxart</b></p>\n<p>The program:&nbsp;<b><a href=\"https://laohu8.com/S/VXRT\">Vaxart, Inc</a></b> seemed out of the race earlier in the year. The company's phase 1 trial showed its oral vaccine candidate didn't produce neutralizing antibodies. They are seen as key to preventing infection. But additional trial data demonstrated strength in producing killer T cell responses. This powerful immune system tool is another way to fight infection. Vaxart said it would launch a phase 2 study of its candidate mid-year. It will start a phase 1/2 study of a variant-specific candidate in the third quarter.</p>\n<p>The share price: Vaxart shares climbed 31% in the first half. That follows last year's 1,500% increase.</p>\n<p>Are more share gains on the horizon? Vaxart remains risky. Any negative news in the second half could be disastrous. Still, the idea of a vaccine in pill form could be a game-changer. If the company announces trial starts as planned, the shares may outperform the market in the coming months. And any positive data could offer a major boost.</p>\n<p><b><a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a></b></p>\n<p>The program: Moderna reported more than $1 billion in profit -- its first profit ever -- after <a href=\"https://laohu8.com/S/AONE.U\">one</a> full quarter of coronavirus vaccine sales. The company expects at least $19.2 billion in vaccine revenue this year. It's already won 2022 orders from countries including the U.S., Israel, and Switzerland. And the company predicts need for the vaccine could be greater next year than this year.</p>\n<p>The share price: Moderna shares rose about 125% in the first half -- and added more than 40% over the past month. That's after a 434% increase last year.</p>\n<p>Are more share gains on the horizon? Moderna is likely to beat the S&amp;P 500 in the second half if three key things happen: The company reports new contracts for 2022, successfully gains authorization for the use of its vaccine in teens, and gets the regulatory nod for a booster. I'm pretty optimistic about each.</p>\n<p><b><a href=\"https://laohu8.com/S/ARCT\">Arcturus Therapeutics Ltd.</a> </b></p>\n<p>The program:<b>Arcturus Therapeutics</b> (NASDAQ:ARCT) is testing its mRNA vaccine in a phase 2 study and plans on reporting data in the second half. The product could stand out from mRNA rivals<b><a href=\"https://laohu8.com/S/PFE\">Pfizer</a></b> and Moderna because it's freeze-dried and given in <a href=\"https://laohu8.com/S/AONE.U\">one</a> dose. The Pfizer and Moderna vaccines require cold storage and are given in two shots.</p>\n<p>The share price: Arcturus shares slipped 22% in the first half. Last year, they surged 299%.</p>\n<p>Is a share price recovery on the horizon? The above advantages sound great. But here's the problem: In a phase 1 study, Arcturus' candidate produced lower neutralizing antibody levels than the Pfizer and Moderna jabs. This translates into lower efficacy. If the next batch of data shows stronger results, the shares could climb. But if performance remains well below rivals, I wouldn't expect Arcturus to beat the S&amp;P 500 in the second half.</p>\n<p><img src=\"https://static.tigerbbs.com/cd5cf54e35734c9da8a1260f2c3436bc\" tg-width=\"720\" tg-height=\"534\" referrerpolicy=\"no-referrer\"></p>\n<p>NVAX data by YCharts</p>\n<p><b>Ocugen</b></p>\n<p>The program:&nbsp;<b>Ocugen</b> (NASDAQ:OCGN) in December announced it would partner with India's Bharat Biotech to co-commercialize its late-stage coronavirus vaccine in the U.S. More recently, the U.S. Food and Drug Administration advised Ocugen to pursue a traditional regulatory path rather than Emergency Use Authorization (EUA). Ocugen also gained rights to co-commercialize the candidate in Canada and has started a rolling submission there.</p>\n<p>The share price: Ocugen stock soared 338% in the first half. That's after climbing more than 251% last year (with almost all of that gain coming after the Bharat partnership announcement).</p>\n<p>Are more share gains on the horizon? Ocugen remains high risk. <a href=\"https://laohu8.com/S/ISBC\">Investors</a> were betting on big revenue from a possible EUA in the U.S. Now, revenue possibilities seem lower and farther off. The stock may continue to climb in the second half if Canada moves quickly on an authorization. But in my opinion, over the long term, the shares are like a house of cards. If U.S. approval doesn't happen or takes too long, they may collapse.</p>\n<p><b><a href=\"https://laohu8.com/S/INO\">Inovio Pharmaceuticals</a> </b></p>\n<p>The program: Earlier this year, the U.S. government dropped plans to fund<b><a href=\"https://laohu8.com/S/INO\">Inovio Pharmaceuticals</a></b>' (NASDAQ:INO) phase 3 trial. The government cited the rapid launch of other vaccines into the marketplace. As a result, Inovio said it would conduct phase 3 primarily outside of the U.S. The company aims to launch the trial with Chinese partner Advaccine Biopharmaceuticals Suzhou this summer. Inovio also is working on a next-generation \"pan-COVID\" vaccine candidate. It plans to start clinical testing on the candidate this year.</p>\n<p>The share price: Inovio added 4.8% in the first half. That's after climbing 168% last year.</p>\n<p>Are more share gains on the horizon? Inovio is another high-risk stock. Its initial candidate may have trouble carving out share in a market dominated by solid players. Most promising is the pan-COVID candidate. Especially considering the growth of variants. But we'll need clinical trial data to see if the potential product actually works. I would be surprised if Inovio beat the S&amp;P 500 in the second half of this year. The pan-COVID candidate makes Inovio a stock to watch -- but from a distance.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Can Last Year's Biggest Vaccine Stocks Crush the Market Again?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCan Last Year's Biggest Vaccine Stocks Crush the Market Again?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-02 20:57 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/02/can-these-big-vaccine-stocks-crush-market-again/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>These players delivered triple- and quadruple-digit gains.\n\nKey Points\n\nLast year, most coronavirus vaccine stocks were high risk.\nToday, there are investment opportunities for aggressive investors ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/02/can-these-big-vaccine-stocks-crush-market-again/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","NVAX":"诺瓦瓦克斯医药","BNTX":"BioNTech SE","VXRT":"Vaxart, Inc","PFE":"辉瑞","ARCT":"Arcturus Therapeutics Ltd.","INO":"伊诺维奥制药","OCGN":"Ocugen"},"source_url":"https://www.fool.com/investing/2021/08/02/can-these-big-vaccine-stocks-crush-market-again/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2156192895","content_text":"These players delivered triple- and quadruple-digit gains.\n\nKey Points\n\nLast year, most coronavirus vaccine stocks were high risk.\nToday, there are investment opportunities for aggressive investors and cautious investors.\n\nCoronavirus vaccine stocks were the biggest investment theme of 2020. Some players soared more than 1,000% as investors bet on their abilities to bring a billion-dollar product to market. That's as the S&P 500 Index rose about 16%.\nSince, two biotech companies --Moderna (NASDAQ:MRNA) and BioNTech SE -- actually have commercialized their vaccines. And they are indeed generating billions of dollars in revenue. But what about some of the other vaccine stocks that scored big on the stock market last year? Let's take a look at where they're at with vaccine programs -- and whether they're on track to beat the market in the second half.\n\nImage source: Getty Images.\nNovavax\nThe program: Novavax's U.S. phase 3 trial of its vaccine candidate showed 90.4% overall efficacy. It demonstrated 100% efficacy in moderate and severe disease. The company fell behind in its submissions to regulators as it ramped up its manufacturing network. For instance, it's faced shortages of certain raw materials needed to produce the vaccine candidate. In May, Novavax said it would file for authorization in various locations worldwide -- including the U.S. -- in the third quarter. And Novavax predicts manufacturing will operate at full capacity as of the fourth quarter.\nThe share price: The stock rose 90% in the first half. That's after soaring 2,700% last year.\nAre more share gains on the horizon? Novavax said in its latest earnings call that it expects to generate billions of dollars in revenue over the next four to six quarters. If Novavax wins vaccine authorization in the coming months, this could become a reality. The company already has orders to deliver 200 million doses to various countries. All of this could equal solid share performance in the second half.\n\nNVAX data by YCharts\nVaxart\nThe program: Vaxart, Inc seemed out of the race earlier in the year. The company's phase 1 trial showed its oral vaccine candidate didn't produce neutralizing antibodies. They are seen as key to preventing infection. But additional trial data demonstrated strength in producing killer T cell responses. This powerful immune system tool is another way to fight infection. Vaxart said it would launch a phase 2 study of its candidate mid-year. It will start a phase 1/2 study of a variant-specific candidate in the third quarter.\nThe share price: Vaxart shares climbed 31% in the first half. That follows last year's 1,500% increase.\nAre more share gains on the horizon? Vaxart remains risky. Any negative news in the second half could be disastrous. Still, the idea of a vaccine in pill form could be a game-changer. If the company announces trial starts as planned, the shares may outperform the market in the coming months. And any positive data could offer a major boost.\nModerna, Inc.\nThe program: Moderna reported more than $1 billion in profit -- its first profit ever -- after one full quarter of coronavirus vaccine sales. The company expects at least $19.2 billion in vaccine revenue this year. It's already won 2022 orders from countries including the U.S., Israel, and Switzerland. And the company predicts need for the vaccine could be greater next year than this year.\nThe share price: Moderna shares rose about 125% in the first half -- and added more than 40% over the past month. That's after a 434% increase last year.\nAre more share gains on the horizon? Moderna is likely to beat the S&P 500 in the second half if three key things happen: The company reports new contracts for 2022, successfully gains authorization for the use of its vaccine in teens, and gets the regulatory nod for a booster. I'm pretty optimistic about each.\nArcturus Therapeutics Ltd. \nThe program:Arcturus Therapeutics (NASDAQ:ARCT) is testing its mRNA vaccine in a phase 2 study and plans on reporting data in the second half. The product could stand out from mRNA rivalsPfizer and Moderna because it's freeze-dried and given in one dose. The Pfizer and Moderna vaccines require cold storage and are given in two shots.\nThe share price: Arcturus shares slipped 22% in the first half. Last year, they surged 299%.\nIs a share price recovery on the horizon? The above advantages sound great. But here's the problem: In a phase 1 study, Arcturus' candidate produced lower neutralizing antibody levels than the Pfizer and Moderna jabs. This translates into lower efficacy. If the next batch of data shows stronger results, the shares could climb. But if performance remains well below rivals, I wouldn't expect Arcturus to beat the S&P 500 in the second half.\n\nNVAX data by YCharts\nOcugen\nThe program: Ocugen (NASDAQ:OCGN) in December announced it would partner with India's Bharat Biotech to co-commercialize its late-stage coronavirus vaccine in the U.S. More recently, the U.S. Food and Drug Administration advised Ocugen to pursue a traditional regulatory path rather than Emergency Use Authorization (EUA). Ocugen also gained rights to co-commercialize the candidate in Canada and has started a rolling submission there.\nThe share price: Ocugen stock soared 338% in the first half. That's after climbing more than 251% last year (with almost all of that gain coming after the Bharat partnership announcement).\nAre more share gains on the horizon? Ocugen remains high risk. Investors were betting on big revenue from a possible EUA in the U.S. Now, revenue possibilities seem lower and farther off. The stock may continue to climb in the second half if Canada moves quickly on an authorization. But in my opinion, over the long term, the shares are like a house of cards. If U.S. approval doesn't happen or takes too long, they may collapse.\nInovio Pharmaceuticals \nThe program: Earlier this year, the U.S. government dropped plans to fundInovio Pharmaceuticals' (NASDAQ:INO) phase 3 trial. The government cited the rapid launch of other vaccines into the marketplace. As a result, Inovio said it would conduct phase 3 primarily outside of the U.S. The company aims to launch the trial with Chinese partner Advaccine Biopharmaceuticals Suzhou this summer. Inovio also is working on a next-generation \"pan-COVID\" vaccine candidate. It plans to start clinical testing on the candidate this year.\nThe share price: Inovio added 4.8% in the first half. That's after climbing 168% last year.\nAre more share gains on the horizon? Inovio is another high-risk stock. Its initial candidate may have trouble carving out share in a market dominated by solid players. Most promising is the pan-COVID candidate. Especially considering the growth of variants. But we'll need clinical trial data to see if the potential product actually works. I would be surprised if Inovio beat the S&P 500 in the second half of this year. The pan-COVID candidate makes Inovio a stock to watch -- but from a distance.","news_type":1},"isVote":1,"tweetType":1,"viewCount":115,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":834243983,"gmtCreate":1629809891742,"gmtModify":1676530138006,"author":{"id":"3581492791156392","authorId":"3581492791156392","name":"FantasyX","avatar":"https://static.tigerbbs.com/d5be60dde27e883d6f8b569b3afe2f3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/834243983","repostId":"1192610173","repostType":4,"repost":{"id":"1192610173","pubTimestamp":1629809650,"share":"https://www.laohu8.com/m/news/1192610173?lang=&edition=full","pubTime":"2021-08-24 20:54","market":"us","language":"en","title":"What Jackson Hole Could Mean For Apple Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=1192610173","media":"TheStreet","summary":"In late August, the markets could be rocked by monetary policy news coming from Jackson Hole, Wyomin","content":"<p>In late August, the markets could be rocked by monetary policy news coming from Jackson Hole, Wyoming. Here is what Apple stock investors should expect.</p>\n<p>The week of August 23 will likely prove to be an important one in the markets. Starting on Thursday, central bank leaders from around the world will meet virtually to talk about monetary policy during a traditional&nbsp;event&nbsp;often referred to simply as “Jackson Hole”.</p>\n<p>Today, the Apple Maven discusses how the upcoming meeting of central bankers could impact Apple stock’s&nbsp;performance in the last few trading sessions of August.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/fb09ec199963ac68c7742982748bf7a0\" tg-width=\"1200\" tg-height=\"800\" width=\"100%\" height=\"auto\"><span>Figure 1: Federal Reserve Chair Jerome Powell in a screen display at NYSE.</span></p>\n<p><b>The interest rate risk</b></p>\n<p>There seems to be a consensus that Federal Reserve chairman Jerome Powell will do little to “rock the boat” this week. Easing off on monetary stimulus is widely expected to occur over the next several months, but few seem confident that Mr. Powell will announce a change in policy as early as August.</p>\n<p>Still, the risk that the Fed will start to scale back its asset purchases later this year is real. Analysts will probably dissect Jerome Powell’s keynote speech, on Friday, in search for clues on the exact timing. Comments perceived to be hawkish could send yields higher – the 10-year treasury rate is only 1.3%.</p>\n<p>If recent history can serve as a guide,climbing yields tend to be bad news&nbsp;for growth stocks. Below are the main reasons why this is the case, as previously discussed on this channel:</p>\n<blockquote>\n “First, monetary tightening is a negative for consumption, everything else held constant. Second, a higher discount rate makes Apple’s far-out financial results less valuable in present value terms.”\n</blockquote>\n<p>For instance, the 10-year rate shot up from around 1% to nearly 1.5% in February alone. Probably not a coincidence, AAPL sank 8% that same month, while the value-rich Dow index managed to reach higher.</p>\n<p><b>Brace for possible volatility</b></p>\n<p>Regardless of which way the stock market may head following the Jackson Hole symposium, volatility could rise as August comes to a close. This is the case because speculation, both on the bullish and bearish sides of the argument, tends to increase around important events like this.</p>\n<p>Volatility is both good and bad news for Apple stock. Market jitters can be uncomfortable for many investors, and some might be tempted to sell or trim their positions after a selloff. On the other hand, a possible pullback that is unrelated to the company’s fundamentals could open an opportunity to buy AAPL on weakness.</p>\n<p>This is precisely what happened in mid-June, following an important Federal Reserve meeting that the market perceived as hawkish. Those&nbsp;who bought AAPL at those levels, a move defended by the Apple Maven, saw the value of their investment rise by 14% in a matter of only about 10 weeks.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>What Jackson Hole Could Mean For Apple Stock</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhat Jackson Hole Could Mean For Apple Stock\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-24 20:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/apple/news/what-jackson-hole-could-mean-for-apple-stock><strong>TheStreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>In late August, the markets could be rocked by monetary policy news coming from Jackson Hole, Wyoming. Here is what Apple stock investors should expect.\nThe week of August 23 will likely prove to be ...</p>\n\n<a href=\"https://www.thestreet.com/apple/news/what-jackson-hole-could-mean-for-apple-stock\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.thestreet.com/apple/news/what-jackson-hole-could-mean-for-apple-stock","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1192610173","content_text":"In late August, the markets could be rocked by monetary policy news coming from Jackson Hole, Wyoming. Here is what Apple stock investors should expect.\nThe week of August 23 will likely prove to be an important one in the markets. Starting on Thursday, central bank leaders from around the world will meet virtually to talk about monetary policy during a traditional event often referred to simply as “Jackson Hole”.\nToday, the Apple Maven discusses how the upcoming meeting of central bankers could impact Apple stock’s performance in the last few trading sessions of August.\nFigure 1: Federal Reserve Chair Jerome Powell in a screen display at NYSE.\nThe interest rate risk\nThere seems to be a consensus that Federal Reserve chairman Jerome Powell will do little to “rock the boat” this week. Easing off on monetary stimulus is widely expected to occur over the next several months, but few seem confident that Mr. Powell will announce a change in policy as early as August.\nStill, the risk that the Fed will start to scale back its asset purchases later this year is real. Analysts will probably dissect Jerome Powell’s keynote speech, on Friday, in search for clues on the exact timing. Comments perceived to be hawkish could send yields higher – the 10-year treasury rate is only 1.3%.\nIf recent history can serve as a guide,climbing yields tend to be bad news for growth stocks. Below are the main reasons why this is the case, as previously discussed on this channel:\n\n “First, monetary tightening is a negative for consumption, everything else held constant. Second, a higher discount rate makes Apple’s far-out financial results less valuable in present value terms.”\n\nFor instance, the 10-year rate shot up from around 1% to nearly 1.5% in February alone. Probably not a coincidence, AAPL sank 8% that same month, while the value-rich Dow index managed to reach higher.\nBrace for possible volatility\nRegardless of which way the stock market may head following the Jackson Hole symposium, volatility could rise as August comes to a close. This is the case because speculation, both on the bullish and bearish sides of the argument, tends to increase around important events like this.\nVolatility is both good and bad news for Apple stock. Market jitters can be uncomfortable for many investors, and some might be tempted to sell or trim their positions after a selloff. On the other hand, a possible pullback that is unrelated to the company’s fundamentals could open an opportunity to buy AAPL on weakness.\nThis is precisely what happened in mid-June, following an important Federal Reserve meeting that the market perceived as hawkish. Those who bought AAPL at those levels, a move defended by the Apple Maven, saw the value of their investment rise by 14% in a matter of only about 10 weeks.","news_type":1},"isVote":1,"tweetType":1,"viewCount":96,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":890361126,"gmtCreate":1628084077765,"gmtModify":1703500886221,"author":{"id":"3581492791156392","authorId":"3581492791156392","name":"FantasyX","avatar":"https://static.tigerbbs.com/d5be60dde27e883d6f8b569b3afe2f3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/890361126","repostId":"2156909108","repostType":4,"repost":{"id":"2156909108","pubTimestamp":1628082780,"share":"https://www.laohu8.com/m/news/2156909108?lang=&edition=full","pubTime":"2021-08-04 21:13","market":"us","language":"en","title":"Can You Retire a Millionaire With ETFs Alone?","url":"https://stock-news.laohu8.com/highlight/detail?id=2156909108","media":"Motley Fool","summary":"ETFs can make you a millionaire, but you have to follow some investment rules to get there.","content":"<p>You can enjoy the retirement of your dreams using exchange-traded funds instead of some complex investing strategy -- but there are a few catches. Reaching $1 million in your investment account isn't easy; that's why most people don't do it. Still, there are some key steps you can follow that don't involve stock picking, high risk, or any advanced trading techniques. There's no guarantee you'll get there as life throws its hurdles at you, but some core rules will lay the groundwork for plenty of long-term growth.</p>\n<h3>How to accumulate $1 million</h3>\n<p>The equation to reach $1 million is simple from a numbers standpoint. Make money, save a fraction of it, and invest those savings for growth. The complications arise in strategy and execution.</p>\n<p>If you can save $500 each month, and you invest those savings to achieve an 8% average annual growth rate, then you'll have accumulated $1 million after 35 years. The<b> S&amp;P 500</b> long-term rate of return is around 10%, so that piece of the plan isn't far-fetched. Instead, this process can get thrown off the rails by inconsistent stock performance or shifting investment goals.</p>\n<p>In real life, you probably won't be able to save the same amount every single month. Not every family can set aside $500 every month. Young families with new children, new mortgages, and other monthly bills usually have to navigate those challenges before they reach their peak earning potential. Unexpected expenses and income disruptions also pop up along the way, and there will be times that you simply can't save.</p>\n<p>On top of all that, most people have to start monitoring volatility as they approach retirement. If you're hit by a market crash too close to the day you stop working, then your 401(k) might not have time to recover. As a result, most people increase their bond allocation as they approach retirement. This is a smart move, but it also limits your growth potential. Suddenly that 8% rate of return isn't as easy to achieve across your entire portfolio.</p>\n<p>As a result, it's important to take full advantage of responsible growth opportunities throughout your investing lifetime. Growth stocks have been a great source of wealth creation for countless investors, but they can be risky and difficult to manage. For many people, growth-focused ETFs are a perfect solution.</p>\n<p><img src=\"https://static.tigerbbs.com/bf6d6e37e27339f7facea56dd3d06885\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Image source: Getty Images.</p>\n<h3>The best ETFs for building wealth</h3>\n<p>The returns provided by index funds are fine for most investors, but you don't have to settle for those growth rates. There are numerous ETFs that have outpaced the S&amp;P 500 over the long term, but they still provide enough diversification to reduce risk and volatility in a way that you can't achieve with individual stocks.</p>\n<p>The <b>Vanguard Growth ETF</b> (NYSEMKT:VUG) is probably the most popular growth-focused ETF, with nearly $83 billion in assets under management. The Vanguard Growth fund offers excellent liquidity and razor-thin expense margins, which are both great for investors. It provides efficient exposure to nearly 300 different large-cap companies with more growth upside than the S&amp;P 500. It's outpaced the market by almost 200 percentage points since 2007, rewarding investors who are willing to take on the higher volatility inherent in growth stock investing. Don't be shocked if this fund gets rocked harder during bear markets, owing to heavy concentration in tech stocks and companies with aggressive valuations.</p>\n<p>The <b>Invesco S&amp;P 500 Equal Weight Technology ETF</b> (NYSEMKT:RYT) is an alternative with a different approach. This fund holds 75 tech stocks from the S&amp;P 500 index, but no single holding makes up more than 2% of the total allocation. This keeps huge companies like <b>Apple</b>, <b>Microsoft</b>, <b>Amazon</b>, and <b>Alphabet</b> from dominating its performance. The result is serious long-term growth. The ETF has returned nearly 600% since launching in 2007, more than 70 percentage points ahead of the Vanguard Growth ETF. Investors have to pay up for the privilege, though -- the 0.4% expense ratio is high compared to most index funds, but it's justified that cost over the long term.</p>\n<p>The <b>Invesco S&amp;P 500 Equal Weight Health Care ETF</b> (NYSEMKT:RYH) is nearly identical, but it holds more than 60 healthcare stocks. Its mixture of device makers, pharmaceutical stocks, biotechs, and care providers has propelled well beyond the S&amp;P 500 since the fund's launch, and it provides a different flavor than most of the other growth ETFs.</p>\n<p><img src=\"https://static.tigerbbs.com/cea9483966e6aa6aa7ca3e22183a1861\" tg-width=\"720\" tg-height=\"387\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>VUG Total Return Level data by YCharts</p>\n<p>There's a huge list of growth ETFs that will provide more than enough growth to achieve millionaire status, but you have to get the fundamentals right to take advantage of the opportunity.</p>\n<p>Retiring a millionaire requires some combination of a solid household income, a high savings rate, and investment growth -- most likely a combination of all three. There's no magic investment strategy that can make up for insufficient savings. Most people aren't successful stock-pickers over the long term, so they'll turn elsewhere to accomplish their goals. If you're doing the hard work to save enough each month, then there are great ETFs available that are more than good enough to make you a millionaire.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Can You Retire a Millionaire With ETFs Alone?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCan You Retire a Millionaire With ETFs Alone?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-04 21:13 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/04/can-you-retire-a-millionaire-with-etfs-alone/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>You can enjoy the retirement of your dreams using exchange-traded funds instead of some complex investing strategy -- but there are a few catches. Reaching $1 million in your investment account isn't ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/04/can-you-retire-a-millionaire-with-etfs-alone/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","SPXU":"三倍做空标普500ETF","OEF":"标普100指数ETF-iShares","SDS":"两倍做空标普500ETF","IVV":"标普500指数ETF","UPRO":"三倍做多标普500ETF","SSO":"两倍做多标普500ETF",".SPX":"S&P 500 Index","SPY":"标普500ETF","OEX":"标普100","SH":"标普500反向ETF"},"source_url":"https://www.fool.com/investing/2021/08/04/can-you-retire-a-millionaire-with-etfs-alone/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2156909108","content_text":"You can enjoy the retirement of your dreams using exchange-traded funds instead of some complex investing strategy -- but there are a few catches. Reaching $1 million in your investment account isn't easy; that's why most people don't do it. Still, there are some key steps you can follow that don't involve stock picking, high risk, or any advanced trading techniques. There's no guarantee you'll get there as life throws its hurdles at you, but some core rules will lay the groundwork for plenty of long-term growth.\nHow to accumulate $1 million\nThe equation to reach $1 million is simple from a numbers standpoint. Make money, save a fraction of it, and invest those savings for growth. The complications arise in strategy and execution.\nIf you can save $500 each month, and you invest those savings to achieve an 8% average annual growth rate, then you'll have accumulated $1 million after 35 years. The S&P 500 long-term rate of return is around 10%, so that piece of the plan isn't far-fetched. Instead, this process can get thrown off the rails by inconsistent stock performance or shifting investment goals.\nIn real life, you probably won't be able to save the same amount every single month. Not every family can set aside $500 every month. Young families with new children, new mortgages, and other monthly bills usually have to navigate those challenges before they reach their peak earning potential. Unexpected expenses and income disruptions also pop up along the way, and there will be times that you simply can't save.\nOn top of all that, most people have to start monitoring volatility as they approach retirement. If you're hit by a market crash too close to the day you stop working, then your 401(k) might not have time to recover. As a result, most people increase their bond allocation as they approach retirement. This is a smart move, but it also limits your growth potential. Suddenly that 8% rate of return isn't as easy to achieve across your entire portfolio.\nAs a result, it's important to take full advantage of responsible growth opportunities throughout your investing lifetime. Growth stocks have been a great source of wealth creation for countless investors, but they can be risky and difficult to manage. For many people, growth-focused ETFs are a perfect solution.\n\nImage source: Getty Images.\nThe best ETFs for building wealth\nThe returns provided by index funds are fine for most investors, but you don't have to settle for those growth rates. There are numerous ETFs that have outpaced the S&P 500 over the long term, but they still provide enough diversification to reduce risk and volatility in a way that you can't achieve with individual stocks.\nThe Vanguard Growth ETF (NYSEMKT:VUG) is probably the most popular growth-focused ETF, with nearly $83 billion in assets under management. The Vanguard Growth fund offers excellent liquidity and razor-thin expense margins, which are both great for investors. It provides efficient exposure to nearly 300 different large-cap companies with more growth upside than the S&P 500. It's outpaced the market by almost 200 percentage points since 2007, rewarding investors who are willing to take on the higher volatility inherent in growth stock investing. Don't be shocked if this fund gets rocked harder during bear markets, owing to heavy concentration in tech stocks and companies with aggressive valuations.\nThe Invesco S&P 500 Equal Weight Technology ETF (NYSEMKT:RYT) is an alternative with a different approach. This fund holds 75 tech stocks from the S&P 500 index, but no single holding makes up more than 2% of the total allocation. This keeps huge companies like Apple, Microsoft, Amazon, and Alphabet from dominating its performance. The result is serious long-term growth. The ETF has returned nearly 600% since launching in 2007, more than 70 percentage points ahead of the Vanguard Growth ETF. Investors have to pay up for the privilege, though -- the 0.4% expense ratio is high compared to most index funds, but it's justified that cost over the long term.\nThe Invesco S&P 500 Equal Weight Health Care ETF (NYSEMKT:RYH) is nearly identical, but it holds more than 60 healthcare stocks. Its mixture of device makers, pharmaceutical stocks, biotechs, and care providers has propelled well beyond the S&P 500 since the fund's launch, and it provides a different flavor than most of the other growth ETFs.\n\nVUG Total Return Level data by YCharts\nThere's a huge list of growth ETFs that will provide more than enough growth to achieve millionaire status, but you have to get the fundamentals right to take advantage of the opportunity.\nRetiring a millionaire requires some combination of a solid household income, a high savings rate, and investment growth -- most likely a combination of all three. There's no magic investment strategy that can make up for insufficient savings. Most people aren't successful stock-pickers over the long term, so they'll turn elsewhere to accomplish their goals. If you're doing the hard work to save enough each month, then there are great ETFs available that are more than good enough to make you a millionaire.","news_type":1},"isVote":1,"tweetType":1,"viewCount":121,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":809845655,"gmtCreate":1627361040877,"gmtModify":1703488378395,"author":{"id":"3581492791156392","authorId":"3581492791156392","name":"FantasyX","avatar":"https://static.tigerbbs.com/d5be60dde27e883d6f8b569b3afe2f3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Wiw","listText":"Wiw","text":"Wiw","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/809845655","repostId":"1162276557","repostType":4,"repost":{"id":"1162276557","pubTimestamp":1627354107,"share":"https://www.laohu8.com/m/news/1162276557?lang=&edition=full","pubTime":"2021-07-27 10:48","market":"us","language":"en","title":"Stock Split Watch: Is Amazon Next?","url":"https://stock-news.laohu8.com/highlight/detail?id=1162276557","media":"Motley Fool","summary":"Key Points\n\nAmazon reports earnings on Thursday, making that an ideal time to announce a stock split","content":"<p>Key Points</p>\n<ul>\n <li>Amazon reports earnings on Thursday, making that an ideal time to announce a stock split.</li>\n <li>There are only three other U.S.-exchange-listed stocks trading at higher price points than Amazon.</li>\n <li>This will be new CEO Andy Jassy's first earnings call as the e-commerce giant's helmsman. A stock split would be a great way to set himself apart from Jeffrey Bezos.</li>\n</ul>\n<p>The chatter calling for&nbsp;<b>Amazon.com</b>&nbsp;(NASDAQ:AMZN)to execute a stock split is diminishing, but that's surprising. The stock continues to rise, making thearguments for a lower share pricevia a split all the more tantalizing.</p>\n<p>There are also a couple of good reasons why Amazon should announce a stock split as soon as later this week. You might think these bookkeeping moves are silly zero-sum games, and that's fair. However, a lot of other market watchers see an Amazon split as the key to attracting even more retail investors while also making life easier for options traders. Let's see why Amazon could be the next major stock to declare a stock split.</p>\n<p><b>Amazon is rocking</b></p>\n<p>It's good to be Amazon. The e-tail king was doing just fine before the pandemic shifted e-commerce into an even higher gear. The38% increase in net salesthat Amazon posted last year was its heartiest top-line gain in nine years.</p>\n<p>Things aren't slowing down in 2021. Revenuesoared 44%during the first three months of this year.</p>\n<p>Investors are paying attention. Amazon held up better than most growth stocks during the correction earlier this year. It enters this trading week within 3% of the all-time high it hit two weeks ago.</p>\n<p>There are only three U.S.-exchange-listed stocks trading at higher price points than the roughly $3,700 that Amazon is fetching as of Monday morning. Amazon's market cap is more than double those of the three higher-priced stocks combined. It's time for a stock split.</p>\n<p><b>The clock is rolling</b></p>\n<p>Amazon reports its second-quarter results after market close on Thursday. Stock splits are often announced during an earnings release, whether the report itself is positive or negative.</p>\n<p>Adding to the likelihood of a stock split is that CEO Jeff Bezos officially stepped down as CEO earlier this month. If new CEO Andy Jassy wants to break the mold, there is no easier move than declaring the stock split that Bezos never cared to execute.</p>\n<p>A stock split is a zero-sum game. A single share of Amazon at $3,700 would be the same thing as 50 shares at $74. However, it's not easy to trade options on a $3,700 stock. We're not just talking about throwing speculators a bone, as there are plenty of conservative risk-management tools available for long-term Amazon investors through the options market.</p>\n<p>Stock splits may not seem to matter as much as they did just a few years ago. Investors can buy fractional shares through a growing number of brokers. Zero-commission trading makes it easier than ever to buy a couple of shares at a time. However, there is still a natural attraction to low stock prices.</p>\n<p>A lower stock price would also make Amazon a no-brainer addition to the Dow Jones Industrial Average the next time the archaic but still relevant index shakes up its 30 members. In short, you don't have to be a fan ofstock splitsto see how an increase in retail and possibly institutional ownership can make Amazon even more valuable.</p>\n<p>Your legacy begins now, Jassy. A stock split makes more sense than you probably think.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Split Watch: Is Amazon Next?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Split Watch: Is Amazon Next?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-27 10:48 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/07/26/stock-split-watch-is-amazon-next/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Key Points\n\nAmazon reports earnings on Thursday, making that an ideal time to announce a stock split.\nThere are only three other U.S.-exchange-listed stocks trading at higher price points than Amazon....</p>\n\n<a href=\"https://www.fool.com/investing/2021/07/26/stock-split-watch-is-amazon-next/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊"},"source_url":"https://www.fool.com/investing/2021/07/26/stock-split-watch-is-amazon-next/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1162276557","content_text":"Key Points\n\nAmazon reports earnings on Thursday, making that an ideal time to announce a stock split.\nThere are only three other U.S.-exchange-listed stocks trading at higher price points than Amazon.\nThis will be new CEO Andy Jassy's first earnings call as the e-commerce giant's helmsman. A stock split would be a great way to set himself apart from Jeffrey Bezos.\n\nThe chatter calling for Amazon.com (NASDAQ:AMZN)to execute a stock split is diminishing, but that's surprising. The stock continues to rise, making thearguments for a lower share pricevia a split all the more tantalizing.\nThere are also a couple of good reasons why Amazon should announce a stock split as soon as later this week. You might think these bookkeeping moves are silly zero-sum games, and that's fair. However, a lot of other market watchers see an Amazon split as the key to attracting even more retail investors while also making life easier for options traders. Let's see why Amazon could be the next major stock to declare a stock split.\nAmazon is rocking\nIt's good to be Amazon. The e-tail king was doing just fine before the pandemic shifted e-commerce into an even higher gear. The38% increase in net salesthat Amazon posted last year was its heartiest top-line gain in nine years.\nThings aren't slowing down in 2021. Revenuesoared 44%during the first three months of this year.\nInvestors are paying attention. Amazon held up better than most growth stocks during the correction earlier this year. It enters this trading week within 3% of the all-time high it hit two weeks ago.\nThere are only three U.S.-exchange-listed stocks trading at higher price points than the roughly $3,700 that Amazon is fetching as of Monday morning. Amazon's market cap is more than double those of the three higher-priced stocks combined. It's time for a stock split.\nThe clock is rolling\nAmazon reports its second-quarter results after market close on Thursday. Stock splits are often announced during an earnings release, whether the report itself is positive or negative.\nAdding to the likelihood of a stock split is that CEO Jeff Bezos officially stepped down as CEO earlier this month. If new CEO Andy Jassy wants to break the mold, there is no easier move than declaring the stock split that Bezos never cared to execute.\nA stock split is a zero-sum game. A single share of Amazon at $3,700 would be the same thing as 50 shares at $74. However, it's not easy to trade options on a $3,700 stock. We're not just talking about throwing speculators a bone, as there are plenty of conservative risk-management tools available for long-term Amazon investors through the options market.\nStock splits may not seem to matter as much as they did just a few years ago. Investors can buy fractional shares through a growing number of brokers. Zero-commission trading makes it easier than ever to buy a couple of shares at a time. However, there is still a natural attraction to low stock prices.\nA lower stock price would also make Amazon a no-brainer addition to the Dow Jones Industrial Average the next time the archaic but still relevant index shakes up its 30 members. In short, you don't have to be a fan ofstock splitsto see how an increase in retail and possibly institutional ownership can make Amazon even more valuable.\nYour legacy begins now, Jassy. A stock split makes more sense than you probably think.","news_type":1},"isVote":1,"tweetType":1,"viewCount":41,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":175434967,"gmtCreate":1627045865659,"gmtModify":1703483162753,"author":{"id":"3581492791156392","authorId":"3581492791156392","name":"FantasyX","avatar":"https://static.tigerbbs.com/d5be60dde27e883d6f8b569b3afe2f3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/175434967","repostId":"2153983451","repostType":4,"repost":{"id":"2153983451","pubTimestamp":1627045260,"share":"https://www.laohu8.com/m/news/2153983451?lang=&edition=full","pubTime":"2021-07-23 21:01","market":"us","language":"en","title":"Is It Too Late to Buy Moderna Stock?","url":"https://stock-news.laohu8.com/highlight/detail?id=2153983451","media":"Motley Fool","summary":"Past performance isn't necessarily indicative of future success -- but in this case it might just be.","content":"<p>If you had invested $100,000 in <b><a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a></b> in early 2020, you would have well over $1,500,000 today, as shares of the biotech have skyrocketed thanks to its successful development of a vaccine for COVID-19. Any investor would be proud of such returns, particularly given the relatively short period it took the vaccine maker to accomplish this feat.</p>\n<p>But that raises an interesting question: After crushing the broader market over the past year and a half, how much upside does Moderna have left? Is it too late to get in on this high-flying biotech? Let's look into Moderna's prospects, both within the coronavirus market and beyond, to determine whether it is still worth purchasing its shares.</p>\n<p><img src=\"https://static.tigerbbs.com/c956dab14bf4026173f313850104ad4c\" tg-width=\"720\" tg-height=\"387\" referrerpolicy=\"no-referrer\"></p>\n<p>^SPX data by YCharts</p>\n<h3>Is the coronavirus vaccine tailwind over?</h3>\n<p>According to the U.S. Centers for Disease Control and Prevention (CDC), as of July 21, 161.9 million people in the U.S. have been fully vaccinated against COVID-19. Many more have received vaccines elsewhere in the world. The two leaders in this space -- Moderna and <b><a href=\"https://laohu8.com/S/PFE\">Pfizer</a></b> -- have both reported that their respective vaccines are still effective after six months.</p>\n<p>There is evidence that Moderna's vaccine, mRNA-1273, is also potent against newer variants of the SARS-CoV-2 virus that causes the disease, including the delta variant that is now responsible for over 80% of new cases in the U.S. One could conclude from these facts that Moderna won't benefit a whole lot more from mRNA-1273.&nbsp;After all, the company's shares have already skyrocketed, and with the number of vaccinated people rising, how much can the biotech continue to profit from its success in this market?</p>\n<p>However, there are good reasons to think Moderna's coronavirus vaccine-related tailwind isn't over. <a href=\"https://laohu8.com/S/FBNC\">First</a>, Moderna continues to seek (and earn) regulatory wins, both in the U.S. and abroad. Back in June, the company applied for an Emergency Use Authorization (EUA) to the U.S. Food and Drug Administration (FDA) for its vaccine to be administered to adolescents between the ages of 12 and 18. Moderna submitted a similar application to regulatory authorities in Switzerland last month, and the company's vaccine recently earned an EUA in India.</p>\n<p><img src=\"https://static.tigerbbs.com/6745743754cc8a567a6c76661e415ed8\" tg-width=\"700\" tg-height=\"393\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: <a href=\"https://laohu8.com/S/GTY\">Getty</a> Images.</p>\n<p>Second, the biotech continues to sign new supply deals for mRNA-1273. Moderna announced a supply agreement with the government of Argentina on June 12 for 20 million doses of mRNA-1273, while both the U.S. government and the European Commission have purchased millions of additional doses of the vaccine.</p>\n<p>Finally, and perhaps most importantly, it still isn't clear how long mRNA-1273 provides immunity. During Moderna's first-quarter earnings conference call, CEO Stéphane Bancel said: \"we believe booster shots will be needed as we believe that the virus is not going away. We also believe from the scientific standpoint, that the highest efficacy booster over time will be provided by multivalent variant-specific booster.\"</p>\n<p>Moderna started evaluating booster candidates for its vaccine earlier this year.&nbsp;Meanwhile, Pfizer's CEO Albert Bourla has said that he believes demand for COVID-19 vaccines could become seasonal, much like the demand for flu vaccines.&nbsp;Of course, none of this is set in stone. The CDC and the FDA released a joint statement on July 8 saying that vaccinated Americans do not need booster shots right now.</p>\n<p>That may be true at the moment, but data from Pfizer has already strongly suggested that a booster dose administered six months post-vaccination produces higher antibodies titers in patients. This is important -- while Pfizer's vaccine remains effective after six months, its efficacy does seem to decrease.</p>\n<p>And with new variants like delta emerging, there are good reasons to think that a booster dose will eventually be needed for vaccinated people. Given these factors, it seems highly likely that Moderna will continue to benefit from its coronavirus vaccine financially, and its shares could still experience significant upside as a result.</p>\n<h3>What else does Moderna have to offer?</h3>\n<p>Beyond COVID-19, Moderna's mRNA vaccine platform shows huge potential. The company's pipeline currently boasts more than a dozen programs, most of which are potential vaccines against various infectious illnesses.&nbsp;In early July, the biotech started a phase 1/2 clinical trial for mRNA-1010, an investigational flu vaccine.</p>\n<p>The company argues that despite the wide availability of approved vaccines for the flu, this disease continues to cause serious health problems, in part because current vaccines are only 40% to 60% effective. Moderna is also looking to develop combination vaccines -- that is, vaccines that can confer immunity against more than <a href=\"https://laohu8.com/S/AONE.U\">one</a> disease.</p>\n<p>There is no doubt the long-term opportunity is there for the company. As Moderna argues, of the more than 80 viruses discovered in the past 40 years, only 4% have commercially available vaccines in the U.S. The company thinks its mRNA approach to vaccination could help it create a raft of effective vaccines against some of these viruses.</p>\n<h3>Not too late to get in</h3>\n<p>There are two important reasons why it's not too late to buy shares of Moderna. <a href=\"https://laohu8.com/S/FFBC\">First</a>, the company will continue to benefit from its COVID-19 vaccine. Second, the biotech's long-term thesis (supported by the success of mRNA-1273) is attractive. Moderna is currently trading at just 12.5 times forward earnings, which, in my view, is more than fair given the company's prospects. <a href=\"https://laohu8.com/S/ISBC\">Investors</a> looking for solid biotech stocks to buy need look no further than Moderna.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is It Too Late to Buy Moderna Stock?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs It Too Late to Buy Moderna Stock?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-23 21:01 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/07/23/is-it-too-late-to-buy-moderna-stock/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>If you had invested $100,000 in Moderna, Inc. in early 2020, you would have well over $1,500,000 today, as shares of the biotech have skyrocketed thanks to its successful development of a vaccine for ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/07/23/is-it-too-late-to-buy-moderna-stock/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://www.fool.com/investing/2021/07/23/is-it-too-late-to-buy-moderna-stock/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2153983451","content_text":"If you had invested $100,000 in Moderna, Inc. in early 2020, you would have well over $1,500,000 today, as shares of the biotech have skyrocketed thanks to its successful development of a vaccine for COVID-19. Any investor would be proud of such returns, particularly given the relatively short period it took the vaccine maker to accomplish this feat.\nBut that raises an interesting question: After crushing the broader market over the past year and a half, how much upside does Moderna have left? Is it too late to get in on this high-flying biotech? Let's look into Moderna's prospects, both within the coronavirus market and beyond, to determine whether it is still worth purchasing its shares.\n\n^SPX data by YCharts\nIs the coronavirus vaccine tailwind over?\nAccording to the U.S. Centers for Disease Control and Prevention (CDC), as of July 21, 161.9 million people in the U.S. have been fully vaccinated against COVID-19. Many more have received vaccines elsewhere in the world. The two leaders in this space -- Moderna and Pfizer -- have both reported that their respective vaccines are still effective after six months.\nThere is evidence that Moderna's vaccine, mRNA-1273, is also potent against newer variants of the SARS-CoV-2 virus that causes the disease, including the delta variant that is now responsible for over 80% of new cases in the U.S. One could conclude from these facts that Moderna won't benefit a whole lot more from mRNA-1273. After all, the company's shares have already skyrocketed, and with the number of vaccinated people rising, how much can the biotech continue to profit from its success in this market?\nHowever, there are good reasons to think Moderna's coronavirus vaccine-related tailwind isn't over. First, Moderna continues to seek (and earn) regulatory wins, both in the U.S. and abroad. Back in June, the company applied for an Emergency Use Authorization (EUA) to the U.S. Food and Drug Administration (FDA) for its vaccine to be administered to adolescents between the ages of 12 and 18. Moderna submitted a similar application to regulatory authorities in Switzerland last month, and the company's vaccine recently earned an EUA in India.\n\nImage source: Getty Images.\nSecond, the biotech continues to sign new supply deals for mRNA-1273. Moderna announced a supply agreement with the government of Argentina on June 12 for 20 million doses of mRNA-1273, while both the U.S. government and the European Commission have purchased millions of additional doses of the vaccine.\nFinally, and perhaps most importantly, it still isn't clear how long mRNA-1273 provides immunity. During Moderna's first-quarter earnings conference call, CEO Stéphane Bancel said: \"we believe booster shots will be needed as we believe that the virus is not going away. We also believe from the scientific standpoint, that the highest efficacy booster over time will be provided by multivalent variant-specific booster.\"\nModerna started evaluating booster candidates for its vaccine earlier this year. Meanwhile, Pfizer's CEO Albert Bourla has said that he believes demand for COVID-19 vaccines could become seasonal, much like the demand for flu vaccines. Of course, none of this is set in stone. The CDC and the FDA released a joint statement on July 8 saying that vaccinated Americans do not need booster shots right now.\nThat may be true at the moment, but data from Pfizer has already strongly suggested that a booster dose administered six months post-vaccination produces higher antibodies titers in patients. This is important -- while Pfizer's vaccine remains effective after six months, its efficacy does seem to decrease.\nAnd with new variants like delta emerging, there are good reasons to think that a booster dose will eventually be needed for vaccinated people. Given these factors, it seems highly likely that Moderna will continue to benefit from its coronavirus vaccine financially, and its shares could still experience significant upside as a result.\nWhat else does Moderna have to offer?\nBeyond COVID-19, Moderna's mRNA vaccine platform shows huge potential. The company's pipeline currently boasts more than a dozen programs, most of which are potential vaccines against various infectious illnesses. In early July, the biotech started a phase 1/2 clinical trial for mRNA-1010, an investigational flu vaccine.\nThe company argues that despite the wide availability of approved vaccines for the flu, this disease continues to cause serious health problems, in part because current vaccines are only 40% to 60% effective. Moderna is also looking to develop combination vaccines -- that is, vaccines that can confer immunity against more than one disease.\nThere is no doubt the long-term opportunity is there for the company. As Moderna argues, of the more than 80 viruses discovered in the past 40 years, only 4% have commercially available vaccines in the U.S. The company thinks its mRNA approach to vaccination could help it create a raft of effective vaccines against some of these viruses.\nNot too late to get in\nThere are two important reasons why it's not too late to buy shares of Moderna. First, the company will continue to benefit from its COVID-19 vaccine. Second, the biotech's long-term thesis (supported by the success of mRNA-1273) is attractive. Moderna is currently trading at just 12.5 times forward earnings, which, in my view, is more than fair given the company's prospects. Investors looking for solid biotech stocks to buy need look no further than Moderna.","news_type":1},"isVote":1,"tweetType":1,"viewCount":228,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}